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Abstract 
The prospects for successful peripheral nerve repair using fibre guides are considered 
to be enhanced by use of a scaffold material which provides a good substrate for 
attachment and growth of glial cells and regenerating neurons. Alginate polymers 
exhibit a highly favourable balance of properties and exhibit the unique property of 
forming hydrogels under mild crosslinking conditions. As a result alginate has been 
widely applied for cell encapsulation. However the polysaccharide exhibits extremely 
poor cell adhesion properties, which limits its application for tissue regeneration.    
 
Alginate fibres were modified by gelatin a) to improve cell adhesion b) to investigate 
the potential for polypeptide growth factor incorporation in the fibres and c) to 
provide a method for macropore production by extraction of the gelatin particles from 
the fibres (Chapter 2). Incubation of hydrated alginate fibres in 0.5% w/w gelatin 
solution at 37 
o
C resulted in low protein loading (1.7% w/w) and rapid release of 
gelatin (90% of the initial load) over 24 h in distilled water at 37 
o
C. In comparison, 
incubation of hydrated alginate fibres in 5% w/v gelatin solution resulted in 
approximately 9% w/w protein loading and gradual protein release (80% of initial 
content) over 9 days. Alginate fibres incorporating gelatin particles were successfully 
produced by wet spinning suspensions of gelatin particles in 1.5% (w/v) alginate 
solution. Gelatin loading of the starting suspension of 40.0, 57.0 and 62.5% w/w 
resulted in gelatin loading of the hydrated alginate fibres of 16, 21 and 24% w/w 
respectively. Around 45 – 60% of the gelatin content of hydrated fibres was released 
in 1 h in distilled water at 37 
o
C, suggesting that a macromolecular structure for cell 
growth would be rapidly established in cell culture. Furthermore, the residual gelatin 
is expected to form a favourable surface for nerve cell adhesion and axonal extension. 
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The production of macroporous alginate fibres for cell encapsulation (Chapter 3) was 
achieved by wet spinning suspensions of gelatin particles in alginate solution into 
CaCl2 crosslinking solution, followed by protein extraction in distilled water.  
Confocal laser scanning microscopy (CLSM) and image analysis provided detailed 
qualitative and quantitative information on pore size and size distribution. CLSM and 
image analysis also provided measurements of the connectivity of macropores within 
the hydrogel scaffold which is essential to permit a high level of cell ingrowth.   
 
The ability of plain alginate fibres and macroporous alginate fibres to maintain 
viability of encapsulated cells and to promote cell growth was assessed using 
fibroblasts in Chapter 4. Swiss 3T3 mouse fibroblasts were encapsulated in alginate 
fibres by wet spinning cell suspensions of alginate solutions. Increasing the cell 
concentration of the spinning solution from 1.4 × 10
4 
to 1.5 × 10
6
 cells/mL resulted in 
no significant improvement of fibroblast extension and growth. Human adult dermal 
fibroblasts (HDFa) were incorporated in macroporous alginate fibres by wet spinning 
alginate solutions containing both gelatin microparticles and suspended cells (cell 
concentration 3 × 10
5
 cells/mL). Cell distribution was evaluated using CLSM 
(following staining with Calcein-AM) at an excitation wavelength of 488 nm. 
Fibroblast-loaded macroporous alginate fibres were characterised by a cell density of 
approximately 360 cells/mm
3
 which was significantly higher (*P<0.05) than that of 
non-macroporous fibres (approximately 140 cells/mm
3
). Cell viability was maintained 
for time periods of at least 12 days. This finding indicates a potential for repair of soft 
tissue by encapsulating cells or genetically modified, growth factor-secreting variants 
in alginate fibres.  
Encapsulation of nerve cells (primary DRG) in macroporous alginate fibres and cell 
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development within the fibre are described in Chapter 5. Marked outgrowth of DRGs 
was evident within the fibre at day 11 in cell culture, indicating that macropores and 
channels created within the alginate hydrogel by gelatin extraction were providing a 
favourable environment for nerve cell development. Evidence of neurite contact was 
obtained at day 9. These findings indicate that macroporous alginate fibres 
encapsulating nerve cells may provide a useful strategy for nerve repair. 
 
Retinal degeneration including retinitis pigmentosa (RP) and age related macular 
degeneration (AMD) caused by progressive and eventual death of photoreceptor cells 
can eventually lead to blindness. Macroporous alginate fibres were produced 
incorporating cone photoreceptor-derived (661W) cells to investigate their potential as 
tissue engineering scaffolds for retinal repair (Chapter 6). Significantly higher cell 
proliferation (*P<0.05) was evident within macroporous fibres at day 14 in cell 
culture compared with non-macroporous fibres. Cell flattening and elongation with 
formation of cell extensions/projections was extensive in 2D culture on tissue culture 
plastic (TCP) but was not observed in 3D culture within the fibres, indicating that a 
suitable pore/channel structure for photoreceptor cell development was not created 
within the alginate hydrogel at 14 days in cell culture. 
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alginate solution. 
Figure 3.10 CLSM images of alginate fibre (A) differential interference contrast (DIC) 
and (B) autofluorescence. Fibre spun from 1.5% alginate solution through a syringe 
needle into 0.5 M CaCl2 solution. 
Figure 3.11 CLSM image of a 21% w/w gelatin particle-loaded alginate fibre 
produced by wet spinning a 57% w/w suspension of gelatin particles in alginate 
solution. (A) differential interference contrast (DIC) and (B) autofluorescence. 
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Figure 3.12 CLSM microscopy of hydrated gelatin-extracted macroporous alginate 
fibres. (A) DIC, (B) autofluorescence, (C) 3D reconstruction showing isolated regions 
of macropore coalescence and (D) 3D projection view. The fibre was produced by 
extracting gelatin particles from a 16% w/w gelatin-loaded alginate fibre produced by 
wet spinning a 40% w/w gelatin particle suspension in alginate solution. 
Figure 3.13 CLSM image analyses of hydrated macroporous alginate fibres - 
frequency distribution of equivalent macropore diameter following extraction of (A) 
16%, (B) 21% and (C) 24% w/w gelatin particle-loaded alginate fibres. 
Figure 3.14 3D visualization of hydrated 24% w/w gelatin-loaded alginate fibre after 
protein extraction. (A) pore volume and (B) volume of fibre body. 
Figure 3.15 Regions of pore coalescence (highlighted in red) identified by CLSM 
analysis of (A) 16%, (B) 21% and (C) 24% (w/w) gelatin-loaded alginate fibres after 
protein extraction. (D) Magnified view of a region of pore coalescence. 
Figure 3.16 Determination of tortuosity in a porous material using the arc-chord ratio. 
(A) Tortuosity of a path through a porous structure (B) Tortuosity determined by the 
ratio of the pore length (L) to the displacement of the ends of the pore (X). (C) On 
compression the magnitude of L remains constant, but displacement X is reduced to 
X‟, resulting in an increase in tortuosity [221]. (D) Example of tortuosity pathway 
through a macroporous alginate fibre. 
Figure 4.1 Cell encapsulation in a hydrogel tissue-engineered scaffold. The hydrogel 
acts as a temporary extracellular matrix (ECM) and neo-tissue replaces the scaffold 
[236]. 
Figure 4.2 Preparation of Swiss 3T3 fibroblast-loaded alginate hydrogel fibres by wet 
spinning. 
Figure 4.3 Preparation of Swiss 3T3 fibroblast-loaded macroporous alginate fibres.  
Figure 4.4 Calcein-acetoxymethyl ester (Calcein-AM) [240].  
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Figure 4.5 Analysis of HDFa cell distribution and density in macroporous alginate 
fibre after 12 days of cell culture. Cells were stained using Calcein-AM prior to 
analysis (viable cells emit strong green fluorescence). (A) Live cells that are in focus 
on each 2D plane were counted within a 1 mm
2
 area in each image section and were 
marked in green. (B) Counted cells from each slide were labelled in different colour 
(red) to avoid double counting. (C) The sum of green-labelled cells in all image 
sections was used to determine the overall cell density. 
Figure 4.6 Internal cell to cell distance measured for HDFa-loaded alginate fibres (1 
mm
3
). (A) non-macroporous alginate fibre, (B) macroporous alginate fibre.  
Figure 4.7 Optical micrograph of (A) control cell-free alginate fibres and (B) Swiss 
3T3 fibroblasts encapsulated in alginate fibres at day 10 in culture. Fibres produced 
by spinning cell-alginate solution (cell density of 1.4 × 10
4
 cells/mL in 1.5% w/v 
alginate solution) into 0.5 M filtered CaCl2 solution. 
Figure 4.8 CLSM images of (A) Swiss 3T3 fibroblasts encapsulated in alginate fibres 
after 8 weeks in cell culture. (B) Magnified view of elongated fibroblasts in selected 
field of view. Fibre produced by spinning cell-alginate solution (cell density of 1.4 × 
10
4
 cells/mL in 1.5% w/v alginate solution) into 0.5 M filtered CaCl2 solution. Cells 
stained with DAPI to label the cell nucleus (blue) and rhodamine to label the actin 
filaments (pink). 
Figure 4.9 Optical micrographs of (A) hydrated cell-free alginate fibres, (B) Swiss 
3T3 fibroblasts encapsulated in alginate fibres at day 17 of cell culture (C) day 23 of 
cell culture (D) magnified view of elongated fibroblasts (arrowed) in selected field of 
view. (E and F) fractured fibre at day 17 of cell culture. Alginate fibre produced by 
spinning suspension of fibroblasts in alginate solution (cell density 1.5 × 10
6
 cells/mL 
in 1.5% w/v alginate solution) into 0.5 M CaCl2 solution. 
Figure 4.10 Cell morphology and organization of 3T3 Fibroblasts encapsulated in 
xxii 
 
GelMA hydrogel. (A) Rhodamine B stained GelMA hydrogel construct shows 
patterned and unpatterned regions. (B) Representative phase contrast images of 
3T3-fibroblasts (10 × 10
6
 cells/mL) encapsulated in patterned (top row) and 
unpatterned regions (bottom row) of the hydrogel on days 1, 3 and 5 of culture. Cell 
elongation increases over time for all hydrogels, while alignment is only induced in 
patterned constructs [263]. 
Figure 4.11 Optical micrographs of (A) cell-free gelatin particle-loaded alginate fibre 
before particle extraction (B) cell-free gelatin particle-loaded alginate fibres following 
particle extraction (C) macroporous alginate fibres incorporating Swiss 3T3 
fibroblasts at day 7 of cell culture (D) magnified view of elongated fibroblasts 
(arrowed) in selected field of view, (E) macroporous alginate fibres incorporating 
Swiss 3T3 fibroblasts at day 13 of cell culture, (F) magnified view of contacting 
fibroblasts (arrowed) in selected field of view. Macroporous alginate fibres produced 
by wet spinning suspension of Swiss 3T3 fibroblasts and gelatin particles in alginate 
solution into 0.5 M CaCl2 (cell density 1.5 × 10
6
 cells/mL, gelatin particle 57% w/w, 
1.5% w/v alginate solution). 
Figure 4.12 Human adult dermal fibroblast cell (HDFa) density in non-macroporous 
and macroporous alginate fibres. HDFa were suspended in alginate solution with or 
without gelatin particles at 3 × 10
5
 cells/mL. Wet spun fibre samples subjected to 
Calcein-AM staining and cell density determined using CLSM. (One way ANOVA 
*P<0.05, n = 5). 
Figure 4.13 CLSM image at day 12 in cell culture of HDFa cells loaded in 
macroporous alginate fibres. WGA- and DAPI-labelled HDFa cells in (A) 
non-macroporous alginate fibre, (B) macroporous alginate fibre. Live/dead staining 
with Calcein-AM of HDFa cells in (C) non-macroporous alginate fibre, (D) 
macroporous alginate fibre. 3D visualisation of DAPI- and WGA-labelled HDFa cells 
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in (E) non-macroporous alginate fibre, (F) macroporous alginate fibre. 
Non-macroporous HDFa-containing alginate fibre produced by spinning cell 
suspension in alginate solution (cell density of 1.3 × 10
6
 cells/mL in 1.5% w/v 
alginate solution) into CaCl2 solution. Macroporous HDFa-containing fibre produced 
by spinning suspension of HDFa fibroblasts and gelatin particles in alginate solution 
into CaCl2 solution (cell density 1.3 × 10
6
 cells/mL, gelatin particle 57% w/w, 1.5% 
w/v alginate solution). 
Figure 4.14. Flowchart illustrating the method of Thevenot et al. to quantify 3D cell 
distribution and infiltration [268]. 
Figure 5.1 Schematic representation of a neuron and detailed view of the growth cone 
with its main cytoskeletal components (actin filaments and microtubules) [284]. 
Figure 5.2 Serial dilutions of the primary antibody (TU-20) in blocking solution. 
Figure 5.3 Sensory peripheral neurons are called pseudounipolor neurons [288]. 
Figure 5.4 Preparation of non-macroprous (blue arrowed) and macroporous (black 
arrowed) alginate fibres encapsulating primary rat DRG cells. 
Figure 5.5 Bright field microscopy images of DRGs encapsulated in a 
non-macroporous alginate fibre at Day 1 (A), Day 5 (B), Day 11 (C) and Day 15 (D) 
in cell culture.  
Figure 5.6 Bright field microscopy of DRGs encapsulated in a alginate fibre by wet 
spinning suspensions of cells and gelatin particles in alginate solution at Day 1 (A), 
Day 2 (B), Day 5 (C), Day 9 (D), Day 11 (E) and Day 15 (F) in cell culture. 
Figure 5.7 Morphology of DRGs encapsulated in alginate fibre and observed using 
inverted microscopy. (A–C) Early stage of neurite outgrowth at day 1–5, (D) a 
pseudounipolar-DRG-like neuron (E–F) DRGs aggregate in balls and extend multiple 
neurites becoming a densely branching network after 9 days, (G–I) evidence of 
neuronal contacts. 
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Figure 5.8 CLSM characterisation of dendritic outgrowth from rat DRG cells 
contained in a macroporous alginate fibre at day 15 in cell culture. (A) Superimposed 
DIC/autofluorescent and (B) autofluorescent images of the neurites.  
DRG-containing fibre produced by wet spinning 1.5% w/v alginate solution 
containing DRGs (cell density 6.25 × 10
3
 cells/mL) and gelatin particles (57% w/w) 
into 0.5 M CaCl2 solution. Autofluorescence produced using UV at excitation 
wavelength 350 nm and emission maximum 460 nm. 
Figure 5.9 Rat dorsal root ganglion cells at 5 days in cell culture, subjected to 
live/dead assay by staining with Calcein-AM. Cells were seeded on 6-well plate at 
densities of 6.25 × 10
3
 cells/mL. The DRG cells display outgrowth and varied cell 
soma size (7–20 µm). 
Figure 5.10 Live/dead staining assay using Calcein-AM of rat DRGs encapsulated in 
non-macroporous alginate fibre at (A) day 2, (B) day 5 in culture. Rat DRGs 
encapsulated in macroporous alginate fibre at (C) day 2 and (D) day 5 in culture.  
DRG-containing macroporous alginate fibre produced by wet spinning alginate 
solution (1.5% w/v) containing DRG (cell density 6.25 × 10
3
 cells/mL) and gelatin 
particles (57% w/w) into 0.5 M CaCl2 solution. Gelatin particles omitted for 
production of DRG-containing non-macroporous fibres. 
Figure 5.11 Imaging of mouse retinal tissues, labelled with Vectashield Anti-fade 
containing DAPI and TU-20, using fluorescence microscopy. Crysections of mouse 
retina tissue were incubated for 24 h at 4 
o
C with anti-ß-tubulin (TU-20) at dilution (A) 
1:100, (B) 1:250, (C) 1:500 and (D) 1:1000. Cryosections were fixed in 4% 
paraformaldehyde for 15 min. and washed with copious D-PBS followed by 
incubation with primary antibodies (TU-20) for 24 h at 4 ºC and with the secondary 
antibody (Cy3-conjugated Affinipure Donkey Anti-Mouse IgG) for 1 h at room 
temperature. 
xxv 
 
Figure 5.12 TU-20 was used as a marker to differentiate encapsulated neurons from 
glia. (A) Hematoxylin and eosin stain of normal rat retina [293]. (B) Cryosections of 
mouse retinal tissue labelled with anti-ß-tubulin (TU-20) 1:250 dilution). 
Figure 5.13 TU-20 (mouse monoclonal anti-tubulin-III antibody)-labelled DRG cells 
in a macroporous alginate fibre at day 15 of cell culture. (A) Superimposed DIC and 
fluorescence (arrowed black) and (B) TU-20 labelled images revealed neurites 
(arrowed white) encapsulated in the alginate fibre. Magnified view of highly branched 
neurite displayed in the selected field. DRG-containing alginate fibre produced by wet 
spinning 1.5% w/v alginate solution containing DRGs (cell density 6.25 × 10
3
 
cells/mL and gelatin particles 57% w/w) into 0.5 M CaCl2 solution. 
Figure 6.1 Photoreceptor cells in the retina of the eye [294]. 
Figure 6.2 The reduction reaction of resazurin dye. 
Figure 6.3 Hoechst 33342 stain for nucleic acid [309].  
Figure 6.4 Phase contrast microscopy images of 661W culture on TCP at Day 0 (A), 
Day 3 (B) and Day 6 (C) in cell culture. Cells were seeded on 6-well plates at a 
density of 4.5 × 10
3 
cells/mL. 
Figure 6.5 Fluorescence imaging of 661W cells cultured on TCP labelled with TUJ-1 
(A) Hoechst dye reveals nuclear DNA in blue (B) resulting composite image (C) at 
day 7 in culture. Cells were seeded on 6-well plates at a density of 4.5 × 10
3 
cells/mL. 
Formalin fixed 661-W cells were permeabilized with 0.1% Triton X-100 in D-PBS for 
15 minutes at room temperature and blocked with 5% NGS + 0.1% Triton X-100 for 
15 minutes at room temperature. Cells were probed with primary antibody (TUJ-1) at 
1:200 dilution for 24 h at 4 ºC and with the secondary antibody (goat anti-rabbit IgG 
(H+L), Alexa Fluor®  594 conjugate) at 1:500 dilution for 1 h at room temperature. 
Nuclei (blue) were stained with Hoechst 33342 dye at 1:500 dilution for 15 minutes. 
Figure 6.6 Differential interference contrast (DIC) images of 661W cells 
xxvi 
 
encapsulated in a non-macroporous alginate fibre at Day 0 (A), Day 6 (B), Day 10 (C) 
and Day 13 (D) in cell culture. Cell concentration of alginate spinning solution 2.5 × 
10
4
 cells/mL. 
Figure 6.7 Differential interference contrast (DIC) images of 661W cells 
encapsulated in a macroporous alginate fibre at Day 1 (A), Day 6 (B), Day 10 (C) and 
Day 13 (D) in cell culture. Cell concentration of alginate spinning solution 2.5 × 10
4
 
cells/mL. 
Figure 6.8 Fluorescence imaging of 661W cells encapsulated in non-macroprous fibre 
labelled with TUJ-1 (A) Hoechst 33342 dye (B) superimposed image (C) and in 
macroporous fibre labelled with TUJ-1 (D) Hoechst dye (E) superimposed image (F). 
661W-containing macroporous alginate fibre produced by wet spinning 1.5% w/v 
alginate solution containing 661W cells (density 2.5 × 10
4
 cells/mL) and gelatin 
particles 57% (w/w) into 0.5 M CaCl2 solution. Non-macroporous fibres produced by 
omitting the gelatin particles. 
Figure 6.9 Live/dead staining assay using Calcein-AM of 661W cells encapsulated in 
non-macroporous alginate fibre (A) and macroporous alginate fibre (B) at day 14 in 
culture. 661W-containing macroporous alginate fibre produced by spinning alginate 
solution (1.5% w/v) containing 661W cells (density 2.5 × 10
4
 cells/mL) and gelatin 
particles (57% w/w) into 0.5 M CaCl2 solution. Gelatin particles omitted for 
production of 661W-containing non-macroporous fibres. 
Figure 6.10 Resazurin assay of 661W cell proliferation in culture on TCP (cells were 
seeded on 6-well plates at a density of 4.5 × 10
3 
cells/mL) (i) encapsulated in 
non-macroporous alginate fibre (ii) and encapsulated in macroporous alginate fibre 
(iii) (cell concentration of spinning solution 2.5 × 10
4
 cells/mL). (Mean ± SEM, One 
way ANOVA *P<0.05, n = 6). 
Table 1.1 Characteristics of an ideal tissue scaffold (adapted from [4]). 
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Table 1.2 Properties of biodegradable synthetic polymers [25-26]. 
Table 1.3 Tissue engineering scaffold manufacturing techniques adapted from [4]. 
Table 1.4 Capabilities and limitations of SFF fabrication techniques. 
Table 1.5 Selective synthetic peptide sequences of extracellular matrix proteins used 
in tissue engineering applications. Adapted from [30]. 
Table 1.6 Neural responses to neurotrophic factors. 
Table 2.1 Diameters of hydrated and dried alginate fibres. Fibres were spun from 1% 
w/v alginate solution into 0.5 M CaCl2 solution. Flow rate of alginate solution to 
needle = 2 mL/min.  
Table 2.2 Tensile properties of dried alginate fibres (n = 5, mean ± SD). 
Table 3.1 Optimal pore size for cell infiltration and host tissue ingrowth [168]. 
Table 3.2 Size distribution of gelatin particles (n = 50, mean ± SEM). 
Table 3.3 Equivalent pore diameters of alginate fibre scaffolds determined by CLSM 
image analysis. 
Table 3.4 Macroporosity of gelatin-extracted alginate fibres determined by CLSM 
image analysis. 
Table 4.1 Natural and synthetic polymer-based hydrogels for tissue engineering. 
Table 4.2 Cell density and inter-cell spacing of HDFa cells encapsulated in alginate 
fibre. 
Table 5.1 A Summary of different approaches for nerve regeneration in vitro. 
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CHAPTER 1 
Introduction 
In the last few decades, the concept of tissue engineering has evolved rapidly into a 
new field of medical therapy and an alternative to conventional transplantation 
methods. There is no precise definition of tissue engineering; it covers a broad range 
of applications, including the introduction of biological entities in vivo (e.g. cells, 
growth factors) that facilitate tissue regeneration and the use of synthetic components 
(implants) to replace, or repair damaged and diseased tissue [1]. Five percent of all 
open wounds in the extremities caused by sports and road accidents are complicated 
by peripheral nerve trauma. Moreover, during complicated births, peripheral nerves 
may be disrupted because of traction [2]. Nerve regeneration is a complex biological 
phenomenon. When the nervous system is impaired, recovery is difficult and 
malfunctions in other parts of the body may occur, because mature neurons do not 
undergo cell division. Present clinical treatments favour autologous nerve grafting. 
However, this approach usually results in limited functional recovery, partial 
denervation at donor sites and the requirement for multiple surgical operations [3]. 
Immunosuppression is required for allografts and xenografts, and there is a high 
possibility of disease transmission [3]. Tissue engineering is expected to overcome 
these limitations by developing new approaches to encourage nerve growth and repair. 
Neural tissue engineering has focused mainly on the following three key components 
that govern new tissue formation: (i) introduction of nerve cells at the injury site, (ii) 
provision of an artificial extracellular matrix (ECM) for cell attachment, proliferation 
and differentiation, and (iii) controlled delivery of growth factors to mimic 
physiological processes.   
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The following literature review describes nerve structure, function and repair to 
highlight the challenges of producing functional and effective nerve replacements. 
The review presents the principles of tissue engineering and considers the various 
synthetic and natural polymers used to produce 3D cell support scaffolds and their 
surface modification by cell adhesion molecules for enhancing cell attachment and 
growth. The review describes the various approaches that have been applied to date 
for tissue engineering of nerves including the controlled release of growth factors. 
Specific attention is given to the advantages of alginate as a biomaterial for cell 
encapsulation to establish the rationale for the studies described in this thesis of 
alginate fibres for nerve repair. 
 
1.1 LITERATURE REVIEW 
1.1.2 Extracellular matrix and the design of artificial scaffolds 
The natural ECM is a complex structural entity that surrounds and supports cells 
within mammalian tissues. The ECM is often referred to as connective tissue and 
comprises a cross-linked network of proteins and glycosaminoglycans, which 
provides a three-dimensional (3D) environment to organize cells in space. 
Furthermore, the ECM provides cells with environmental signals to direct 
site-specific cellular regulation, leading to tissue regeneration and organogenesis. The 
body is remarkably efficient at self-repair; however, in many cases such as excessive 
skin loss caused by severe injuries or non-union bone fractures, the self-repair process 
may be inadequate to completely regenerate the tissue. Therefore, one of the principal 
strategies of tissue engineering attempts to achieve healing through the introduction of 
cells, the use of synthetic implants, or a combination of both techniques. Cell 
provision by itself may be inadequate to induce tissue growth, since the supplied cells 
require their own supportive matrix to integrate with existing tissue. Thus, the 
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incorporation of cells within a scaffold or artificial ECM is necessary to promote cell 
attachment, proliferation and differentiation (Figure 1.1). Biomaterials selected for 3D 
scaffold production should be biocompatible, biodegradable, non-toxic, 
non-immunogenic, mechanically strong, sterilizable and capable of production in an 
economical and scalable manner (Table 1.1) [4]. 
 
Figure 1.1 Biodegradable three-dimensional scaffold used to promote cell attachment, 
proliferation and differentiation. The scaffold with or without cells and/or biological 
signalling molecules (e.g. growth factors, cytokines, chemokines and genes) is applied 
to a defect in vivo to induce tissue and organ regeneration. 
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Table 1.1 Characteristics of an ideal tissue scaffold (adapted from [4]). 
 
1.1.3 Nerve structure and regeneration  
The anatomical divisions of the nervous system are the central nervous system (CNS), 
which includes the brain and spinal cord, and the peripheral nervous system (PNS), 
which includes the neural tissue outside the CNS. The nervous system includes all of 
the neural tissue in the body, and its basic functional unit is the individual cell or 
neuron. A typical neuron is composed of a cell body, dendrites, an axon and a synapse 
(Figure 1.2). The cell body is comprised of a large nucleus with a prominent nucleolus, 
which contains genetic material in the form of chromosomes and other organelles, 
including neurofilaments, neurotubules and neurofibrils. The dendrites are branched 
projections that extend out from the cell body to receive electrochemical signals from 
other neurons. After receiving the signals, the axon (a long, slender projection) 
Characteristics Requirement
Biocompatible
Biologically compatible with host tissue (i.e. should not provoke
immune rejection, inflammation or toxicity)
Biodegradable
Degradation rate should match tissue regeneration rate and degradation
products must be non-toxic to tissues
Promotes vascularisation
Provide channels for blood supply by vascularization to promote and
maintain tissue regeneration
Corrosion resistant Stability against corrosion at physiological pH and body temperature
Porosity with interconnected pores
Maximise space for cell adhesion, growth, ECM secretion,
revascularization. Allows adequate nutrient  and oxygen supply without
compromising mechanical strength
3D structure Provides framework to restore original volume of host tissue
High surface area to volume ratio Promote cellular ingrowth and transport of nutrients and oxygen
Surface modifiable
Improve cell adhesion using functionalised chemical or biomolecular
groups or by adsorption of cell adhesion molecules
Adequate mechanical strength Withstand in vivo  stress and surgical implantation
Sterilizable Prevent contamination by microorganisms
Growth factor delivery Modulate cell behaviour and function
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propagates an electrical impulse known as an action potential that stimulates the 
release of neurotransmitters, such as acetylcholine, amino acids (glutamate, 
gamma-aminobutyric acid), monoamines (dopamine) and neuropeptides at the distal 
terminations of the branches of an axon called synaptic terminals to allow 
communication between neurons and other cells. Synaptic terminals are separated 
from neighbouring neurons by a small gap called a synapse, across which impulses 
are sent.  
 
 
Figure 1.2 Peripheral motor neuron [5].  
 
Axons within a peripheral nerve are the lengthy extension of cell bodies located in the 
dorsal root ganglia (sensory neurons), autonomic ganglia (autonomic neurons), or the 
ventral horn of the spinal cord of brain stem (motor neurons). Since their terminals are 
quite distant from the cell bodies, axons are insulated from each other, bundled 
together, and protected by three connective tissue layers – the endoneurium, the 
perineurium, and the epineurium (Figure 1.3). Axons, Schwann cells, and endoneurial 
components are bundled by a sheath of perineurium to form a nerve fascicle. Within 
the endoneurium, all axons are intimately associated with Schwann cells. As shown in 
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Figure 1.4, the myelin of each myelinated axon is formed from the plasma membrane 
of a Schwann cell wrapped tightly multiple times around the axon. However, the 
myelin sheath is not continuous. Individual myelinating Schwann cells cover about 
100 micrometres of an axon corresponding to approximately 10,000 Schwann cells 
along a 1 metre length of the axon which can be up to a metre or more in length. The 
gaps between adjacent Schwann cells are called nodes of Ranvier (Figure 1.4) [6]. 
Bundles of axons bathed in endoneurial fluid are grouped into fascicles by dense 
connective tissue called perineurium. The perineurium is formed by up to 15 layers of 
flat perineurial cells interspersed with layers of type I and type II collagen fibrils and 
elastic fibres in circumferential, oblique, and longitudinal orientations [7]. These 
layers of collagen and perineurial cells provide mechanical strength, making the 
perineurium the primary load-bearing portion of the nerve [8-10]. Nerve fascicles are 
held together and surrounded by epineurium. The epineurial layer includes bundles of 
type I and type III collagen fibrils and elastic fibres, as well as fibroblasts, mast cells, 
and fat cells. It usually encases multiple nerve fascicles, as well as blood vessels 
which supply the nerve [11]. Supporting cells or neuroglia (also known as glial cells) 
separate and protect the neurons to provide a supportive framework for neural tissue 
(Figure 1.5). Various glial cells are present in the CNS and PNS, and each type plays 
distinctive roles in the nervous system. Four types of neuroglial cells including 
ependymal cells, astrocytes, oligodendrocytes and microglia are found in the CNS. 
Satellite cells and Schwann cells (SC) are found in the PNS.  
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Figure 1.3 Schematic drawing of a peripheral nerve [12].  
 
 
Figure 1.4 Cross-sectional anatomy of a peripheral nerve. Inset at left shows an 
unmyelinated fibre. Inset at bottom shows a myelinated fibre [13].  
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Figure 1.5 A photomicrograph of nerve tissue. A single neuron and numerous smaller 
supporting cells can be seen [14].  
 
The nervous system allows information to be received and transmitted throughout the 
body. Thus, the brain, spinal cord and peripheral nerve tissue pose unique challenges 
when designing tissue engineering scaffolds to serve as replacements for injured or 
diseased tissue. Peripheral injuries are the most common type of nerve injury in daily 
life and mainly result from trauma to the upper extremities leading to loss of motor or 
sensory function (Figure 1.6). 
 
Figure 1.6 Types of peripheral nerve injuries [15].  
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Injury to the PNS immediately elicits Wallerian degeneration (Figure 1.7). During 
nerve repair, the axon distal to the injury site degenerates, and macrophages migrate 
into the basal lamina to engulf the debris at the distal segment. SCs then proliferate 
from the proximal nerve segment and form a solid cellular cord that follows the path 
of the original axon. As the neurons recover, the axon‟s neurolemma (the outermost 
layer of the neuron made of Schwann cells) does not degenerate and remains as a 
hollow tube. Within 96 hours after the injury, macrophages produce interleukin-1, 
which stimulates Schwann cells (SCs) to secrete growth factors that attracts the 
proximal axonal sprouts to grow (at 3 to 4 mm/day) towards the distal end of the 
lesion. SCs then form a myelin sheath around the re-innervating axonal sprout to 
re-establish the synaptic contacts. However, if the axon stops growing or deviates in a 
new direction, neuronal function may be lost. Short nerve gaps resulting from injury 
may be functionally repaired by end-to-end suturing whereas tubular structures are 
necessary for bridging larger gaps [16, 17]. Nerve autografts are the gold standard for 
clinical repair of large lesion gaps in the peripheral nervous system. Nerve segments 
are taken from another part of the body (the donor site) and inserted into the lesion to 
provide endoneurial tubes for axonal regeneration across the gap. However, these 
treatments are limited by tissue availability, donor site morbidity and potential 
mismatching of nerve fascicles leading to a negative effect on the recovery of nerve 
function [17-19]. 
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Figure 1.7 Schematic diagram of peripheral nerve regeneration. (A) Normal neuron, 
(B) Appearance at 2 weeks, (C) 3 weeks, and (D) 3 months after injury. (E) 
Appearance several months after neuron injury with unsuccessful nerve regeneration 
[20]. 
1.1.4 Polymers used for scaffold manufacture 
Both natural and synthetic polymers have been applied as tissue engineering scaffolds 
for nerve repair in various forms including films, micro/nanoparticles, fibres, inserts 
or matrices. Synthetic polymers include those based on non-degradable silicone 
elastomers as well as biodegradable materials such as poly(L-lactic acid) (PLLA), 
polyglycolic acid (PGA) and poly(ε-caprolactone) (PCL). Natural polymers include 
laminin, fibronectin, collagen and gelatin and polysaccharides such as chitosan and 
alginate. 
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1.1.4.1 Synthetic polymers used in tissue engineering 
The synthetic polymers investigated for manufacture of cell-support scaffolds (or 
artificial ECM) maybe classified into two main groups: (i) non-biodegradable 
materials and (ii) biodegradable materials. Silicone tubes have been used extensively 
for nerve regeneration. They are not biodegradable or permeable to large molecules, 
but create an isolated environment for nerve regeneration that allows the study of the 
effect of different ECM analogues on, for example, axonal elongation. 
Non-degradable artificial nerve guides have also been fabricated using silicone [21] 
and polyethylene (PE) [22] (Figure 1.8). However, the major drawbacks of 
non-biodegradable materials include chronic foreign body reaction caused by 
excessive scar tissue formation and lack of flexibility in certain cases such as PE.  
 
Si
CH3
O
CH3
**
n
        
Silicone               Polyethylene 
Figure 1.8 Chemical structures of silicone elastomer and polyethylene. 
 
Many studies have focussed on the use of biodegradable synthetic polymers to 
address the problems associated with non-biodegradable polymeric scaffolds (Figure 
1.9). Polymers such as PLLA [23, 24], PGA [25] and poly-ε-caprolactone (PCL) [26, 
27] have good biocompatibility and low antigenicity and have been reported as 
suitable for nerve regeneration. They are intended to produce temporary support 
structures that resorb progressively over time as the nerve regenerates. 
Copolymerization has been used to obtain materials with tailored characteristics in 
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terms of degradation behaviour, mechanical performance, thermal properties and 
wettability [28] (Table 1.2). The repair of nerve defects generally requires up to 1 year 
for nerve regeneration and maturation; thus, during the regeneration period, it is 
possible that resorption and permeation of nerve guides produced from 
semi-crystalline polymers such as PLLA and PCL would decrease because of an 
increase in crystallinity over time. Polymer crystallinity affects the permeability and 
biodegradation of nerve guides because of the increase in packing density of polymer 
chains, which restricts fluid ingress. Moreover, crystalline debris formed during 
degradation may cause an inflammatory response that might jeopardize regeneration 
and recovery of nerve function [29]. 
 
H
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O
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n
          
Poly(L-lactic acid)             Polyglycolic acid  
*
O
O
*
n
    Poly(ε-caprolactone)   
Figure 1.9 Chemical structure of poly(L-lactic acid), polyglycolic acid and 
poly-ε-caprolactone. 
 
Table 1.2 Properties of biodegradable synthetic polymers [30, 31]. 
Melting
Point (ºC)
Glass
Transition (ºC)
Strength (Mpa)
Poly-l-lactic acid  (PLLA) 173-178 60-65  45-70 E, IM, CM, SC >24
 Polyglycolic acid (PGA) 220-225 35-40 60.8-71.8 E, IM, CM, SC 6 to 12 
Poly (ε-caprolactone)  (PCL) 60-65 – 65-60 23 E, IM, CM, SC >24
 E = extrusion, IM = injection moulding, CM = compression moulding, SC = solvent casting,
Thermal & Mechanical Properties
Processing Method
Biodegradable Synthetic
Polymer
Degradation Time
(Month)
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1.1.4.2 Natural polymers used in tissue engineering 
Natural polymers have been widely used as biomaterials in tissue engineering for 
several decades. Components of the natural ECM such as laminin, fibronectin and 
collagen have been used extensively for nerve reconstruction [32] because of their 
biocompatibility, lack of toxicity and innate cell adhesion capabilities. There has also 
been growing interest in the use of gelatin and polysaccharides such as chitosan, 
agarose and alginate for nerve repair.  
Laminin (Figure 1.10) is the first ECM protein expressed during embryogenesis and 
contains various cell-binding domains such as RGD (Arg-Gly-Asp), YIGSR 
(Tyr-Ile-Gly-Srg-Arg) and IKVAV (Ile-Lys-Val-Ala-Val) on the α chain [33]. Several 
studies have found that laminin assists in the guidance of developing neurites and 
promotes neurite outgrowth [34, 35]. Labrador et al. [36] found that collagen and 
laminin gels contained in a silicone nerve guide, promoted nerve regeneration across 
4-mm and 6-mm gaps of mice sciatic nerve. Evidence of laminin-mediated physical 
and chemical guidance for SCs and enhanced adhesion and alignment on a 
micropatterned biodegradable polymer substrate in vitro was reported by Miller et al. 
[37].  
Fibronectin (Figure 1.11) is a dimeric glycoprotein that is composed of several 
rod-like domains, one of which (type III repeat) contains the RGDs sequence 
(Arg-Gly-Asp-Ser), which regulates cell adhesion [28]. Fibronectin has been found to 
play a key role in axonal growth by regulating neurite attachment and outgrowth [38, 
39].  
14 
 
 
Figure 1.10 Laminin molecular structure consisting of three large polypeptides α, β1 
and β2 crosslinked by disulfide bonds [40].  
 
Figure 1.11 The modular structure of fibronectin and its binding domains [41].  
 
Collagen (Figure 1.12) is one of the most widely used natural polymers for 
manufacturing tissue scaffolds due to its advantageous properties of biocompatibility, 
biodegradability non-toxicity and cell-adhesion Although more than 28 types of 
collagen exist, the most abundant types in native tissue are types I and III. However, 
collagen extracted chemically from natural tissues is capable of inducing 
immunogenic responses upon implantation [4]; it has a relatively high cost and tends 
to exhibit a more rapid deterioration in mechanical properties compared with the 
natural non-processed forms.  
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Figure 1.12 Simplified chemical structure of collagen showing the main amino acid. 
 
Gelatin (Figure 1.13) is derived from collagen and has become a material of choice in 
tissue engineering, because it is not antigenic under physiological conditions. Gelatin 
has a lower cost than collagen and is easier to prepare in the form of concentrated 
solutions. Moreover, gelatin is biodegradable and has excellent biocompatibility, 
plasticity and cell-adhesiveness [28]. Gelatin is extensively used for pharmaceutical 
purposes in the form of hard- and soft-shell gelatin capsules for drug administration. It 
was also the first biodegradable material to be tested as a nerve guide [42]. Gelatin 
contains primary carboxyl groups along the chain backbones that give it the potential 
to covalently bind to growth factors via an appropriate cross-linking agent [43-45]. 
For example, the water-soluble cross-linking agent carbodiimide was used by Chen et 
al. [46] to bind to the amine groups of the nerve growth factor (NGF) to carboxyl 
groups on the surface of tricalcium phosphate and glutaraldehyde-crosslinked gelatin. 
SCs successfully attached to the material in vitro, and NGF was released during 
biodegradation.  
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Figure 1.13 Chemical structure of gelatin. 
 
Chitosan (Figure 1.14) is a copolymer of D-glucosamine and 
N-acetyl-D-glucosamine, obtained from N-deacetylation of chitin. Chitosan has been 
widely investigated for tissue engineering and drug delivery because of its 
biodegradability and biocompatibility, anti-tumour [47] and anti-bacterial activities 
[48]. Chitosan has a molecular structure similar to that of the glycosaminoglycans in 
the basal membranes of tissues and ECM that permits interactions between chitosan 
and extracellular adhesion molecules such as laminin, fibronectin and collagen. 
Moreover, chitosan has been studied as a candidate material for guiding nerve 
regeneration. Studies have shown that chitosan fibres support adhesion [49], 
migration, and proliferation of SCs as well as peripheral nerve reconstruction when 
used in a chitosan–laminin 3D scaffold [50].  
 
 
 
 
 
 
Figure 1.14 Chemical structure of chitosan. 
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1.1.5 Alginate 
Alginate (Figure 1.15), also known as alginic acid, is abundant in the cell wall of 
brown algae. The properties of alginate vary among species, and the main commercial 
sources are Ascophyllum, Durvillaea, Ecklonia, Laminaria, Lessonia, Macrocystis, 
Sagassum and Turbinaria.  
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Figure 1.15 Chemical structure of alginate. 
 
The Food Chemical Codex [51] gives specifications for alginate and its propylene 
glycol ester as well as its ammonium, calcium, potassium and sodium salts. These 
four salts have been granted GRAS (generally recognized as safe) status in the USA, 
and propylene glycol alginate has been approved as an emulsifier, stabilizer or 
thickener in food [52]. Alginate is widely used in textile printing (as a viscosity 
modifier), paper production (for surface sizing), the food industry (as a viscosity 
enhancing agent) and the pharmaceuticals industry (as a disintegrating agent in 
tablets). More recently, because of its good biocompatibility, alginate has been 
fabricated using numerous techniques into films, membranes, fibres, 
micro/nanoparticles, capsules and reservoir devices for tissue engineering and/or drug 
delivery. 
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Structure of alginate  
Alginate is a linear anionic polysaccharide that consists of various ratios of 
L-guluronic and D-mannuronic acid units linked by 1,4-glycosidic bonds (Figure 
1.16A). The classical Haworth chemical structures for the monomers and 3D „chair‟ 
arrangement are shown in Figure 1.15. The alginate polymer is formed by linking 
each monomer at the C-1 and C-4 positions through the ether–oxygen bridge. 
Alginates are not random copolymers; according to the algae source, the polymer 
chain comprises three types of regions or blocks. The G blocks contain only units 
derived from L-guluronic acid, the M blocks contain D-mannuronic acid and the MG 
blocks contain a combination of D-mannuronic and L-guluronic acid units, each of 
which have different conformational preferences and behaviour [53-55] (Figure 1.17). 
As examples, the M/G ratio of alginate from Ascophyllum rodosum is approximately 
1.56, whereas that from Laminaria hyperborea is approximately 0.62. Thus, the M 
and G blocks actually exhibit a different shape; the M block features equatorial 
groups at C-1 and C-4, and forms a relatively planar structure similar to a ribbon. On 
the other hand, the G block features axial groups at C-1 and C-4, and the resulting 
MG copolymer chain are buckled (Figure 1.16). 
 
 
Figure 1.16 (A) Chemical structure of the two monomeric units of alginate. (B) 
Structures in Figure 1.16A expressed as „chair‟ forms. 
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Figure 1.17 The chemical structure of the M block, G block and MG copolymer of 
alginate. 
 
Sodium alginate 
Sodium alginate is the sodium salt of alginate, and its empirical chemical formula is 
NaC6H7O6. The chemistry of the processes used to make sodium alginate from brown 
seaweed is relatively simple (Figure 1.18).  
Sodium alginate can be produced by two different processes: the calcium alginate 
process and the alginate process (Figure 1.18). In the former process, calcium alginate 
is formed as an intermediate along with alginic acid. In the second approach, no 
calcium alginate is formed, only alginate. Both methods have advantages and 
disadvantages. The calcium alginate process is performed by size reduction of the raw 
material via treatment with formalin solution followed by acid treatment to convert 
the insoluble calcium and magnesium salts into insoluble alginic acid and finally into 
soluble sodium alginate by reaction with sodium carbonate and sodium hydroxide. In 
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brown seaweed, alginate is present mainly as the calcium salt of alginate, although 
magnesium, potassium and sodium salts may also be present. Treatment with 
formaldehyde removes the remaining phenolic compounds and discoloration. The 
seaweed particles are then extracted with alkali to convert the alginate to a soluble 
form (sodium alginate) so that it can be separated from the rest of the seaweed. This 
step offers the advantage of control over the viscosity of the final product. Use of 
higher temperatures and longer extraction times can further break down the uronic 
acid chains resulting in lower viscosity sodium alginate. The extracted sodium 
alginate is separated from the alkali-insoluble seaweed residue by flotation and 
filtration. Since evaporation of the solution is not practical, sodium alginate extract is 
typically precipitated as a calcium salt or alginate (alginic acid) using HCl after 
bleaching to improve the colour and odour. Finally, the purified and concentrated 
solid alginate obtained from the original alkaline extract is converted to solid sodium 
alginate using sodium carbonate. As sodium alginate forms, it dissolves in the small 
amount of water present to give a heavy paste, which is oven-dried and milled to an 
appropriate particle size, usually around 60 mesh. 
The alginate process is similar to the calcium alginate process. The first five stages 
(from size reduction of the raw material to separation of insoluble seaweed residue) 
are identical. Rather than precipitation of calcium alginate, the extracted sodium 
alginate undergoes bleaching and clarification followed by treatment with a dilute 
mineral acid (HCl or H2SO4) to form a gelatinous precipitate of alginate. Following 
precipitation, the alginate gel is dehydrated by mixing with methanol or ethanol. The 
final step is to convert alginate to sodium alginate. Alginate is suspended in methanol 
or ethanol at room temperature, and a strong sodium hydroxide solution (40%) is 
added to exchange the H
+
 and Na
+
 ions. The final product is obtained by grinding. 
There are several drawbacks to the alginate method, including the difficulty in 
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separating alginate from the gelatinous precipitate, the relatively low overall yield of 
alginate, and costly and time-consuming nature of the process.  
 
Figure 1.18 Production of sodium alginate.  
 
Rheological properties of alginate 
The physical properties of alginate depend on the relative proportion of the three 
types of blocks (M, G and M/G) [56-59]. The degree of polymerisation (DP) and 
molecular weight of sodium alginate relate directly to the viscosity of alginate 
solutions. Sodium alginate is manufactured in various grades, usually described as 
low, medium and high viscosity. Manufacturers are able to control the molecular 
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weight (DP) and provide products with a viscosity of 10–1,000 mPa.s (1% solution) 
and DP of 100–1,000 units. Low viscosity sodium alginate may be stored at 10–20 °C 
for 3 years without any change in properties. Medium viscosity alignate shows 10% 
loss at 25 °C and 45% loss at 33 °C after a year. High viscosity alginate is less stable 
[60]. The viscosity of alginate solution can be affected by several factors including 
molecular weight, concentration, temperature, pH and the presence of calcium ions. 
Furthermore, the higher the molecular weight of soluble alginate, the greater is the 
viscosity of its solution. McDowell [60] derived a useful empirical equation relating 
the viscosity and concentration of an alginate solution for various alginates over at 
least a hundredfold change in viscosity:  
  
 
Where a is a constant related to degree of polymerization (DP) of the alginate sample 
and b is a constant for a particular type of alginate [60]. The viscosity of alginate 
solutions decreases with increase in temperature at a rate of about 2.5% per °C 
(Figure 1.19) [61]. The viscosity usually returns to a slightly lesser value than the 
original on cooling. However, depolymerisation may occur with a subsequent 
permanent loss of viscosity if alginate solutions are kept above 50 °C for too long. 
Alginate solutions are most stable at pH 5–9. The viscosity of alginate solutions is 
usually unaffected at pH 5–11. Under acidic conditions, the free –COO− ions in the 
polymer protonate to –COOH, resulting in a reduction of the electrostatic repulsion 
between chains as hydrogen bond formation occurs, and thereby, a higher viscosity 
[52]. Gelation usually occurs at pH 3–4. However, if the pH is maintained above 11, 
slow depolymerisation may occur with a resulting decrease in viscosity. 
 
23 
 
 
Figure 1.19 Viscosity of 1% alginate solution at different temperatures (adapted from 
[61]). 
 
Alginate–Calcium complex 
Low concentration (0.2–1.2%) of calcium ions in an alginate solution will increase 
the viscosity (7–20%), whereas a higher concentration will cause gelation [62]. Most 
commercial alginates made by the calcium alginate process contain residual quantities 
of calcium. The effect of calcium on the viscosity of a calcium-containing alginate 
can be estimated by measuring the viscosity of a solution before and after the addition 
of a sequestering agent, such as sodium hexametaphosphate, which removes the 
calcium ions as a complexed phosphate ion. The effect of calcium on the viscosity of 
an alginate solution is difficult to predict and is usually determined by 
experimentation. The viscosity will depend on the uronic acid composition and DP of 
alginate; alginates with higher molecular weights and/or higher M/G ratios having 
higher viscosity. 
Calcium is a popular divalent ion for alginate gel formation, because it is commonly 
found in the salt form, is of low cost, readily available and non-toxic. Addition of 
sodium alginate solution to calcium chloride solution results in hydrogel formation. 
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Blocks of guluronic acid residues along the alginate chain molecule bind to Ca
2+
 
cations to generate a 3D network of alginate strands held together by ionic 
interactions. Gel formation is related to the content of guluronic acid which creates a 
cavity that acts as a binding site for the cation [63]. Grant et al. proposed an „egg-box‟ 
model in 1973 that requires the cooperative binding of two or more chains, shown in 
Figure 1.20 [64, 65]. The resulting network is affected by the frequency and length of 
contiguous guluronic acid residues as well as the concentration and type of the cation 
[66]. Alginates high in guluronic acid residues form stiffer and more porous gels, thus 
maintaining their integrity for extended time periods. Moreover, these gels do not 
undergo excessive swelling and subsequent shrinkage during cationic cross linking 
[67]. In contrast, alginates rich in mannuronic acid residues, form softer and less 
porous gels that disintegrate rapidly with time [67].  
 
Figure 1.20 Gel formation via G blocks of alginate polymers: egg-box model [65]. 
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1.1.6 Cell encapsulation in alginate polymers  
Alginate polymers have been widely investigated for cell encapsulation but the effects 
of alginate composition on the growth characteristics and metabolic activity of 
encapsulated cells have yet to be completely assessed. Although alginates with high 
guluronic acid content produce stronger hydrogels, recent studies have shown that 
such alginates may hinder cell growth and diminish the metabolic activity of the 
culture for a period of up to 40 days before the encapsulated cultures recover and 
proliferate [68-70]. Conversely, high mannuronic acid content alginates provide an 
environment that supports cell growth [68-70]. Simpson et al. [71] hypothesized that 
the strength of the alginate gel network is the principle factor responsible for 
differences in the growth characteristics of encapsulated cells in different alginates. 
They varied the calcium concentration at the time of gelation or during culture and 
found that increasing the concentration of the CaCl2 solution increased the gel 
strength. At the same time, cell growth characteristics were impeded in alginates with 
a high guluronic acid content [71]. In contrast, the gel strength of alginates with a 
high mannuronic acid content was not affected by changes in the concentration of 
CaCl2, because of the low fraction of crosslinking sites provided by the guluronic acid 
residues. 
 
1.1.7 Scaffold design and manufacture for tissue engineering  
Tissue engineering scaffolds are usually fabricated to provide a synthetic replacement 
for the natural ECM and a temporary support structure for growing cells and tissues. 
Numerous techniques have been employed to prepare scaffolds with controlled 
morphology, shape, size, pore structure and physicochemical and mechanical 
properties to optimise cell–scaffold interaction during tissue regeneration. These 
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techniques include solvent casting/particulate leaching, phase separation, solid 
free-form fabrication (SFF) and electrospinning [4, 16, 72, 73] (Table 1.3). A major 
challenge of scaffold manufacture is controlling the pore structure (pore size, 
geometry, connectivity and orientation) to permit in-growth of regenerating tissue. 
Solvent casting and particulate leaching are able to produce highly porous structures. 
However, these methods are limited to the production of thin membranes (2–3 mm), 
because of the difficulty in ensuring complete removal of embedded particles. In 
addition, they have been unsuccessful in controlling the internal architecture to a high 
degree of accuracy or homogeneity. Phase separation involves dissolving a polymer 
such as a poly(α-hydroxy acid), PLA in a solvent such as dioxane, dichloromethane or 
acetone and producing polymer separation or hardening by freezing, gelation, solvent 
extraction and drying [72]. The advantage of these methods is that bioactive 
molecules can often be incorporated into the matrices without loss of activity and the 
morphology and properties of the resultant scaffolds can be varied depending on the 
phase separation mechanism [72, 74].  
 
Table 1.3 Tissue engineering scaffold manufacturing techniques adapted from [4]. 
Manufacturing techniques General description Advantage Disadvantage
Self-assembly
Atoms, molecules and
supramolecular aggregates
organize and arrange themselves
into an ordered structure through
weak non-covalent bonds; typically
involves a bottom–up approach
Mimics the biological process
Complex process,
limited to a few
polymers
Phase separation
Involves various steps, typically
polymer dissolution, freezing
gelation, solvent extraction and
drying, to form porous, foam-like
structures
Simple process, controllable
mechanical properties and pore
structure
Limited to a few
polymers, long
processing times
Electrospinning
Employs electrostatic forces for
production of polymer nanofibre
scaffolds; typically involves a top–
down approach.
Simple and cost-effective process,
capable of producing long and
continuous fibres, films or membranes
produced with control over fibre
orientation, versatile and applicable to
many polymers
Use of high-voltage
apparatus
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More recently, rapid prototyping or SFF fabrication techniques have been used to 
manufacture porous scaffolds, based on the principle that a material in powdered or 
liquid form is solidified one layer at a time to build up a 3D structure. The principal 
systems include fused deposition modelling (FDM) [75-81], selective laser sintering 
(SLS) [76-82], 3D printing [76-83] and precision extrusion [77, 80, 84, 85]. In general, 
SFF fabrication is very time consuming and requires sophisticated equipment. Each 
technique offers its own advantages such as achieving controlled pore size, complete 
pore interconnectivity. However, some techniques are associated with major 
disadvantages including the requirement for toxic organic solvents, heat input and 
lack of mechanical strength of the finished scaffold (Table 1.4). Over the last few 
years, electrospinning has attracted great attention for production of fibrous scaffolds 
that attempt to mimic the structural features of native ECM using various biomaterials, 
particularly polymeric materials [4]. Electrospinning is a simple and versatile 
technique that essentially employs electrostatic forces to produce polymer fibres that 
range in diameter from a few microns to tens of nanometres [86]. This method is able 
to produce fine scaffolds with precise fibre orientation, large surface area and 
controlled pore geometry that favours cell growth in vitro and in vivo [4].  
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Table 1.4 Capabilities and limitations of SFF fabrication techniques. 
 
1.1.7.1 Scaffold production for nerve regeneration 
Regenerated nerve tissues should ideally mimic the structure of nerve fascicles and 
permit the transfer of electrical impulses along the axons to the synaptic terminals 
(Figure 1.21) [29]. To successfully regenerate nerves (and other tissues) using tissue 
engineering approaches, the scaffold material, pore size and structure, degradation 
characteristics and mechanical properties must be optimised to promote cell 
attachment, growth, differentiation and organisation during tissue formation. 
Scaffolds for nerve guidance and nerve regeneration have been fabricated 
predominantly as hollow tubes, aiming to mimic the endoneurium nerve architecture 
(Figure 3). These methods include fibre extrusion [87, 88], magnetic polymer fibre 
alignment [89, 90], injection moulding [91, 92], phase separation [93] and 
freeze-drying and lyophilizing [94]. Flynn et al. [95] developed a fibre templating 
technique involving solubilization (using acetone) of PCL fibres which were 
Porosity (%) Ref.
<80 [75-81]
<40 [76-82]
<45-60 [76-83]
<70 [77, 80, 84, 85]
 Limitations
Powder-based processing
Selective Laser Sintering (SLS)
Extrusion-based processing
Fused Deposition Modelling (FDM)
Technique Pore Size (μm) Advantages
45-100 
 250-1000 
High porosity; solvent free; good
mechanical strength; cost
effective; complete pore
interconnectivity
High surface area to volume ratio;
solvent free
High heat effect on
material; rigid filament
Easy process; cost effective;
independent control of porosity
and pore size;  complete pore
interconnectivity
Use of toxic organic
solvents; lack of
mechanical strength;
limited to small pore sizes
High processing
temperatures; limited to
small pore sizes;
expensive machinery
Needs filament
preparation; limited
choice of filament
materials; high processing
temperatures; limited to
large pore sizes
Three Dimentional Printing (3DP) 45–100 
High porosity; no requirement of
filament preparation; control of
pore size
Precision Extruding Depostion (PED) 200-300 
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embedded in poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogels to create 
oriented pHEMA scaffolds for neural tissue engineering. Longitudinally oriented 
channels (diameters of 100–200 μm and 300–400 μm) were created within the 
hydrogel to act as conduits, providing support and contact guidance for extending 
axons and invading cells [87].  
High-strength magnetic fields have been employed to align collagen gels in the form 
of 4 mm diameter rods during the self-assembly of type I collagen monomers into 
fibrils [90]. Dubey et al. [90] reported that a magnetically aligned type I collagen gel 
directed the invasion of neurites and SCs from dorsal root ganglia cultured on the gel 
surface, and consequently, increased the depth of invasion relative to a control 
collagen gel. This behaviour was attributed to a contact guidance response of growth 
cones and SCs to the aligned collagen fibrils. Thus, by pre-filling a tube with a 
magnetically aligned collagen gel, the desired directionality of cell growth was 
induced by the alignment of collagen fibrils along the tube axis. It was also reported 
that tubes filled with collagen gels, which were not pre-aligned, yielded fewer 
myelinated axons [95] and poorer functional recovery [96] compared to saline-filled 
tubes in the repair of a 4-mm gap in the mouse sciatic nerve. Sunback et al. [91] used 
a novel pressure injection moulding technique to generate a porous 
poly(DL-lactide-co-glycolide) (DL-PLGA) nerve conduit by thermally induced phase 
transition. Conduits were produced with different channel configurations and 
diameters ranging from 1.35 mm (single channel) to 0.08 mm (hundred channels). 
The porous conduit provided increased surface area for SC migration, adherence and 
axonal elongation. It was reported that approximately 2.5- and 12.5-times more SCs 
adhered in a monolayer at the lumenal surfaces of the 7- and 100-channel conduits, 
respectively, compared with a single-channel conduit [91].  
Freeze-drying has been investigated for producing porous polymeric scaffolds by 
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utilising the water present in hydrogels to form ice crystals that are subsequently 
removed by sublimation to create a particular micro-architecture [94]. Stokols et al. 
[94] utilised freeze-drying to create nerve guidance scaffolds from agarose, with 
uniaxial linear pores of 125 ± 25 and 119 ± 26 μm for the hydrated and dry scaffolds, 
respectively. NGF-loaded agarose conduits induced neurite extension in a greater 
number of PC12 cells (cell line derived from a pheochromocytoma of the rat adrenal 
medulla) (43 ± 8.1%) in comparison to the control in the absence of NGF (5.0 ± 3.1%) 
after 4 weeks of cell culture at 37 °C [94]. Other studies have investigated the use of 
extruded or spun hollow fibres of biomaterials such as collagen and PCL combined 
with multiple growth stimuli to enhance neuron regeneration, adhesion, viability and 
extension.  
 
 
Figure 1.21 Properties of a nerve guidance channel or conduit. Adapted from [29]. 
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1.1.8 Cell interaction with polymeric scaffolds  
Successful tissue engineering requires an understanding of the effect of the scaffold 
structure on cell viability, growth and function. The cellular response to a material 
surface is governed by a number of factors that include surface chemistry, topography, 
surface charge, structural heterogeneity, scaffold mechanical properties and the 
physiological environment [97]. The growth and function of many tissue-derived cells 
requires their attachment and spreading on a surface; thus the strength of cell adhesion 
has been found to be an important determinant of the rate of cell spreading, cell 
migration and differentiated cell function [97]. Several studies have shown that cell 
adhesion appears to be maximised on surfaces with intermediate (water) wettability. 
For example, decreased adhesion of platelets and fibroblasts was observed on highly 
hydrophilic copolymers [98, 99]. Cell adhesion is enhanced on positively charged 
surfaces [99]. Other reports have identified specific chemical groups at the polymer 
surface, such as hydroxyl (–OH) and carboxyl (–COOH) [100, 101] or surface C–O 
functionalities [102], as important factors in modulating the fate of surface-attached 
cells. Curtis et al. [100] modified non-polar polystyrene by introducing hydrophilic (–
OH) moieties into polystyrene surface chains resulting in significant improvements of 
adhesion of baby hamster kidney (BHK) and leukocyte cells compared with the 
non-treated control. For most surfaces, adhesion requires the presence of serum 
components, in particular cell adhesion molecules (CAMs) such as fibronectin and 
laminin [103].  
The surface morphology of an implanted material can also significantly affect cell 
behaviour. Cultured cells react differently to rough and smooth surfaces. In many 
cases, cells orient and migrate along fibres or ridges in the surface. This phenomenon 
was termed contact guidance in early studies on neuronal cell cultures [104]. 
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Fibroblasts have also been observed to orient on grooved surfaces, particularly when 
the texture dimensions are 1–8 μm [105].  
Several studies have used advanced approaches to create sophisticated synthetic 
and/or natural polymeric scaffolds to mimic natural repair processes. However, 
polymeric scaffolds may not interact with cells in a desired manner because their 
surface chemistry may not promote adequate cell adhesion [106] and may induce 
toxic and inflammatory reactions [107]. In addition, the rate of polymer resorption is 
an important factor since the scaffold should provide sufficient support throughout the 
repair process. Cell adhesion problems can be resolved by surface modification to 
enhance cell attachment and cell growth and limit toxic effects.  
Many studies have used ECM proteins such as fibronectin, vitronectin and laminin for 
surface modification of scaffolds because of the presence of cell binding domains, 
such as RGD sequences along the protein chain. Enhancing fibronectin adsorption 
from bovine calf serum-containing culture media on poly-ethyleneterephthalate (PET) 
and polystyrene surfaces by introducing the oxygen-rich functional group (i.e. C–O, 
C=O, and O=C–O groups) was shown to facilitate spreading and subsequent 
replication of Swiss mouse 3T3 fibroblasts and MM14 mouse skeletal myoblasts in 
culture [102]. Campos et al. [106] developed a fibronectin-functionalized, electrospun, 
poly(d,l-lactide-co-glycolide) (PLGA) scaffold for periodontal ligament regeneration 
to overcome the hydrophobicity of the polyester. Yao et al. [107] coated PLGA 
scaffolds with collagen type I or laminin to ameliorate neurite growth. Liu et al. [108] 
improved cell adhesion by crosslinking gelatin with poly(α-hydroxy acids) PLLA 
films in a gelatin/dioxane/water mixture. Chemically modified PLLA films showed a 
45% increase in MC3T3E1 osteoblast cell number on the gelatin modified film 
surface compared with the control 4 h and 1 day after cell seeding [108]. Dhoot et al. 
[109] modified the surface of alginate gels by coating with laminin and by covalent 
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attachment of laminin-derived peptide YIGSR (Tyr–Ile–Gly–Ser–Arg) peptide. The 
modified alginate gels elicited significant increases (> 60%) in NB2a neuroblastoma 
cell attachment compared with unmodified alginate gel (1.5%) [109]. Specific cell 
adhesion fragments (short peptides) have proven in certain cases to be advantageous 
over the long chain native ECM proteins such as fibronectin (FN), vitronectin (VN), 
and laminin (LN) for cell adhesion [110, 111]. Short peptides are more advantageous 
because, unlike the long chains that fold randomly upon adsorption causing the active 
protein domains to be sterically unavailable, short peptides remain stable and do not 
hide the receptor binding domains when adsorbed. Another advantage of short 
peptides is that they can be produced more economically due to the smaller size [35]. 
The selective synthetic peptide sequences used in tissue engineering applications are 
summarised in Table 1.5.  
 
Table 1.5 Selective synthetic peptide sequences of extracellular matrix proteins used 
in tissue engineering applications. Adapted from [35]. 
 
1.1.9 Cell migration 
Migration of individual cells over or within a tissue engineering scaffold is important 
to fully colonise the scaffold and complete the repair process. Cell migration may 
occur in association with the surface of a material by contact guidance or through an 
Synthetic Peptide Sequences Origin  Function Ref.
RGD  Fibronectin, Vitronectin Cell adhesion [112, 113]
KQAGDV  Smooth muscle cell adhesion [114]
YIGSR Laminin B1 Cell adhesion [115, 116]
REDV Fibronectin Endothelial cell adhesion [117, 118]
IKVAV Laminin Neurite extension [115, 119]
RNIAEIIKDI Laminin B2 Neurite extension [119]
KHIFSDDSSE Neural cell adhesion molecules Astrocyte adhesion [120]
VPGIG Elastin Enhance elastic modulus of artificial ECM [118]
FHRRIKA Heparin binding domain Improve osteoblastic mineralization [121]
KRSR Heparin binding domain Osteoblast adhesion [122]
NSPVNSKIPKACCVPTELSAI BMP-2 Osteoinduction [123]
APGL Collagenase mediated degradation [124]
VRN Plasmin mediated degradation [124]
AAAAAAAAA Elastase mediated degradation [125]
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ensemble of other cells. In neuronal regeneration, SCs provide the natural substrate 
for axon migration [126, 127]. They produce structural and cell adhesive ECM 
molecules such as laminin and collagen, and express many cell adhesion molecules 
and neurotrophin factors that can serve as guidance cues for axonal growth [49].  
 
1.1.10 Cell adhesion and integrin receptors  
Over the past few decades, various receptor–ligand systems for cell–cell and cell–
matrix binding have been identified and characterised. Some of the most common cell 
surface molecules involved in cell adhesion and motility are the integrins which are 
heterodimeric membrane proteins, consisting of non-covalently associated α and β 
subunits (Figure 1.22) [128]. Each member of the integrin family can be characterised 
by the combination of subunits involved; for example, α1β1 binds to collagen and 
laminin, α5β1 to fibronectin, and β2 to ligands on cell surfaces. Integrin binding is Ca
2+
 
dependent. Integrin-mediated cell adhesion is usually associated with cell–matrix 
interactions where the extracellular domain of the integrin receptor binds to an ECM 
protein and the cytoplasmic integrin domain binds to the protein cytoskeleton. 
Therefore, integrin receptors provide a critical connection between the extracellular 
and intracellular environments. Matrix proteins such as fibronectin, collagen, laminin, 
vitronectin, thrombospondin, tenascin and entactin contain the three amino acid 
sequence, arginyl-glycyl-aspartic acid (RGD). The short amino acid sequences, 
identified by analysis of active fragments of ECM molecules, appear to compete for 
the integrin receptor site and bind to receptors on cell surfaces to mediate cell 
adhesion. Moreover, different integrins bind selectively to different proteins at 
RGD-containing sites, suggesting that binding is also affected by polypeptide 
domains adjacent to the RGD domain, but specific to each protein.  
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Figure 1.22 Schematic architecture of integrin heterodimeric adhesive 
receptors consisting of α- and β-subunits. The ligand binding site is provided by the 
N-terminal domain of the α- and β-integrin subunits (the β-propeller and the βA 
domain, respectively) which are assembled in most integrins by non-covalent 
interactions to form a “head”. It is known that in eight α integrin subunits (α1, α2, α10, 
α11, αL, αM, αX and αD), the αA domain, which is homologous to the βA domain of 
the β-integrin subunit, is inserted into the β-propeller domain. This is the main 
ligand-binding site in these integrins [128]. 
 
1.1.11 Growth factors and nerve regeneration 
The effect of neurotrophic factors in neural development, axonal survival, outgrowth 
and branching has been examined in detail at various levels, from molecular 
interactions to macroscopic tissue responses, in the PNS and CNS. Various types of 
neurotrophic factors are active at the site of neural injuries, including neurotrophins 
such as NGF, brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5. 
Furthermore, cytokines and insulin derivatives, ciliary neurotrophic factor, glial cell 
line-derived growth factor and acidic and basic fibroblast growth factors induce 
important neurotrophic effects [43, 129-131] (Table 1.6).  
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Table 1.6 Neural responses to neurotrophic factors. 
*BDNG, brain-derived nerve growth factor; NT-3, neurotrophin-3; N/T-4/5, neurotrophin-4/5; CNTF, 
ciliary neurotrophic factor; GDNF, glial cell line-derived growth factor; aFGF/bFGF, acidic and basic 
fibroblast growth factor. 
 
Consequently, the controlled release of neurotrophic factors from tissue engineering 
scaffolds has been studied with the aim of enhancing nerve regeneration. Several 
delivery systems such as polymer matrices [132], microspheres [133, 134], viral 
vectors [135, 136] and liposomes [137] may be used to supply neurotrophic factors in 
conjunction with the use of nerve guides or scaffolds, but challenges exist in 
delivering the necessary quantities and types of neurotrophic compounds at the rates 
conducive to regeneration. Ideally, a delivery system should improve the molecular 
stability of growth factors, control the rate of release and achieve cell targeting.  
 
 
 
 
 
 
Neurotrophic factors Neural response promoted
BDNG, NT-3, NT-4/5, CNTF, GDNF Motor neuron survival
BDNG, NT-3, NT-4/5, CNTF, GDNF Motor neuron outgrowth
NGF, NT-4/5, GDNF Sensory neuron survival
NGF, BDNF, NT-3 Sensory neuron outgrowth
NGF, NT-3, CNTF, FGFs Spinal cord regeneration
NGF, NT-3, NT-4/5, CNTF, GDNF, FGFs Peripheral nerve regeneration
NGF, NT-3, GDNF, FGFs
Sensory nerve growth across the PNS – CNS
transition zone
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Specific Research Objectives 
The prospects for successful peripheral nerve repair using tissue engineering 
principles are considered to be enhanced by use of a 3D scaffold which promotes 
attachment and growth of regenerating neurons and glial cells. The overall aim of the 
research described in this thesis was to evaluate in vitro the potential of alginate 
polysaccharide fibres as tissue engineering scaffolds for nerve repair.  
The specific objectives were as follows: 
1. To produce alginate fibres by wet spinning and modify them with gelatin a) to 
produce an adhesive surface for nerve cell adhesion b) to investigate the potential for 
polypeptide growth factor incorporation in the fibres and c) to provide a method for 
macropore production by extraction of gelatin particles from the fibres. The latter 
approach was aimed at producing macropores of sufficient size and connectivity to 
permit proliferation of nerve cells, neurite outgrowth and axonal extension to restore 
nerve function.  
2. To characterise in detail the 3D structure of macroporous alginate fibres (pore 
dimensions, porosity, interconnected pores) using confocal laser scanning microscopy 
and image analysis to elucidate the relationship between macropore structure and 
formulation parameters and to permit subsequent correlations with the growth of 
encapsulated nerve cells.  
3. To establish wet spinning techniques for encapsulation of fibroblasts in alginate 
fibres and cell growth behaviour in culture as a precursor to experiments with nerve 
cells.  
4. To encapsulate dorsal root ganglion (DRG) cells in macroporous alginate fibres and 
investigate in cell culture the extent of neurite outgrowth and the formation of 
neuronal contacts throughout the scaffold.  
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5. To encapsulate photoreceptor-derived (661W) cells in macroporous alginate fibres 
and investigate their capacity to function as carriers for photoreceptor cells for 
applications in retinal regeneration.  
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CHAPTER 2 
Production of Alginate Fibres for Nerve Tissue Engineering 
 
ABSTRACT 
The prospects for successful peripheral nerve repair using fibre guides are considered 
to be enhanced by use of a scaffold material which provides a good substrate for 
attachment and growth of glial cells and regenerating neurons. Alginate polymers 
exhibit a highly favourable balance of properties and form hydrogels under mild 
crosslinking conditions. As a result, alginate has been widely applied for cell 
encapsulation. However, the polysaccharide exhibits extremely poor cell adhesion 
properties, which limits its application for tissue regeneration. Experimental nerve 
guides were thus produced from alginate fibres with the dual aim of providing a 
favourable substrate for cell adhesion and a delivery system for growth factors. Firstly, 
the diameters of the hydrated and dried fibres produced by extrusion of alginate 
solution into CaCl2 crosslinking solution through syringe needles of various sizes 
were determined using light microscopy and scanning electron microscopy (SEM). 
The mean diameter of hydrated fibres could be increased from approximately 450 to 
1300 µm by increasing the internal diameter of the needle used for fibre spinning. A 
major reduction in diameter by a factor of up to 10 occurred upon drying the fibres 
using ethanol treatment. A syringe needle with a size of 0.6 × 32 mm was 
subsequently selected for further experiments, since the spun fibres were easier to 
handle, and the dried fibres rehydrated efficiently. Tensile testing showed that alginate 
fibres dried with ethanol exhibited a mean tensile stiffness that was approximately 10 
times higher (26.2 MPa) than that of fibres dried at 60 °C (2.1 MPa), with a doubling 
of the tensile strength and reduction in failure extension. This behaviour may be 
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explained by rapid dehydration of the alginate fibres in ethanol, when compared with 
heating at 60 °C, which causes molecular extension and alignment. SEM examination 
of alginate fibres dried by ethanol treatment revealed a rough-textured, oriented 
surface that is expected to improve nerve cell adhesion. Alginate fibres were modified 
by gelatin a) to improve cell adhesion b) to investigate the potential for polypeptide 
growth factor incorporation in the fibres and c) to provide a method for macropore 
production by extraction of the gelatin particles from the fibres. Thus alginate fibres 
were a) incubated in 0.5, 1, 2 and 5% w/v gelatin solution b) wet spun into 
gelatin/CaCl2 solution c) wet spun from a mixed alginate/gelatin solution d) wet spun 
from alginate solution containing dispersed (undissolved) gelatin particles.  
Incubation of hydrated alginate fibres in 0.5% w/w gelatin solution at 37 
o
C resulted 
in low protein loading (1.7% w/w) and rapid release of gelatin (90% of the initial load) 
over 24 h in distilled water at 37 
o
C. In comparison, incubation of hydrated alginate 
fibres in 5% w/v gelatin solution resulted in approximately 9% w/w protein loading 
and gradual protein release (80% of initial content) over 9 days. The approach of wet 
spinning alginate solution into CaCl2 crosslinking solution containing dissolved 
gelatin was unsuccessful and resulted in extremely low or non-detectable protein 
loading (0–0.03% w/w) in the resulting fibres. Wet spinning a co-solution of alginate 
and gelatin into CaCl2 crosslinking solution resulted in low protein loadings of 1.2–
1.7% w/w for both hydrated and dried fibres. Major release (>70% initial content) 
occurred in 24 h. Alginate fibres incorporating gelatin particles were successfully 
produced by wet spinning suspensions of gelatin particles in 1.5% (w/v) alginate 
solution. Gelatin loading of the starting suspension of 40.0, 57.0 and 62.5% w/w 
resulted in gelatin loading of the hydrated alginate fibres of 16, 21 and 24% w/w 
respectively. Around 45 – 60% of the gelatin content of hydrated fibres was released 
in 1 h in distilled water at 37 
o
C, suggesting that a macromolecular structure for cell 
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growth would be rapidly established in cell culture. Furthermore, the residual gelatin 
is expected to form a favourable surface for nerve cell adhesion and axonal extension. 
 
2.1 INTRODUCTION 
The prospects for successful peripheral nerve repair using fibre guides are considered 
to be enhanced by using a scaffold material that provides a good substrate for 
attachment and growth of glial cells and regenerating neurons [16]. Various synthetic 
and natural biomaterials have been considered as cell supporting matrices. As a result, 
bicomponent fibres have been produced from synthetic polymers such as 
poly(ε-caprolactone) (PCL) in combination with the cell adhesion molecule collagen, 
to promote binding with α1β1 integrin receptors on the surface of axons and neuroglial 
cells, and thus, improve nerve repair [138]. Polymers of natural origin are attractive 
options for scaffold production due to their presence in ECM in some cases (e.g. 
collagen), their chemical versatility and biocompatibility. Alginate is a naturally 
occurring anionic, hydrophilic polysaccharide, derived primarily from brown seaweed 
and bacteria, which has been investigated extensively as a biomaterial. Alginate has 
been applied in the form of hydrogels for bone regeneration [139, 140], microspheres 
for bioactive and controlled release drug delivery [141-143], freeze-dried sponges to 
stimulate axonal regeneration [144], foams loaded with antimicrobial agent [145] and 
fibres as a carrier to deliver zinc [146], silver [147] and other active compounds that 
are beneficial for wound healing [148, 149]. Alginate exhibits excellent 
biocompatibility and biodegradability and can be easily modified via chemical and 
physical reactions to obtain derivatives having various structures, properties, function 
and applications [150]. Cell adhesion plays a critical role in cell migration, 
proliferation and differentiation. However, naturally derived polysaccharides do not 
readily promote cellular attachment and function due to an absence of ligands in the 
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chain structure that can bind with cell surface receptors. Thus alginate has been 
commonly modified using the amino acid sequence arginine-glycine-aspartic acid 
(RGD), derived from ECM proteins including fibronectin [151], laminin [152], and 
collagen [153] to provide cell anchorage via integrin cell surface receptors [154]. 
Addition of fibronectin to alginate hydrogel was shown to improve Schwann cell 
viability and proliferation in vitro [151]. Laminin-coated and YIGSR peptide 
conjugated alginate hydrogel (peptide/alginate ratios of 1 mg/g) improved NB2a 
neuroblastoma cell attachment by 44 and 60% respectively compared with the control 
[152]. Alginate-gelatin crosslinked (ADA-GEL) hydrogel (synthesized by covalent 
crosslinking of alginate di-aldehyde (ADA) with gelatin) was developed to support 
normal human dermal fibroblasts (NHDF) cell attachment, spreading and proliferation 
[140]. 
Gelatin is derived from collagen by breaking the natural triple-helix structure into 
single-strand molecules by hydrolysis and has been widely used for the production of 
cell support structures because of its cell adhesion properties and biocompatibility. 
The presence of acidic and positively charged lysine and arginine residues in the 
denatured collagen molecule promote electrostatic binding with negatively charged 
cell surfaces. In addition, specific cell adhesion (RGD) sequences along the protein 
molecule bind with cell surface integrin receptors (see Chapter 1, Section 1.1.10). 
Indirect cell–gelatin binding is also possible via interactions between integrin cell 
surface receptors and the RGD domain of fibronectin following formation of a 
fibronectin/gelatin interface.  
This chapter describes the production and characterisation of wet-spun alginate fibres 
and their modification using gelatin to investigate their potential as scaffold material 
for nerve regeneration. Alginate fibres were modified by gelatin a) to improve cell 
adhesion b) to investigate the potential for polypeptide growth factor incorporation in 
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the fibres and c) to provide a method for macropore production by extraction of 
gelatin particles from the fibres. The latter approach was intended to provide a 
connected macropore structure that would allow axonal growth throughout the fibre 
from neurons encapsulated in the fibres during wet spinning. 
 
2.2 MATERIALS 
Sodium alginate (Protanal RF 6650, G:M 2:1, pH 6.0–8.0) was obtained from IMCD 
Australia Limited. Calcium chloride (dried, 0.5 M, UniLab), gelatin from porcine skin 
(type A bloom 300, average molecular mass 50-100 kDa), bicinchoninic acid (BCA) 
reagents were purchased from Sigma-Aldrich Chemicals Australia. 
 
2.3 METHODS 
2.3.1 Wet spinning of alginate fibres 
Sodium alginate was dissolved in distilled water at a concentration of 1% w/v, and 0.5 
mL of the alginate solution was wet spun into 50 mL of 0.5 M CaCl2 solution through 
a syringe needle (0.6 × 32 mm). A syringe pump was used to feed the alginate 
solution into the needle tip at a rate of 2 mL/min. The alginate fibres (30–35 cm) 
were collected from the spinning bath, transferred to 20 mL of 0.5 M CaCl2 solution 
and incubated for 1 h. After treatment, the fibres were rinsed in distilled water and 
used in the hydrated (wet) form for further investigations or dried with absolute 
ethanol. The hydrated alginate fibres were dried with ethanol by immersion in an 
ethanol bath for 30 s at 25 °C, followed by transfer to the bench top to allow ethanol 
evaporation for 5 min (Figure 2.1). The treatment was repeated three times and 
ethanol was allowed to evaporate at room temperature for 30 min. 
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Figure 2.1 Production of alginate fibres by wet spinning. 
 
2.3.2 Gelatin modification of alginate fibres 
Wet-spun sodium alginate fibres were modified using gelatin a) to improve nerve cell 
adhesion to the fibres b) to investigate the potential for polypeptide growth factor 
incorporation in the fibres and c) to provide a method for macropore production by 
extraction of gelatin particles from the fibres which would permit axonal growth.  
 
2.3.2.1 Surface modification of alginate fibres with gelatin  
Gelatin was dissolved in distilled water (40 °C) to produce solutions of concentrations 
of 0.5, 1, 2 and 5% w/v respectively. Hydrated and dried alginate fibres 
(approximately 15-cm in length, produced according to the procedure described in 
Section 2.3.1) were incubated in 20 mL of the respective concentration of gelatin 
solution at 37 °C for 48 h. The fibres were rinsed with distilled water twice before 
further testing.  
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2.3.2.2 Alginate fibre spinning into a co-solution of gelatin and CaCl2 
Sodium alginate was dissolved in distilled water at a concentration of 1% w/v. Gelatin 
type A was dissolved in 0.5 M CaCl2 (40 °C) solution at a concentration of 2% w/v. 
Alginate solution (0.5 mL) was wet spun into the gelatin/CaCl2 solution through a 
syringe needle (0.6 × 32 mm). A syringe pump was used to feed the alginate solution 
into the needle tip at a rate of 2 mL/min. The alginate fibres were collected and 
transferred to 20 mL of 0.5 M CaCl2 solution and incubated for 1 h. After treatment, 
the fibres were rinsed once in distilled water. Hydrated or ethanol-dried fibres were 
assayed for protein content using the BCA assay (Section 2.3.4).  
 
2.3.2.3 Fibre spinning using co-solutions of alginate and gelatin  
Gelatin type A was dissolved in distilled water (40 °C) at a concentration of 2% w/v 
and then added into an alginate solution (1% w/v) at a ratio of 1:1 (gelatin solution: 
alginate solution). The gelatin/alginate solution (0.5 mL) was wet spun into 0.5 M 
CaCl2 solution through a needle (0.6 × 32 mm). A syringe pump was used to feed the 
solution into the needle tip at a rate of 2 mL/min. The alginate fibres were collected 
and transferred to 20 mL of 0.5 M CaCl2 solution and incubated for 1 h. After 
treatment, the fibres were rinsed in distilled water. Hydrated or ethanol-dried fibres 
were tested for protein content using the BCA assay (Section 2.3.4). 
 
2.3.3 Incorporation of gelatin in alginate fibres as a porogen for producing 
macropores  
Wet-spun sodium alginate fibres were modified by incorporation of gelatin particles 
with the aim of producing a connected macroporous structure that would facilitate 
neurite outgrowth and axonal regeneration from encapsulated neurons. Gelatin 
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powder was passed through a <90 micron mesh sieve, and either 100, 200 or 250 mg 
of sieved powder were homogenised in cold (4 
o
C) 1.5% w/v alginate solution (10 mL) 
at speed 2 for 30 s using a homogeniser (IKA Ultra-Turrax®  T25 basic). This 
produced suspensions with gelatin:alginate (w/w) ratios of 2:3, 4:3 and 5:3, 
respectively (corresponding to 40.0, 57.0 and 62.5% gelatin loading as a fraction of 
the total polymer content). The suspensions were wet spun through a syringe needle 
(0.6 × 32 mm) into 0.5 M CaCl2 solution to produce hydrated alginate fibres 
containing increasing amounts of gelatin particles. Fibre samples were rinsed in 
distilled water and dehydrated by immersion in ethanol as described in Section 2.3.1.  
 
2.3.4 Determination of the gelatin loading of alginate fibres  
Gelatin-modified alginate fibres (n = 10) were dissolved in 0.2 M sodium citrate 
solution (3 mL), and the gelatin concentration was determined using the bicinchoninic 
acid (BCA) protein assay (Sigma) by comparison with a calibration curve generated 
using serial dilutions of gelatin in distilled water (concentrations of 1000, 900, 800, 
600, 500, 400, 300 and 250 µg/mL). Gelatin loading of the fibres was subsequently 
expressed as % w/w of the dried fibre. The bicinchoninic acid assay (BCA assay), also 
known as the Smith assay, after its inventor, Paul K. Smith at the Pierce Chemical 
Company [155], is a biochemical assay for determining the total concentration of 
protein in a solution (0.5 μg/mL to 1.5 mg/mL). The total protein concentration is 
measured using the colour change of the sample solution from green to purple in 
response to protein concentration. The BCA assay primarily relies on two reactions. 
First, the peptide bonds in protein reduce Cu
2+
 ions from cupric sulfate to Cu
+
 (a 
temperature dependent reaction). The amount of Cu
2+
 reduced is proportional to the 
amount of protein present in the solution. Next, two molecules of bicinchoninic acid 
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chelate with each Cu
+ 
ion, forming a purple-coloured product that strongly absorbs 
light at a wavelength of 562 nm. The bicinchoninic acid Cu
+
 complex is influenced in 
protein samples by the presence of cysteine/cystine, tyrosine, and tryptophan side 
chains. At higher temperatures (37 to 60 °C), peptide bonds assist in the formation of 
the reaction product. Incubating the BCA assay at higher temperatures is 
recommended as a way to increase assay sensitivity while minimizing the variation 
caused by unequal amino acid composition [156]. The amount of protein present in a 
solution is quantified by measuring the absorption spectra and comparing with protein 
solutions of known concentration.  
 
2.3.5 Gelatin release from gelatin-modified alginate fibres 
Triplicate samples of the three types of fibres (i) alginate/gelatin fibres prepared by 
spinning from blended solutions (ii) alginate fibres incubated in gelatin solution and 
(iii) alginate fibres spun into gelatin/CaCl2 solution were placed in distilled water (3 
mL) in 10 mL (capped) centrifuge tubes and retained at 37 °C for 9 days. The release 
medium was replaced completely by distilled water on days 1, 3, 5, 7 and 9. The 
concentration of gelatin in the release medium was determined using the BCA protein 
assay by comparison with a calibration curve produced using series dilution of gelatin 
in distilled water (concentrations of 1000, 900, 800, 600, 500, 400, 250 and 220 
µg/mL). Gelatin release from the fibres was subsequently expressed as the weight of 
gelatin released (μg) versus time (days) and cumulative release (% w/w) versus time. 
Cumulative gelatin release was calculated from the released amount and the weight of 
gelatin remaining in the fibres at day 9. The fibres were broken down with 0.2 M 
sodium citrate (1.5 mL) and the residual gelatin content was obtained by comparison 
with a calibration curve of gelatin in sodium citrate.  
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2.3.6 Gelatin release from hydrated alginate fibres containing gelatin particles  
Cumulative gelatin release from fibres spun from suspensions having gelatin:alginate 
ratios of 2:3, 4:3 and 5:3 respectively, was measured for triplicate samples of hydrated 
and dried fibres respectively. Samples were retained in distilled water (3 mL) at 37 °C 
for 48 h and the release medium was replaced completely with fresh distilled water at 
20, 40 and 60 min as well as 24 h and 48 h. Gelatin concentration in the release 
medium was determined by the BCA protein assay (Sigma). The fibres were broken 
down on day 3 with 0.2 M sodium citrate (1.5 mL) to obtain the residual gelatin 
content. The amount of gelatin released from the fibres at each time interval and the 
residual gelatin content following breakdown of the fibres (Section 2.3.2) were 
determined using a calibration curve produced using a series dilution of gelatin in 
distilled water (concentrations of 1000, 900, 800, 600, 500, 400, 250 and 220 µg/mL). 
Cumulative gelatin release (% w/w) versus time (h) was calculated from the amount 
released at each time interval and the residual gelatin content. 
The gelatin loading of the fibres was calculated as a percentage (w/w) of the dried 
fibres: 
 
 
 
2.3.7 Tensile properties of dried alginate fibres 
Fibre nerve guides which are intended to provide a support scaffold for cells in vitro 
and eventual surgical implantation are required to possess adequate strength and 
stiffness to permit surgical placement without breakage. The tensile properties of 
alginate fibres dried by two different techniques (ethanol drying and drying at 60 
o
C) 
were determined to compare the effect of drying techniques on fibre strength, stiffness 
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and elongation. The alginate fibres were prepared as described in Section 2.3.1 
Following incubation in the second 20 mL volume of 0.5 M CaCl2 solution for 1 h, 
the alginate fibres were rinsed with distilled water and dried in an incubator at 60 °C 
for 30 min or dried using ethanol as described in Section 2.3.1. Fibres were cut to a 
length of 9–10 cm for examination of tensile properties. The diameter of fibres dried 
with ethanol (circular cross section, approximately 85 µm) and the width of those 
dried at 60
 °
C (flat rectangular cross section, approximately 1 mm dimension) were 
measured using optical microscopy (Olympus BH-2 Trinocular Microsope) at 10× 
magnifications, calibrated with a 1-mm scale slide. Fibres were tested using an Instron 
5543 tensile testing machine. Uniaxial testing of the dried alginate fibres was 
performed in tension mode using the ramp force procedure. A ramp force of 0.1 
N/min was applied using a 5 N load cell. Fibre extension was measured using an 
optical encoder. Stress versus strain curves were generated for different samples (n = 
5) and used to determine the tensile modulus (stiffness, tensile strength and fibre 
failure extension.  
 
Young’s modulus (modulus of elasticity) 
Young's modulus is the most common elastic modulus, also known as the modulus of 
elasticity. It is a measure of the stiffness of an elastic material and is calculated from 
the ratio of stress (force per unit area) along an axis to the strain (ratio of deformation 
over initial length) along that axis in the range of stress in which Hooke's law holds 
[157]. 
Strain 
Strain is "deformation of a solid due to stress" - change in dimension divided by the 
original value of the dimension - and can be expressed as 
ε = dL / L         (1) 
50 
 
where 
ε = strain (m/m) 
dL = elongation or compression (offset) of the object (m) 
L = length of the object (m) 
Stress 
Stress is force per unit area and can be expressed as 
σ = F / A         (2) 
where 
σ = stress (N/m2)  
F = force (N) 
A = cross-sectional area of object (m
2
)  
Young's Modulus (Tensile Modulus) 
Young's modulus or tensile modulus (E) is expressed as 
E = stress / strain = (F / A) / (dL / L)  
 
2.3.8 Morphology of hydrated alginate fibres using cryo-scanning electron 
microscopy  
The morphology of hydrated alginate fibres was examined using a Philips XL30 
scanning electron microscope (SEM). The XL30 has an Oxford CT1500 Cryo transfer 
system fitted for cryo-scanning electron microscopy (cryo-SEM) that allows suitable 
hydrated specimens to be examined frozen. The samples were mounted on an 
aluminium stub using a small amount of graphite paste and then introduced into the 
air lock of the cryo-preparation chamber, where evacuation was initiated. The 
specimen was immediately transferred to the cold stage of the preparation chamber, 
pre-cooled to approximately –180 °C, and sputter-coated with platinum in an argon 
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atmosphere inside the chamber before examination at a voltage of 5 kV. 
 
2.3.9 Morphology of dried alginate fibre using scanning electron microscopy  
The morphology of dried alginate fibres was examined using a Philips XL30 scanning 
electron microscope (SEM). Samples were mounted on carbon stubs and 
sputter-coated with platinum using an Eiko-Sputter coater automatic mounting press 
prior to examination at a voltage of 10 kV.  
 
2.4 RESULTS AND DISCUSSION  
2.4.1 Dimensions and morphology of alginate fibres 
In the current study, alginate fibres were prepared successfully and reproducibly by 
wet spinning solutions of 1% w/w alginate (G:M ratio 2:1) into 0.5 M CaCl2 
crosslinking solution (Section 2.3.1). The ratio of guluronic/mannuronic acid, the 
length of the guluronic acid residues, and the molecular weight of the polymer [66] all 
significantly affect the crosslink characteristics of the gel. In the egg-box model of 
alginate postulated by Grant et al. [64] described earlier (Chapter 1, Section 1.1.5), the 
guluronic acid sequences along the alginate molecule primarily bind to each other via 
calcium ions. Gel properties are known to be influenced by the concentration of 
alginate solution, the duration of gelation, the molarity of the divalent crosslinking 
solution [158, 159] and method of sterilization [160]. Therefore, alginate featuring a 
high guluronic acid content (G:M ratio 2:1) was selected based on previous studies 
[160, 161], in order to provide mechanically stable cell support [71]. Furthermore, 
Bohari et al. [162] reported that as the concentration of alginate increased to 2 and 5%, 
major 3T3 fibroblast cell death (30–50%) occurred within the hydrogel matrix at day 
one while cell viability was maintained in excess of 90% when encapsulated using 0.5 
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or 1% alginate solution. This behaviour was explained by the higher viscosity of 
alginate solution at higher concentration which exerts high shear stresses that damage 
the cells during homogenisation in sodium alginate solution [163]. Based on the work 
of Bohari et al. [162] alginate solution at a concentration of 1 – 1.5% w/w was used in 
the present study as an optimum concentration for subsequent spinning of 
cell-containing fibres. 
Experimental fibre nerve guides were initially produced entirely from alginate with 
the aim of providing a substrate for modification by cell adhesion proteins. The 
diameters of the hydrated and dried fibres produced using needle sizes of 1.1 × 38 
mm, 0.6 × 32 mm and 0.3 × 13 mm were measured using light microscopy and 
scanning electron microscopy (SEM). The mean diameter of hydrated fibres could be 
varied from approximately 450 µm to 1300 µm by increasing the internal diameter of 
the needle used for fibre spinning (Table 2.1). A major reduction in diameter by a 
factor of up to 10 occurred upon drying the fibres using ethanol (Table 2.1). Dried 
fibres spun from the smaller syringe needle were found to rehydrate more rapidly than 
the larger fibres because of the lower fibre volume. A syringe needle with a size of 0.6 
× 32 mm was subsequently selected for further experiments, since the fibres generated 
(typically around 700 µm in diameter) were easier to handle, and the dried fibres 
rehydrated efficiently. 
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Table 2.1 Diameters of hydrated and dried alginate fibres. Fibres were spun from 1% 
w/v alginate solution into 0.5 M CaCl2 solution. Flow rate of alginate solution to 
needle = 2 mL/min. 
 
 
2.4.1.1 Alginate fibre morphology 
The optical micrograph of a hydrated alginate fibre in Figure 2.2A reveals the 
translucent appearance and uniform structure. The longitudinal ripples or flow lines 
visible are probably formed by passage of the alginate solution through the syringe 
needle. The cryo-scanning electron micrograph in Figure 2.2B reveals the fine 
textured microporous structure of the hydrated alginate fibre. The pore size was 
approximately 1 µm. The microporous structure of the alginate fibre is expected to be 
highly inter-connected and therefore advantageous to permit nutrient supply to 
encapsulated cells and allow oxygen exchange in the inner regions of the scaffold to 
maintain cell viability. SEM examination of the alginate fibres dried by ethanol 
treatment revealed a rough-textured, oriented surface (Figure 2.3).  
 
 
Figure 2.2 (A) Optical micrograph of hydrated fibre. (B) Cryo-scanning electron 
Syringe needle
Hydrated fibre
diameter (µm)
Dried fibre
dimension (µm)
19G × 1.5" (1.1 × 38 mm) 1300 ± 100 120 ± 10
23G × 1.25" (0.6 × 32 mm) 680 ± 30 87 ± 5
30G × 0.5" (0.3 × 13 mm) 447 ± 6 40 ± 3
*Values are mean ± SD of five individually prepared fibres for each needle size. 
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micrograph of hydrated fibre. (Pore size approx. 1 μm). The fibre was produced by 
wet spinning a 1% alginate solution through a syringe needle (0.6 × 32 mm) into 0.5 
M CaCl2 solution. 
 
Figure 2.3 (A) Dried alginate fibre and (B) its oriented surface. Fibres produced by 
wet spinning from a 1.2 × 38 mm needle and dehydrated by ethanol treatment. 
 
Interactions between biomaterials and cells are known to be influenced by the surface 
characteristics of the material, including topography, charge and chemical 
composition. It is generally accepted that rough, textured and porous surfaces 
stimulate cell attachment, differentiation and the formation of extracellular matrix 
[164-167]. For example, connective tissue cells, endothelium epithelium, peripheral 
nerves, and bone cells attach to rough surfaces move easily than to smooth surfaces of 
various polymer and metallic implants [168-170]. One explanation for this 
phenomenon is that a rough surface increases the effective surface area for cell 
attachment and promotes mechanical interlocking (bonding strength) by tissue 
ingrowth [171, 172]. The rough-textured, oriented surface of dried alginate fibres 
produced in the present study (Figure 2.3) may therefore be advantageous for 
promoting nerve cell adhesion and guiding axonal extension. 
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2.4.2 Tensile properties of dried alginate fibres  
In tissue engineering, it is preferable to use biomaterials with a modulus or stiffness 
close to that of the target tissue to prevent possible stress-shielding effects and to 
maintain sufficient mechanical support for cells during in vitro and/or in vivo cell 
growth and tissue remodelling. The Young‟s modulus of alginate fibres dried with 
ethanol was found to be 26.2 ± 15.2 MPa, a factor of 10 greater than alginate fibres 
dried at 60 C (2.1 ± 0.4 MPa) (Table 2.2). These values are comparable to those of 
human articular cartilage (0.7 – 15.3 MPa) [74]. The mean tensile strength of the 
fibres was 0.95 MPa when dried with ethanol and 0.4 MPa when dried at 60 °C, while 
the extension at failure was approximately 46 and 80%, respectively. The fibres dried 
with ethanol exhibited a tensile stiffness that was approximately 10 times higher than 
that of the fibres dried at 60 °C, with a doubling of the tensile strength and reduction 
in failure extension. This behaviour may be explained by rapid dehydration of the 
alginate fibres in ethanol, compared with heating at 60 °C, which causes molecular 
extension and alignment.  
 
 
 
 
 
 
 
 
Figure 2.4 (A) Stress–strain curves of alginate fibres dried using ethanol treatment. 
(B) Stress–strain curves of alginate fibres dried at 60 °C (n = 5). 
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Table 2.2 Tensile properties of dried alginate fibres (n = 5, mean ± SD). 
 
2.4.3 Gelatin modification of alginate fibres by incubation in gelatin solution 
Surface modification of hydrated and dried alginate fibres by gelatin was investigated 
by immersion of fibres in gelatin solution of different concentration (0.5, 1, 2 and 5% 
w/v) (Section 2.3.2.1) with the aim of improving the adhesion of nerve cells to 
potential fibre nerve guides and the adhesion of myofibroblasts to the external surface 
of tissue engineered nerves to form a biomimetic epineurium (Figure 1.3, Chapter 1). 
The hydrated fibres (produced as described in Section 2.3.1) following incubation of 
the fibres in 2% gelatin solution (20 mL) at 37 °C for 48 h were found to exhibit a 
fairly uniform gelatin loading of 9.3 ± 0.9% w/w (Figure 2.5). However, the gelatin 
loading of alginate fibres dried by ethanol treatment (Section 2.3.1) was inconsistent 
(15.4 ± 11.6% w/w) and varied by a factor of 10 from 3.4 – 40% w/w (Figure 2.5).  
Figure 2.5 Gelatin loading of alginate fibres (n = 10, mean ± SD) following 
incubation in 2% w/v gelatin solution at 37 °C for 48 h. (1) Hydrated alginate fibres. 
Drying technique
Young’s modulus (Tensile
stiffness) (MPa)
Ultimate tensile stress
(MPa)
Extension at break (%)
Ethanol treatment 26.2 ± 15.2 0.95 ± 0.3 46.8 ± 23.8
Heating at 60 °C 2.1 ± 0.4 0.4 ± 0.1 80.7 ± 29.0
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Mean gelatin loading using BCA assay = 9.3% w/w (standard deviation: 0.9). (2) 
Alginate fibres dried in ethanol. Mean gelatin loading using BCA assay = 15.4% w/w 
(standard deviation: 11.6). 
 
2.4.3.1 Gelatin release from hydrated alginate fibres modified by protein 
adsorption 
Hydrated alginate fibres that were incubated in 0.5% w/v gelatin solution were 
characterised by a low protein loading (1.7% w/w) and high burst release (90% of the 
protein content) on day 1 (Figure 2.6B). Hydrated alginate fibres that were modified 
by incubation in 1, 2 and 5% w/v gelatin solution resulted in a similar gelatin loading 
(8.9, 8.5 and 9.7% w/w respectively), and gradual protein release occurred over 9 
days (Figure 2.6B). This behaviour may be explained by the higher concentration of 
gelatin present in the incubation solution, which results in more efficient chain 
entanglement and hence entrapment of gelatin molecules at the fibre surface. It is 
apparent from Figure 2.6 that gelatin release is delayed from fibres incubated in 
higher concentration gelatin solutions (2 and 5% w/v) where around 50% of the 
absorbed protein is retained by the fibre at day 3, suggesting that a cell-adhesive 
surface may be provided for improved cell-attachment and growth.   
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Figure 2.6 (A) Gelatin release from hydrated alginate fibres (µg/mg fibre) and (B) 
Cumulative release of gelatin from hydrated alginate fibres (% w/w) in distilled water 
at 37 °C over 9 days. Mean fibre weight was 294 ± 26 mg. Fibres were incubated in 
0.5, 1, 2 and 5% w/v gelatin solution at 37 °C for 48 h before release testing. 
Corresponding gelatin loading of fibres was 1.7, 8.9, 8.5 and 9.7% w/w. 
 
2.4.3.2 Gelatin release from dried alginate fibres modified by protein adsorption 
Incubation of dried alginate fibres in gelatin solutions of increasing concentration (0.5, 
1, 2 and 5% w/v) resulted in a corresponding increase of adsorbed protein (0.4, 10.6, 
24.5 and 72.8% w/w, respectively). As in the case of the hydrated fibres, this 
behaviour suggests that association of protein molecules in solution was leading to 
enhanced protein density at the fibre surface. However, the increased protein 
adsorption on dry fibres may result from rehydration effects and requires further study. 
Insertion of gelatin molecules in completely rehydrated alginate fibres is controlled by 
protein diffusion from the incubation medium, whereas protein transport into the 
rehydrating fibre may be assisted by fluid flow effects and may be an important 
determinant of the protein loading of dried fibres. Gelatin adsorption on dried fibres 
exhibited a pronounced burst effect (100% of the protein load) observed for fibres 
modified using low gelatin solution concentration (0.5% w/v) (Figure 2.7B). Gradual 
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release of gelatin occurred from the fibres over 9 days in distilled water when the 
dried fibres had been incubated in gelatin solutions of 1, 2 and 5% w/v. A major 
decrease in the cumulative release to around 20% at 9 days was measured for fibres 
incubated in gelatin solutions with the highest concentration (5% w/v) (Figure 2.7B). 
Taken together, these findings suggest that surface modification of alginate fibres by 
gelatin may be maintained sufficiently to enhance nerve cell attachment and extension 
along fibre guides. Surface modification by gelatin may also be useful for adhesion of 
myofibroblasts to form a surface layer on tissue engineered nerve substitutes that 
mimics the epineurium.  
Figure 2.7 (A) Gelatin release from alginate fibres dried using ethanol (µg/mg fibre) 
in distilled water at 37 °C over 9 days. (B) Cumulative release (% w/w) of gelatin 
from alginate fibres dried using ethanol. Mean fibre weight was 24 ± 9 mg. Fibres 
incubated in 0.5, 1, 2 and 5% w/v gelatin at 37 °C for 48 h. Corresponding gelatin 
loading of fibres was 0.4, 10.6, 24.5 and 72.8% w/w. Release medium: distilled water 
at 37 °C. 
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2.4.4 Gelatin loading and release from alginate fibres spun into gelatin/CaCl2 
solution 
Attempts were made to modify alginate fibres with cell-adhesive gelatin molecules by 
wet spinning alginate solution into CaCl2 crosslinking solution containing dissolved 
gelatin. The aim was to entrap protein in the fibre surface during the process of 
alginate gelation induced by crosslinking with divalent Ca
2+
 ions. This approach was 
unsuccessful and resulted in extremely low or non-detectable protein loading in the 
resulting alginate fibres (0% for dried fibres, 0.03% w/w for hydrated fibres) (Figure 
2.8). The working range of the standard BCA assay protocol was limited to 200 – 
1,000 mg/ml (20 – 100 mg of total protein). In addition, complete loss of protein 
occurred rapidly in 24 h in distilled water (Figure 2.8B).  
 
Figure 2.8 (A) Gelatin release (µg/mg fibre) and (B) cumulative gelatin release (% 
w/w) from alginate fibres over 9 days in distilled water at 37 °C. (1) Fibres were 
manufactured by extruding alginate solution (1% w/w) into 0.5 M CaCl2 crosslinking 
solution containing dissolved gelatin (2% w/v). (2) Dried alginate fibres were 
prepared using ethanol treatment.  
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2.4.5 Gelatin loading and release from fibres wet spun from a mixed 
alginate/gelatin solution  
Attempts were made to modify alginate fibres with gelatin molecules by wet spinning 
a co-solution of alginate and gelatin into CaCl2 crosslinking solution. Dried 
alginate/gelatin fibres were prepared by ethanol treatment (Section 2.3.1). Low 
protein loadings of 1.7 and 1.2% w/w were obtained for hydrated and dried 
gelatin-loaded fibres respectively with major release of more than 70% of the protein 
content occurring in 24 h (Figure 2.9). The loading and release behaviour was similar 
to hydrated fibres modified with gelatin by incubation in low concentration (0.5%) 
gelatin solution (Figure 2.6B).  
Figure 2.9 (A) Gelatin release (µg/mg fibre) and (B) cumulative gelatin release (% 
w/w) from alginate fibres over 9 days in distilled water at 37 °C. (1) Fibres were 
manufactured by spinning a mixture of gelatin (2% w/v) and alginate (1% w/v) 
solution (gelatin:alginate volume ratio 1:1) into 0.5 M CaCl2 solution. (2) Dried 
alginate fibres were prepared by ethanol treatment. Total gelatin loading of (1) 
hydrated and (2) dried fibres was 1.7 and 1.2% w/w, respectively.  
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2.4.6 Incorporation of gelatin particles in alginate fibres to produce macropores 
Alginate fibres were successfully loaded with gelatin particles by wet spinning 
suspensions of gelatin particles in 1.5% (w/v) alginate solution. The aim was to create 
a macroporous network within the alginate fibre by extraction of the protein porogen 
to facilitate proliferation of nerve cells and axonal extension throughout the fibre with 
the formation of synaptic contacts. Three gelatin particle:alginate ratios (2:3, 4:3, 5:3) 
were investigated, equivalent to a gelatin content of 40.0, 57.0 and 62.5% in the 
starting suspension, to explore the potential for controlling the macropore content of 
the fibre and pore connectivity. The ratios were calculated as follows. 
 
Gelatin: 0.25 g  
1.5% alginate solution (10 mL): 0.15 g/10 mL  
Ratio: gelatin (0.25 g):alginate (0.15 g) = 5:3 (w/w)  
Note. Gelatin particle size and shape are characterised and presented in Chapter 3 
(Figure 3.4, Table 3.3). 
 
Gelatin loading of the starting suspension of 40.0, 57.0 and 62.5% (w/w) resulted in 
actual gelatin loading of the hydrated alginate fibres of 16, 21 and 24% w/w 
respectively (Figure 2.10). Hydrated fibres exhibited a burst release of around 45 – 
60% of the gelatin content in 1 h and only minor additional amounts of gelatin were 
released in 48 h (Figure 2.10B). This behaviour suggests that a macromolecular 
structure for cell growth would be rapidly established in cell culture. In addition, the 
plateau of gelatin release vs. time for the hydrated fibres is noteworthy and suggests 
that a fraction of the gelatin content may be bound within the alginate fibre, where it 
may function to improve cell adhesion. In comparison, the gelatin loading of alginate 
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fibres dried using ethanol treatment was 12.4, 18.0 and 36.0% w/w respectively 
(Figure 2.11). Gelatin release from dry fibres was reduced to 3 – 20% in the first hour 
and to 10 – 30% over 48 h (Figure 2.11B). As expected, the gelatin content was 
retained more effectively by the dried fibres compared with the hydrated fibres 
reflecting the time required for fibre rehydration and the corresponding lag time for 
dissolution of the gelatin particles.  
 
Figure 2.10 (A) Gelatin release (µg/mg fibre) and (B) cumulative gelatin release (% 
w/w) from hydrated gelatin-loaded alginate fibres over 2 days in distilled water at 37 
°C. Fibres were produced from suspensions of sieved gelatin particles (<90 µm) in 
alginate solution with gelatin contents of 40.0, 57.0 and 62.5% w/w. The 
corresponding (actual) loading of gelatin in the spun fibres was 16, 21 and 24% w/w.  
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Figure 2.11 (A) Gelatin release (µg/mg fibre) and (B) cumulative gelatin release (% 
w/w) from dried gelatin-loaded alginate fibres over 2 days in distilled water at 37 °C. 
Fibres were produced from suspensions of sieved gelatin particles (<90 µm) in 
alginate solution with gelatin contents of 40.0, 57.0 and 62.5% w/w and were dried 
using ethanol. The corresponding (actual) loading of gelatin in the spun fibres was 
12.4, 18.0 and 36.0% w/w. 
 
2.5 CONCLUSION 
Wet-spun alginate fibres were successfully modified by gelatin via a) protein 
adsorption b) wet spinning into gelatin/CaCl2 solution c) wet spinning from a mixed 
alginate/gelatin solution and d) by suspending gelatin particles in the alginate 
spinning solution. Gelatin surface modification of hydrated and dried alginate fibres 
by adsorption from gelatin solution resulted in retention of 50% and 90% respectively 
of the protein content after incubation in distilled water at 37 
o
C for 3–4 days. This 
behaviour indicates a method for improving nerve cell adhesion to tissue engineering 
scaffolds prepared from alginate fibres. Alginate fibres incorporating gelatin particles 
up to a loading of 24% w/w were successfully produced by wet spinning suspensions 
of gelatin particles in alginate solution. Around 45–60% of the gelatin content of 
hydrated fibres was released in 1 h in distilled water at 37 
o
C, suggesting that a 
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macroporous  structure potentially advantageous for nerve cell growth would be 
rapidly established in cell culture. Furthermore the residual gelatin is expected to form 
a favourable surface for nerve cell adhesion and axonal extension.  
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CHAPTER 3 
Production and Characterisation of a Macroporous Structure in 
Alginate Fibres for Nerve Repair 
 
ABSTRACT 
The production of macroporous alginate fibres with transverse dimensions of around 
400 µm for nerve cell encapsulation was achieved by wet spinning suspensions of 
gelatin particles in alginate solution into CaCl2 crosslinking solution, followed by 
gelatin extraction in distilled water. Confocal laser scanning microscopy (CLSM) and 
image analysis provided detailed qualitative and quantitative information on pore size 
and size distribution and provided an estimate of pore connectivity and maximum 
porosity (14.6%). CLSM also revealed that protein residues lined the macropore 
cavities and had migrated into the body of the alginate scaffolds. This finding 
provides evidence for macropore surface modification by cell adhesion molecules, 
which is potentially advantageous for nerve cell growth and axonal extension. 
 
3.1 INTRODUCTION 
One of the primary aims of tissue engineering scaffolds is to support cell attachment 
and growth so that cells are able to proliferate and occupy the whole volume of the 
scaffold. This establishes a need for scaffold structures that are not only 
biocompatible and biodegradable but also possess optimum porosity, pore size and 
pore connectivity conducive to cell–cell contact and proliferation. A major restraint on 
progress in tissue engineering results from unsatisfactory scaffold pore structures that 
impede tissue ingrowth, nutrient supply to cells and metabolite dispersion. As a result 
numerous studies have focused on establishing the critical macropore size for cell 
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infiltration into various scaffolds produced using different biomaterials (Tables 3.1) 
[173].  
 
Table 3.1 Optimal pore size for cell infiltration and host tissue ingrowth [173]. 
 
The most common techniques used to create porosity in a biomaterial are salt leaching, 
gas foaming, phase separation, freeze-drying and sintering [182-184]. The most 
versatile methods involve incorporating water-soluble particulates as porogens in 
polymer matrices formed using solution or melt processing [185-187]. Studies have 
shown that the porosity and pore size of the scaffolds can be controlled by alternating 
both the size and amount of leachable particles. However, enhancing porosity in tissue 
engineering scaffolds, while facilitating tissue ingrowth and the exchange and 
diffusion of nutrients and gases, may also adversely reduce the mechanical strength of 
the scaffolds [188, 189]. Therefore, balancing the porosity, pore morphology, pore 
interconnectivity and mechanical properties is of key importance in scaffold 
fabrication. Nam et al. [190] showed that macropores with a size of 100–200 µm, 
generated between layers of PCL electrospun meshes after salt leaching, promoted 
cartilage/CFK2 cell infiltration to a depth of 4 mm with cellular coverage of up to 
70%. In contrast, cellular infiltration through the non-modified meshes was minimal 
(approximately 160 µm) over the same culture duration [185].  
Cell/tissue type Optimal pore size (μm) Scaffold material Ref.
Human skin fibroblasts <160 µm PLA/PLG [174]
Bone 450 µm P.P.M.M. [175]
Bone >100–150 µm Bioceramic [176]
Fibrocartilaginous tissue 150–300 µm Polyurethane [177]
Adult mammalian skin cells 20–125 µm Collagen–glycosaminoglycan (CG) [178]
Osteogenic cells 100–150 µm Collagen–GAG [179]
Smooth muscle cells 60–150 µm PLA [180]
Endothelial cells <80 µm Silicon nitride [181]
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Yang et al. reported that PLA and PLGA scaffolds (produced by salt leaching) having 
a pore size smaller than 160 µm facilitated growth of human skin fibroblasts [191]. 
Porous poly(methylmethacrylate) (PMMA) resin when implanted into skeletal and 
non-skeletal sites in vivo showed connective tissue ingrowth for a pore size of 100 µm 
and osseous tissue ingrowth in pores of 450 µm [192]. The issue of pore 
interconnectivity within scaffolds has attracted less attention than pore size, but plays 
a key role in determining the extent of tissue ingrowth. Pore structures often consist of 
irregularly shaped voids and connecting channels (connects) that can be difficult to 
define due to merging of adjacent cavities, resulting in the presence of fenestrations 
(windows) in the void walls [186]. Regardless of the type of material, it is vital to be 
able to characterise the pore network of scaffolds in 3D to determine the potential for 
cell ingrowth. Ma and Cho [193] prepared paraffin spheres as porogens (size range 
250–500 µm) to create spherical pores with well-controlled pore connectivity and 
porosity of 95% in biodegradable PLLA and PLGA polymer foams. Jones et al. [194] 
applied micro-CT to characterise the size, geometry and connectivity of macropores 
in bioactive glass scaffolds produced by a sol–gel foaming process and intended for 
bone repair (Figure 3.1). The pore structure was analysed by applying computer 
algorithms and then validated against mercury intrusion porosimetry and 3D image 
analysis [195]. The study also showed that micro-CT could be used to generate finite 
element models to predict scaffold mechanical properties and permeability. Soliman et 
al. [196] determined scaffold porosity from measurements of the void fraction in 
top-view scanning electron micrographs of electrospun scaffolds composed of 
poly(ε-caprolactone). The SEM images were converted to black and white binary 
images, and the percentage of white pixels in each image was determined to define 
the pore phase [196]. However, this approach does not yield actual information 
regarding the internal pore structure. Few studies have attempted to characterise the 
69 
 
fragile, hydrogel materials applied in soft tissue regeneration because of poor image 
resolution. Partap et al. [197] applied mercury intrusion porosimetry (MIP) and 
helium pycnometry to determine a porosity range for alginate hydrogels of 83–97% 
and a pore volume range of 4.5–20.3 cm3/g. X-ray microtomography (XMT) and 
scanning electron microscopy (SEM) provided information on pore size, (i.e., 
monodisperse pores with a diameter of 32.5–164 µm) and 2D and 3D morphology.  
 
 
 
 
 
 
 
 
Figure 3.1 Micro-CT image of a bioactive glass scaffold produced by a sol–gel 
foaming process, with streak lines showing the calculated paths of fluid flow [194]. 
 
The porosity of alginate tissue engineering scaffolds has also been investigated using 
electron microscopy [198, 199], gel permeation chromatography and diffusion 
measurements [200]. By studying electron micrographs of thin sections of alginate 
scaffolds, Smidsrød [199] found that the alginate gel core consists of pores ranging 
from 5 to 200 nm, whereas the gel network on the surface featured pores with a 
narrower size range (5–16 nm). In addition, gels prepared from alginate with a high 
guluronic acid (G) content have been reported to display open pore structures and 
therefore allow high rates of protein diffusion [199]. The porosity of alginate scaffolds 
is affected by various factors such as the drying method, physical properties, 
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concentration of alginate solution, pH and nature of the cross-linking agent. 
Exchanging the divalent crosslinking calcium ions with strontium or barium reduces 
the porosity slightly, because the gel network is resists swelling [200]. The nanoscale 
porosity in alginate gels allows small molecules such as glucose and other nutrients to 
diffuse freely, which explains the success of alginate microspheres for encapsulation 
of cells such as pancreatic islets [201]. Although the diffusion of nutrients and oxygen 
and the elimination of waste products of cell metabolism would be expected to occur 
freely in alginate hydrogel scaffolds, encapsulated cells are required to be within 100 
µm of a capillary to survive. The utility of alginate hydrogels as tissue engineering 
scaffolds also depends on the achievement of cell–cell contact and cell proliferation, 
which would be hindered by an absence of or insufficient macroporosity and pore 
interconnectivity. To overcome this limitation, many techniques have been applied to 
produce macroporous alginate matrices, including freeze-drying [202], particulate 
leaching (e.g. using supercritical fluids) [202, 203], gas foaming [204, 205] and 
micelle templating (MT) [196]. Partap et al. dispersed self-assembled 
cetyltrimethylammonium bromide (CTAB) surfactant micelles in the cross-linking 
(alginate – calcium) solution as a pore-forming template, followed by addition of 
adipic acid to yield porous alginate hydrogels. The MT hydrogel displayed controlled 
porosity of 83–97% and pore size distribution ranging from 32.5–164.0 µm [196].  
 
As mentioned previously (Chapter 2, Section 2.1), a major limitation of alginate 
hydrogels for cell support involves the lack of inherent cell adhesive properties 
leading to minimal interaction between encapsulated cells/tissue and the surrounding 
alginate hydrogel [202]. Cells in general do not present surface receptors for most 
hydrogel-forming polymers. Attempts to resolve this shortcoming have involved 
modifying synthetic scaffolds [203] and hydrogels [204] with ECM proteins such as 
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fibronectin (FN), vitronectin (VN), laminin (LN) and collagen for binding with cell 
adhesive receptors. Zhang et al. [204] reported that bone marrow stromal cells grow 
and migrate into electrospun PCL/gelatin scaffolds to twice the infiltration depth (114 
µm) compared with PCL scaffolds. Brynda et al. [205] modified the surface of 
poly(2-hydroxyethylmethacrylate) (PHEMA)-based hydrogels with collagen I 
attached with fibronectin and showed that the attachment of mesenchymal stromal 
cells (MSCs) and astrocytes improved markedly compared with unmodified hydrogels. 
Furthermore, the attachment of fibronectin and laminin to the collagen layer resulted 
in extensive cell growth compared with the poor adhesion and lack of proliferation 
displayed by the unmodified hydrogel. 
This chapter describes the production and characterisation of macroporous alginate 
fibres for specific application in nerve repair and for general application in soft tissue 
engineering such as tendon reconstruction. A wet spinning technique is described for 
producing macropores within alginate fibres via extraction of incorporated gelatin 
particle porogens. The aim was to provide macropores of sufficient size and 
interconnectivity to permit proliferation of nerve cells such as Schwann cells and 
neurons and axonal outgrowth so that electrical connections and nerve function are 
established. The use of gelatin was also anticipated to provide residual cell adhesion 
molecules following particle extraction to enhance cell attachment to the scaffold. The 
3D structure of the alginate fibres was characterised in detail using confocal laser 
scanning microscopy and image analysis to quantitatively define pore dimensions and 
porosity and to trace interconnected pores within the fibres. These investigations were 
designed to elucidate the relationship between pore structure and formulation 
parameters to enable subsequent correlations with the growth of encapsulated nerve 
cells. 
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3.2 MATERIALS  
Sodium alginate (Protanal RF 6650; G:M, 2:1) was obtained from IMCD Australia 
Limited. Calcium chloride (dehydrate, UniLab), Gelatin from porcine skin (Type A, 
Bloom 300, average molecular mass 50–100 kDa) was purchased from Sigma. 
 
3.3 METHODS 
3.3.1 Production of macroporous alginate fibres  
Gelatin powder was passed through a <90 micron mesh sieve, and either 100, 200 or 
250 mg of sieved powder were homogenised in cold (4 
o
C) 1.5% w/v alginate solution 
(10 mL) at speed 2 for 30 s using a homogeniser (IKA Ultra-Turrax®  T25 basic). This 
approach produced alginate solution with gelatin particle contents of 40.0, 57.0 and 
62.5% w/w (corresponding to 16, 21 and 24% w/w (actual) loading of gelatin in the 
spun fibres (described in Chapter 2, Section 2.4.6)). The resulting suspensions were 
wet spun into 0.5 M CaCl2 solution (50 mL) using a syringe needle (0.6 × 32 mm) to 
produce alginate fibres containing increasing amounts of gelatin particles. A 
suspension flow rate of 2 mL/min was applied using a syringe pump (Harvard 
Apparatus PHD 2000). The gelatin-loaded alginate fibres were rinsed and triplicate 
samples were retained in distilled water (15 mL) at 37 
o
C for 2 days to extract gelatin, 
thereby producing an internal macroporous structure.  
 
3.3.2 Gelatin particle size distribution 
The particle size (smallest and largest dimensions) of the sieved and unsieved gelatin 
powder was measured before and after homogenisation of gelatin powder suspensions 
in alginate solution (1.5% w/v) for 30 s, using an IKA Ultra-Turrax®  T25 basic. 
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Images and particle size measurements were acquired using an optical microscope 
(Olympus BH-2 trinocular microscope). 
 
3.3.3 Morphology of macroporous alginate fibres  
The morphology of dried gelatin-extracted alginate fibres was examined using a 
Philips XL 30 scanning electron microscope (SEM). Samples were mounted on 
carbon stubs and sputter-coated with platinum using an Eiko-Sputter coater automatic 
mounting press prior to examination at a voltage of 10 kV.  
 
3.3.4 Preparation of alginate fibre cryosections 
Alginate fibres without incorporation of gelatin particles were prepared as described 
previously (Chapter 2, Section 2.3.1) and macroporous alginate fibres were prepared 
following extraction of 21% w/w gelatin particle-loaded fibres (Section 3.3.1). 
Prepared fibres were stained with 1% w/v methylene blue solution (20 mL) overnight 
for subsequent visualization under the optical microscope. Fibres were rinsed with 
distilled water and placed into a pre-labeled cryomold. Each cryomold was then filled 
with cryo-embedding media (Tissue Tek®  O.C.T. Compound) and frozen at –80 oC 
for 24 h. Frozen blocks were transferred to a cryostat (Leica microsystems CM1850) 
at –20 °C prior to sectioning to allow the temperature to equilibrate to the temperature 
of the cryostat. Frozen fibre blocks were longitudinally sectioned along the flat plane 
of the construct. The first 10–15 sections (each 20 μm thick) were discarded 
followed by sectioning to produce 8 μm thick (middle) sections. Samples were 
collected onto glass slides prior to examination using an inverted optical microscope 
(CKX 41; Olympus) equipped with a digital camera (DP21; Olympus) and DP 
Controller software (Olympus). 
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3.3.4 FluoView Confocal Laser Scanning Microscopy (CLSM) 
A FluoView FV1000 confocal microscope (Olympus Corporation, Japan) was used to 
visualize and record images of alginate fibre sections placed in 2-well Lab-Tek 
chamber slides (Permanox® ) in contact with distilled water. To acquire stacks of 2D 
parallel images, laser excitation at 405 nm and emission detection at 415–515 nm 
were used in conjunction with a 10× objective lens with a numerical aperture (NA) of 
0.4. The image size was 640 × 640 pixels, with each pixel corresponding to 1.9884 
µm in the x and y directions. Images were acquired using a z-axis spacing of 4 µm. 
The image datasets were saved as .oif files and exported to .tif files for further 
analysis. 
 
3.3.5 Quantitative analysis of the internal pore structure of alginate fibres 
Analysis of transverse 2D confocal images (Figure 3.2A) obtained using a z-axis 
spacing of 4 µm provided a quantitative estimation of pore size distribution in alginate 
fibres following gelatin extraction for correlation with the initial particle size 
distribution. Software developed at Kingston University London based on MATLAB 
(The MathWorks Inc., Natick, MA, USA) was used to pre-process the 2D confocal 
images of the alginate fibres prior to 3D visualization of the pore structure. In 
summary, the 2D images were first converted to a grey scale and processed using 
thresholding to detect the pore boundary and form a binary image (Figure 3.2B and 
3.2C). The grey-scale images were filtered and the contrast was adjusted so that the 
applied threshold could be used to detect the dark regions of the pores. The threshold 
level was adjusted manually to best define the pores in each image [206]. Higher level 
processing involved the removal of small objects and the removal of the image border 
region prior to calculation of the pore area [206]. Pores on the borders of the images 
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were not included because they may not be complete and hence their shape would not 
be accurately represented. 
3D images of the pores were constructed using Amira v 5.3.1 software (Visage 
Imaging GmbH, Berlin, Germany). In this system, a network is used to obtain an 
isosurface representation of the pores and a partial outline of the fibre. Once the 2D 
CLSM shadow images were converted to grey scale using MATLAB, sequential 
grey-scale images (typically 110 slices) were processed to produce a 3D image using 
the Amira software v 5.3.1 programme. In addition, individual pores were shown in 
grey and interconnected pores were highlighted in red. The macroporosity (%) of 
alginate scaffolds produced by extraction of gelatin particles from 16, 21 or 24% w/w 
(actual) gelatin-loaded fibres was analysed using in-house computed algorithms. The 
porosity was calculated by comparing the volume of the pore phase with the total 
volume of the fibre section. It was difficult to obtain high-quality images all the way 
through the fibre thickness using CLSM because the diameter was typically 850–900 
µm. Thus a stack of approximately 100 images was selected for 3D reconstruction and 
analysis of macroporosity. In addition, the pore data for two sections from an image 
stack were used to provide a measure of the frequency distribution of equivalent pore 
diameters in the macroporous alginate fibre; the two sections were located towards 
either end of the image stack to prevent inclusion of the same pores twice. 
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Figure 3.2 Sequential images of an alginate fibre selected from a z-axis stack (slides 
95–100). (A) pre-processed fluorescence confocal images (B) binary image of the 
pore phase and (C) binary image of the fibre boundary. Images obtained from a 
hydrated gelatin-extracted macroporous alginate fibre produced by wet spinning a 
62.5% (w/w) gelatin particle suspension in alginate solution. Actual gelatin loading of 
fibre = 24% w/w. 
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3.4 RESULTS AND DISCUSSION 
Macroporous alginate fibres were successfully produced by wet spinning suspensions 
of gelatin particles in 1.5% (w/v) alginate solution at gelatin:alginate loading ratios of 
5:3, 4:3 and 2:3 (w/w). Fibres were spun into 0.5 M CaCl2 cross-linking solution 
followed by protein extraction in distilled water at 37 °C to produce the macroporous 
form. High protein loadings of 16, 21 and 24% (w/w) were obtained in the dried 
fibres corresponding to gelatin loadings of 40.0, 57.0 and 62.5%, respectively, in the 
starting suspension used for fibre spinning. An even distribution of gelatin particles 
was apparent in the fibres and they tended to be localized at the centre of the alginate 
fibre (Figure 3.3). 
 
 
Figure 3.3 Optical micrograph of a gelatin particle-loaded alginate fibre produced by 
wet spinning a 57% w/w suspension of gelatin particles in alginate solution. 
Corresponding gelatin loading of dried spun fibre = 21% w/w. 
 
The starting gelatin powder was composed of particles of irregular shape (block, 
wedge and cuboid forms; Figure 3.4). Prior to fibre spinning, the gelatin powder was 
passed through a 90-µm mesh sieve to obtain a particle size range <90 µm. This size 
was selected since a variety of mammalian cells appear to proliferate within 100 µm 
78 
 
pores, Table 3.1). The particle size of the sieved powder was measured before and 
after homogenisation for 30 s in alginate solution to determine the effect of shear 
conditions and the aqueous environment on the size of the particles incorporated 
within the fibre and thus on the expected macropore dimensions. 
Figure 3.4 Scanning electron micrographs of (A) unsieved, (B) sieved gelatin 
particles in a size range <90 microns. Magnified view at top right. 
 
Approximately 50 gelatin particles were randomly selected for measurement of the 
size distribution of unsieved (control) and sieved particles before and after 
homogenisation in alginate solution (Figure 3.5). The smallest and largest dimensions 
(µm) were measured by optical microscopy. The results in Table 3.2 and Figure 3.6 
show that the sieved gelatin particles exhibited dimensions as small as 57 ± 3 µm and 
as large as 102 ± 6 µm (Table 3.2). However, following homogenisation in alginate 
solution for 30 s at 4 
o
C (intentionally to prevent gelatin from swelling too much), the 
smallest and largest dimensions of the sieved gelatin particles increased by 
approximately three fold. This behaviour can be explained by the tendency of gelatin 
below a temperature of 35 – 40 °C to swell and absorb 5 – 10 times its weight of 
water [207].  
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Table 3.2 Size distribution of gelatin particles (n = 50, mean ± SEM). 
 
 
Figure 3.5 Optical micrographs of gelatin particles suspended in 1.5% w/v alginate 
solution. (A) unsieved (B) sieved particles before homogenisation (C) unsieved and 
(D) sieved particles following homogenisation in 1.5% alginate solution for 30 s at 4 
o
C.  
 
 
 
Small dimension
(μm)
Large dimension
(μm)
Small dimension
(μm)
Large dimension
(μm)
Gelatin particles 375 ± 17 511 ± 22 57 ± 3 102 ± 6
Gelatin particles
(following homogenisation in
alginate solution)
462 ± 22 600 ± 24 209 ± 7 276 ± 10
n = 50
p < 0.0001 (vs. Control)
Unsieved Sieved <90 µm
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Figure 3.6 Distribution of gelatin particle size. (A) smallest and largest dimensions of 
unsieved and sieved particles and (B) smallest and largest dimensions of unsieved 
(control) and sieved particles following homogenisation in 1.5% (w/v) alginate 
solution or 30 s at 4 
o
C. 
 
SEM examination of dried alginate fibres produced by wet spinning 1.5% w/v 
alginate solution alone (without suspended gelatin particles) into 0.5 M CaCl2 solution 
revealed a uniform fibre shape, a fibre diameter of approximately 200 µm and a 
rough-textured oriented or fibrillar surface (Chapter 2, Figure 2.11). Fibres were dried 
by treatment with ethanol. The pore size of the hydrated alginate fibres revealed by 
cryo-SEM was approximately 1 μm (Chapter 2, Figure 2.10B). The microporous 
structure of the alginate fibres is advantageous for the transport of metabolites, the 
supply of nutrients to cells and oxygen exchange in the inner regions of the scaffold to 
maintain cell viability. This feature is especially advantageous for the complex tissue 
engineering of organs. In comparison, alginate fibres produced by wet spinning 
alginate solution containing suspended gelatin particles exhibited a distorted, bulbous 
form after gelatin extraction and drying (Figure 3.7A, arrowed) with cross-sectional 
dimensions of approximately 350 µm (Figure 3.7). A macropore is partly visible in the 
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fibre cross-section (Figure 3.7B, arrowed). Cryo-sectioning of hydrated fibres 
revealed the internal macroporous structure (arrowed) produced by gelatin extraction 
(Figure 3.8C & 3.8D) while the plain alginate fibre (without incorporation of gelatin) 
exhibited a smooth gel texture (Figure 3.8A & 3.8B). The macroporous fibres appear 
to have retained a macropore size around 150–200 µm as defined by the gelatin 
particles. The cryosection images in Figure 3.8B also reveal the fibre surface 
discontinuities and depressions produced by solubilisation of gelatin particles which 
were located at the fibre surface and the consequent local thinning of the fibre. 
 
 
Figure 3.7 Scanning electron micrographs (A and B) of a dried gelatin-extracted 
alginate fibre produced by wet spinning a 57% w/w suspension of gelatin particles in 
alginate solution. Macropores are partially visible (arrowed). 
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Figure 3.8 Cryosection images of hydrated alginate fibres without incorporation of 
gelatin particles (A and B) reveal a smooth gel surface. The internal macroporous 
structure (arrowed) of an alginate fibre produced by gelatin extraction (C and D) 
shows macropores of irregular shape corresponding to the original gelatin particles. 
Fibres were stained by methylene blue for visualisation using inverted optical 
microscopy. 
 
FluoView CLSM 
FluoView CLSM analysis was capable of resolving the macroporous structure of 
gelatin particle-loaded alginate fibres (Figure 3.11B). Z-stack images were originally 
recorded at an excitation wavelength of 405 nm using an emission detection range of 
415–445 nm. However, the intensity of the autofluorescence signal was weak in some 
planes of the image stacks, which created difficulty in 3D reconstruction, because the 
software was unable to clearly define the pore boundaries. To ascertain the optimum 
excitation wavelength and emission detection wavelengths, wavelength scanning was 
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performed for gelatin-loaded and gelatin-extracted fibre samples to determine the 
maximum autofluorescence emission wavelength. The scan was set at an excitation 
wavelength of 405 nm and an emission detection range of 400–700 nm. Both 
gelatin-loaded (Figure 3.9A) and gelatin-extracted (Figure 3.9B) alginate fibre 
samples displayed two peaks at wavelengths of approximately 450 and 490 nm, 
respectively, with the non-extracted samples exhibiting a higher intensity signal 
(Figure 3.9A).  
Figure 3.9 Wavelength intensity of alginate fibres (A) before and (B) after gelatin 
extraction in distilled water. Fibres spun from 57% w/w gelatin particle suspension in 
alginate solution. 
 
CLSM image acquisition was subsequently performed using an emission detection 
range of 415–515 nm to deliver optimum intensity and improved image quality at 
lower laser power, thereby preventing damage to the sample. CLSM visualisation at 
the original emission settings of 415–445 nm required setting the laser power to 
100% to acquire clear images; however, subsequent operation at the higher bandwidth 
settings only required 50% of the laser power. 
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Figure 3.10 CLSM images of alginate fibre (A) differential interference contrast (DIC) 
and (B) autofluorescence. Fibre spun from 1.5% alginate solution through a syringe 
needle into 0.5 M CaCl2 solution. 
 
 
Figure 3.11 CLSM image of a 21% w/w gelatin particle-loaded alginate fibre 
produced by wet spinning a 57% w/w suspension of gelatin particles in alginate 
solution. (A) differential interference contrast (DIC) and (B) autofluorescence. 
 
CLSM micrographs of both gelatin-free and gelatin particle-loaded alginate fibres 
displayed intense autofluorescence (Figure 3.10B, 3.11B). Autofluorescence emission 
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is commonly reported in cells and originates from biological entities such as 
mitochondria and lysosomes when certain molecules are excited by UV/visible 
radiation of suitable wavelengths [208]. The most commonly observed 
autofluorescent molecules are NADPH and flavins. However, the extracellular matrix 
can also contribute to autofluorescence, because of the intrinsic properties of proteins 
such as collagen and elastin [209, 210]. The emission spectra of these molecules are 
mainly confined within 300–600 nm. The intrinsic fluorescence of proteins occurs at 
280–350 nm, requires excitation between 250 and 280 nm and is related to the 
aromatic amino acids tryptophan, tyrosine and phenylalanine [210]. Among the 
endogenous fluorophores, collagen and elastin have a relatively high quantum yield. 
They fluoresce broadly between 400–600 nm with excitation occurring at 300–400 
nm [211, 212]. Gelatin contains approximately 1% tyrosine, 2–3% phenylalanine 
and no tryptophan [213]. Phenylalanine is not excited in most cases, because of its 
low quantum yield; hence, the emission in gelatin mainly results from tyrosine. Liu et 
al. [214] reported that gelatin exhibited an intense blue fluorescence at 415 nm and 
proposed that it may be affected by the steric arrangement of tyrosine residues. 
Skjåk-Bræ k et al. [215] suggested that alginate autofluorescence may be caused by 
phenolic compound impurities present in most commercially available alginates. The 
process of sodium alginate production has been described in Chapter 1 (Section 1.1.5). 
Formaldehyde pretreatment is performed prior to alkaline extraction to remove 
phenolic compounds and discoloration [216]. However, small amounts of phenolic 
materials can persist in alginates. Analysis of purified alginates by fluorescence 
spectroscopy by Skjåk-Bræ k et al. [208] and Kuhtreiber et al. [217] revealed the 
continued presence of residues that exhibit emission at 450 nm. 
The present CLSM study showed that the gelatin particle-loaded alginate fibres 
exhibited higher emission intensity than alginate (Figure 3.9). This behaviour 
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advantageously caused the gelatin particles to stand out against the background 
fluorescence of the alginate phase (Figure 3.11B) thus facilitating analysis of particle 
distribution in the fibres. Interestingly, CLSM micrographs of gelatin-extracted fibres 
(Figure 3.12B) showed a bright blue ring around the pore structures (black colouring). 
This observation suggests that protein residues lined the pore cavity following protein 
extraction and had migrated into the body of the alginate fibre to a depth of around 
20–30 µm. This finding is consistent with the gelatin release behaviour observed for 
gelatin particle-loaded hydrated fibres (Chapter 2, Section 2.4.6) where 50% of the 
gelatin content was retained at 48 h. As a protein, gelatin exhibits amphoteric 
behaviour due to the presence of terminal amino and carboxyl groups and is positively 
charged below its isoeletric point (IEP) (Gelatin Type A exhibits an IEP of pH 7–9) 
[218, 219]. On the other hand, alginate is uncharged at pH 2 due to complete 
protonation and becomes more negatively charged with increasing pH until it is fully 
deprotonated at pH > 6.5. Velings and Mestdagh‟s [220] finding on the interactions 
governing protein/alginate association suggests that alginate and protein interact 
electrostatically in nature. Similarly, it is expected that gelatin binds electrostatically 
with the alginate fibre to surface modify the macropores and provide a cell adhesion 
property that would be anticipated to be highly advantageous for attachment and 
growth of encapsulated nerve cells and axonal extension.  
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Figure 3.12 CLSM microscopy of hydrated gelatin-extracted macroporous alginate 
fibres. (A) DIC, (B) autofluorescence, (C) 3D reconstruction showing isolated regions 
of macropore coalescence and (D) 3D projection view. The fibre was produced by 
extracting gelatin particles from a 16% w/w gelatin-loaded alginate fibre produced by 
wet spinning a 40% w/w gelatin particle suspension in alginate solution. 
 
Analysis of sequential CLSM image slices provided detailed quantitative information 
on the range of pore sizes and frequency distribution of pore sizes in the alginate fibre 
scaffold (in terms of equivalent pore diameter) (Figure 3.13). The 24% w/w 
gelatin-loaded alginate fibre after particle extraction exhibited a median pore diameter 
of 56 µm and a wide range of pore diameters (9–228 μm), with the majority between 
36–87 μm (Table 3.3). Gelatin-loaded fibres (16% w/w) after particle extraction 
exhibited a similar pore diameter and pore size range. The equivalent macropore 
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diameter of 21% gelatin-loaded alginate fibres following extraction of gelatin was 
found to measure around 70 μm (Table 3.3). It is also apparent on inspection of the 
frequency distribution curve in Figure 3.13B that the majority of the macropores 
(around 90%) are grouped in the range 25–100 μm. In comparison less than 75% of 
the macropores are in a similar size range for 16 and 24% gelatin loaded fibres 
following extraction. The macropore size distribution in Figure 3.13 revealed that 
around 50% of the macropores are smaller than 50 μm in diameter for all gelatin 
loadings. The narrowest pore size distribution was obtained in 21% gelatin loaded 
alginate fibres, demonstrating a capacity for controlling macropore structure by 
adjusting fibre spinning conditions. 
 
Table 3.3 Equivalent pore diameters of alginate fibre scaffolds determined by CLSM 
image analysis. 
 
 
 
 
 
 
 
 
 
Gelatin loading of
fibre (% w/w)
Sieved particle size
(μm)
No. of pores
analysed
Median equivalent pore diameter
(Inter-Quartile-Range)
Total range
equivalent pore
diameter (μm)
16 68 47 (35–87) 22–209
21 54 69 (40–90) 23–332
24 61 56 (36–87) 9–228
<90μm
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Figure 3.13 CLSM image analyses of hydrated macroporous alginate fibres - 
frequency distribution of equivalent macropore diameter following extraction of (A) 
16%, (B) 21% and (C) 24% w/w gelatin particle-loaded alginate fibres. 
 
Analyses of fibre macroporosity was carried out based on 3D image reconstructions 
generated using Amira software (Figure 3.14) and computed algorithms to define the 
pore volume (Figure 3.14A) within a corresponding fibre volume (Figure 3.14B). The 
macroporosity of alginate fibres prepared by extracting gelatin particles has been 
summarised in Table 3.4. A maximum porosity of 14.6% was obtained following 
particle extraction from 21% w/w gelatin-loaded fibres. Contrary to expectations 
increasing the gelatin loading of the alginate spinning solution did not increase the 
fibre porosity. It is interesting that maximum porosity coincided with fibres showing 
the narrowest pore size distribution (i.e. 90% pore < 100 µm, Figure 3.13B). The 
relatively low macroporosity values reflect the low efficiency of incorporation of 
gelatin particles in the alginate fibres (16–24% w/w) and suggest that particles have 
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been excluded from the extruded liquid filament or thread on passage through the 
syringe needle. Macropores produced by dissolution of gelatin particles that were 
embedded near the fibre surface are visible in the 3D section view in Figure 3.12D. It 
is also evident from the cryosections in Figure 3.8C and 3.8D that some particles were 
located at the fibre surface and produced curved indentations on dissolution, rather 
than complete internal macropores. 
 
Table 3.4 Macroporosity of gelatin-extracted alginate fibres determined by CLSM 
image analysis. 
 
 
 
Figure 3.14 3D visualization of hydrated 24% w/w gelatin-loaded alginate fibre after 
protein extraction. (A) pore volume and (B) volume of fibre body. 
 
 
 
 
Gelatin loading of
fibre (% w/w)
Gelatin loading of
spinning suspension
(%)
Pore volume Fibre volume % Porosity
16 40 4.6 × 107 4.0 × 108 11.3
21 57 2.4 × 107 1.6 × 108 14.6
24 62.5 2.7 × 107 2.3 × 108 12.1
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Figure 3.15 Regions of pore coalescence (highlighted in red) identified by CLSM 
analysis of (A) 16%, (B) 21% and (C) 24% (w/w) gelatin-loaded alginate fibres after 
protein extraction. (D) Magnified view of a region of pore coalescence. 
 
Macropore interconnectivity is essential to allow cell ingrowth throughout a scaffold 
and its eventual replacement by regenerated tissue. Macropore connectivity was 
assessed using the concept of „tortuosity‟ (τ), which describes the pore path length 
through the material. Tortuosity can be estimated by the arc-chord ratio, which is the 
ratio of the actual pore length (L) to the distance between the ends of pore (X) (Figure 
3.16) [220]. 
τ = 
L
X
 
The potential for quantifying macropore connectivity in the alginate fibre scaffolds 
was evaluated by tracing regions of macropore coalescence in selected 3D image 
presentations (Figure 3.15). As expected, alginate fibres with high gelatin particle 
loadings (Figure 3.15B and 3.15C) displayed a greater probability of pore coalescence 
than fibres with low gelatin loadings (Figure 3.15A). Connected pore lengths of 252 
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µm, 607 µm and 509 µm were measured for macroporous fibres produced by 
extraction of 16, 21 and 24% gelatin-loaded fibres respectively. Again it is interesting 
to note that the 21% w/w gelatin-loaded fibres displaying the narrowest pore size 
distribution (90% <100 µm, Figure 3.13B) resulted in the highest macropore 
interconnectivity. This finding indicates opportunities for improving pore connectivity 
for cell infiltration or axon extension by controlling the particle size distribution and 
content of porogens. However, it should be borne in mind that the dimensions of 
interconnecting channels (connects) and fenestrations or windows in the pore surface 
must also be of sufficient size to allow cell ingrowth and these structural features can 
be difficult to analyse. 
Figure 3.16 Determination of tortuosity in a porous material using the arc-chord ratio. 
(A) Tortuosity of a path through a porous structure (B) Tortuosity determined by the 
ratio of the pore length (L) to the displacement of the ends of the pore (X). (C) On 
compression the magnitude of L remains constant, but displacement X is reduced to 
X‟, resulting in an increase in tortuosity [221]. (D) Example of tortuosity pathway 
through a macroporous alginate fibre. 
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3.5 CONCLUSIONS 
Macroporous alginate fibres for application in nerve tissue engineering were produced 
by wet spinning suspensions of gelatin particles in alginate solution followed by 
extraction of gelatin. CLSM image analysis exploited the autofluorescence properties 
of alginate and gelatin to provide detailed 3D reconstructions of the pore structure, 
macropore dimensions, pore size distribution, porosity and pore connectivity for 
correlation with fibre spinning conditions and subsequent cell ingrowth behaviour. 
CLSM also revealed modification of the alginate macropore surface by gelatin, which 
is expected to be advantageous for nerve cell adhesion and axonal extension. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
94 
 
CHAPTER 4 
Cell Encapsulation of in Alginate Hydrogel Fibres Using Wet 
Spinning Techniques 
 
ABSTRACT 
The ability of plain alginate fibres and macroporous alginate fibres to maintain 
viability of encapsulated cells and to promote cell growth was assessed using 
fibroblasts. Swiss 3T3 mouse fibroblasts were encapsulated in alginate fibres by wet 
spinning cell suspensions of alginate solutions. Optical micrographs and cell staining 
(DAPI staining of nuclei and rhodamine staining of actin filaments) showed that cells 
were evenly distributed in the fibre and the majority remained as rounded cells with a 
few adopting a spindle-shaped structure characteristic of fibroblasts. Encapsulated 
cells remained viable over 50 days and were capable of continuing growth outside the 
fibre after this time period. Increasing the cell concentration of the spinning solution 
from 1.4 × 10
4
 to 1.5 × 10
6
 cells/mL resulted in no significant improvement of 
fibroblast extension and growth. This behaviour may be explained by efficient 
encapsulation of the cell within a closed hydrogel environment which only permits 
exchange of nutrients metabolites and oxygen to maintain cell survival. Human adult 
dermal fibroblasts (HDFa) were incorporated in macroporous alginate fibres by wet 
spinning alginate solutions containing both gelatin microparticles and suspended cells 
(cell concentration 3 × 10
5 
cells/mL). Cell distribution was evaluated using CLSM 
(following staining with Calcein-AM) at an excitation wavelength of 488 nm. 
Fibroblast-loaded macroporous alginate fibres were characterised by a cell density of 
approximately 360 cells/mm
3 
which was significantly higher (*P<0.05) than that of 
non-macroporous fibres (approximately 140 cells/mm
3
). Cell viability was maintained 
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for time periods of at least 12 days. This finding indicates a potential for repair of soft 
tissue by encapsulating cells or genetically modified, growth factor-secreting variants 
in alginate fibres.  
 
4.1 INTRODUCTION 
The primary aim of tissue engineering is to replace or facilitate regeneration of 
damaged or diseased tissues by applying combinations of biomaterials, cells and 
bioactive molecules. Conventional strategies for tissue repair frequently involve tissue 
transplantation from autogeneic (from the host), allogeneic (from the same species) 
and xenogeneic (from a different species) sources [222]. However, these approaches 
are associated with several drawbacks, such as limited tissue availability, 
immunogenicity and disease transmission and it is necessary therefore to find an 
alternative. Studies conducted in the last two decades have increasingly utilised 
polymeric matrices to control and guide wound healing and tissue regeneration, to 
elicit specific cellular interactions, functions and tissue responses, and most 
importantly, to serve as scaffolds to support cell transplantation.  
Hydrogels have been applied as cell support scaffolds for tissue engineering of 
cartilage [203, 223-226], cornea [227], skin [228, 229], tendon [230], vascular [231] 
and neural tissue [232-235] (Table 4.1). Cells are usually suspended in an aqueous 
precursor solution prior to encapsulation (Figure 4.1) [236]. Thus, the gelation process 
must be mild to avoid cell damage. The hydrogel scaffold in turn must be 
biocompatible and ideally biodegradable, while maintaining sufficient strength and 
stiffness to provide mechanical support for cell growth and tissue formation.  
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Table 4.1 Natural and synthetic polymer-based hydrogels for tissue engineering. 
 
Figure 4.1 Cell encapsulation in a hydrogel tissue-engineered scaffold. The hydrogel 
acts as a temporary extracellular matrix (ECM) and neo-tissue replaces the scaffold 
[236]. 
 
Many studies of cell encapsulation have utilised hydrogels formed from the linear 
polysaccharide, alginate, due to its biocompatibility and low toxicity. The most 
common technique involves suspension of cells in alginate solution prior to gelation 
under mild aqueous conditions involving crosslinking of guluronic acid sequences 
along the alginate chain molecule with divalent metal cations such as Ca
2+
. Lim and 
Sun [237] in 1980 first reported success in encapsulating pancreatic islets in 
Material Used cells Application  Ref.
Natural
Hyaluronic acid (HA) Fibroblasts Skin [228]
Collagen Astroglial cells Neural [234]
Gelatin Mesenchymal stem cells Cartilage [231]
Chitosan Chondrocyte, Foetal mouse cortical cells (FMCCs) Cartilage, Neural [226, 233]
Agarose Corneal stromal cells Cornea [227]
Alginate Chondrocytes Cornea, Neural [227, 235]
Synthetic
Poly(ethylene oxdie) (PEO) Chondrocytes Cartilage [223]
Poly(vinyl alcohol) (PVA) Chondrocytes Cartilage [205, 224]
Poly(ethylene glycol) (PEG) Primary human fibroblasts, Pheochromocytoma PC12 cells Cartilage, Neural [225, 232]
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alginate-polylysine-alginate (APA) microcapsules for the treatment of diabetes. 
Microencapsulated islets implanted into diabetic rats remained viable and glucose 
levels were controlled for up to three weeks. Maysinger et al. [238] described the 
encapsulation of genetically engineered rat fibroblasts producing nerve growth factor 
(NGF) in alginate polylysine-alginate gels intended for treatment of brain injury. 
Peirone et al. [239] encapsulated recombinant cells (epithelial cells, fibroblasts, and 
myoblasts) in three kinds of alginate-based microcapsules for delivery of therapeutic 
gene products and showed high cell viability (65–90%) in culture.  
Alginate composition and strength of the gel network are known to affect the growth 
of encapsulated cells. Alginates consisting of higher guluronic acid content have been 
reported to hinder cell growth and reduce metabolic activity for up to 40 days before 
recovery and proliferation [68, 70]. Use of a high crosslinking solution (CaCl2) 
concentration has also been shown to increase the gel strength, which may hinder cell 
elongation or proliferation [71].  
This chapter describes investigations of cell encapsulation in alginate fibres for 
application in tissue engineering. Fibre wet spinning techniques and cell culture 
conditions were established using fibroblasts not only as a precursor to experiments 
with nerve cells (Chapter 5) but also of the lower cost and robustness of these cells 
compared with nerve cells. The investigations were also useful for exploring the 
potential of cell-encapsulated alginate fibres for a) soft tissue repair in general and b) 
sustained delivery of growth factors or hormones produced in-situ by genetically 
modified cells.  
 
4.2 MATERIALS 
Sodium alginate (Protanal RF 6650, G:M 2:1) was obtained from IMCD Australia 
Limited. Calcium chloride (dehydrate) was purchased from UniLab. Gelatin from 
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porcine skin (Type A, Bloom 300, average molecular mass 50–100 kDa) and 
Dulbecco‟s phosphate-buffered saline (D-PBS; with MgCl2 and CaCl2, liquid, sterile 
filtered, suitable for cell culture, D8662) were purchased from Sigma. Complete 
culture medium prepared from Dulbecco‟s modified Eagle medium (DMEM; 
Invitrogen) supplemented with 10% foetal bovine serum and 1% penicillin and 
Calcein-AM (C3100-MP) were purchased from Invitrogen. Paraformaldehyde and 
dimethyl sulphoxide (DMSO; anhydrous, ≥99.9%) were purchased from 
Sigma-Aldrich. Phalloidin - FluoProbes®  415 FP-BP1240, 300 units* (Interchem) 
was purchased from Thermo Scientific. Wheat germ agglutinin (WGA) conjugates 
and 4,6-diamidino-2-phenylindole (DAPI) were purchased from Invitrogen. Swiss 
3T3 fibroblasts were contributed by the National Centre for Adult Stem Cell Research 
(NCASCR), Griffith University, Brisbane, Australia. Human adult dermal fibroblasts 
(HDFa) were contributed by the National Physical Laboratory, Teddington, UK. 
 
4.3 METHODS 
4.3.1 Culture of Swiss 3T3 fibroblasts 
Swiss 3T3 fibroblasts were cultured in a humidified incubator at 37 °C under 5% CO2 
in complete culture medium prepared from DMEM supplemented with 10% foetal 
bovine serum and 1% penicillin. The cells were cultured for 7 days and then detached 
with trypsin–ethylenediaminetetraacetic acid (EDTA; Invitrogen). Trypsin–EDTA (3 
mL) was added to the culture flask, which was then placed in an incubator for 3–5 
min. Following trypsin treatment, DMEM (3 mL) was added to deactivate the enzyme. 
Cell density was determined using a haemocytometer. The cell suspension was 
centrifuged at 1000 rpm for 8 min to obtain a cell pellet, which was resuspended in 
complete culture medium (2 mL) to obtain the required cell concentration for 
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subsequent encapsulation of fibroblasts in alginate fibres. 
 
4.3.2 Encapsulation of Swiss 3T3 fibroblasts in alginate fibres by wet spinning 
Sodium alginate was dissolved in distilled water at a concentration of 2% w/w and 
filtered using a syringe filter (0.2 µm 33 mm Millex Filter Units, Millipore). Swiss 
3T3 fibroblasts were suspended in complete culture medium (6.2 × 10
4
 cells/mL, 3 
mL) and added to the filtered alginate solution (10 mL) to obtain a cell density of 1.4 
× 10
4
 cells/mL in 1.5% w/v alginate solution. Cell–alginate solution (0.5 mL) was wet 
spun into 0.5 M filtered CaCl2 solution (50 mL) through a syringe needle (0.6 × 32 
mm). A syringe pump was used to feed the cell–alginate solution into the needle tip at 
a rate of 2 mL/min. Alginate fibres were collected from the spinning bath and rinsed 
in distilled water. The fibres spun from 0.5 mL cell-alginate solution were cultured in 
complete culture medium (5 mL) contained in 6-well tissue culture plate for 8 weeks. 
A schematic of the cell encapsulation process is shown in Figure 4.2.  
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Figure 4.2 Preparation of Swiss 3T3 fibroblast-loaded alginate hydrogel fibres by wet 
spinning. 
 
The effect of increasing cell density of the spinning solution on encapsulation of 
Swiss 3T3 fibroblasts in alginate fibres was investigated by dispersing fibroblasts (6.5 
× 10
6
 cells/mL, 3 mL) in filtered alginate solution (2% w/v, 10 mL) to obtain a cell 
density of 1.5 × 10
6
 cells/mL in 1.5% w/v alginate solution. Cell–alginate solution 
(0.5 mL) was wet spun into 0.5 M filtered CaCl2 (50 mL) as described in section 4.3.2 
to produce fibroblast-loaded alginate fibres.  
 
4.3.3 Encapsulation of Swiss 3T3 fibroblasts-in macroporous alginate fibres 
Gelatin type A was sieved through a 90-µm mesh sieve. The collected powder was 
sterilized under UV irradiation (Philips TUV 15W/G15 T8) in a cell culture hood for 
20 min. The container was agitated during sterilization to ensure that all particles were 
exposed to UV. A 2% w/v alginate solution (10 mL) was sterilized by filtration 
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through a syringe filter CA (0.2 × 33 mm Millex filter units, Millipore). Antiseptic 
techniques were strictly followed to prevent contamination. All instruments used, 
including the homogeniser and syringe pump, were sterilized by wiping the surfaces 
with 70% ethanol. Glassware and tools were autoclaved. Sterilized gelatin particles 
(<90 µm, 200 mg) were added to cold filtered 2% w/v alginate solution (10 mL) and 
homogenised using a IKA Ultra-Turrax
®
 T25 Basic homogeniser in the cell culture 
hood. Suspensions were produced with gelatin:alginate w/w ratios of 4:3, 
corresponding to 57% w/w gelatin loading as a fraction of the total polymer content. 
Swiss 3T3 fibroblasts (6.5 × 10
6
 cells/mL, 3 mL) were dispersed in the prepared 
gelatin/alginate suspension (10 mL) to achieve a final cell concentration of 1.5 × 10
6
 
cells/mL in an equivalent 1.5% w/v alginate solution. Cell–gelatin/alginate suspension  
(0.5 mL) was wet-spun into 0.5 M filtered CaCl2 solution (50 mL) through a syringe 
needle (0.6 × 32 mm) as described in section 4.3.2 to produce fibroblast-loaded 
alginate fibres. A schematic of the cell encapsulation process with incorporation of 
gelatin particles is shown in Figure 4.3.  
Figure 4.3 Preparation of Swiss 3T3 fibroblast-loaded macroporous alginate fibres.  
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4.3.4 Imaging of Swiss 3T3 mouse fibroblasts encapsulated in alginate fibres 
using confocal laser scanning microscopy 
Hydrated alginate fibres incorporating fibroblasts which had been maintained in cell 
culture for 8 weeks were examined by confocal laser scanning microscopy (CLSM; 
Leica SP5). Fibre samples were cut into approximately 1-cm long segments and 
rinsed with D-PBS for 20 min. The samples were then fixed and stored in 4% 
paraformaldehyde/D-PBS (1 mL) before staining. The paraformaldehyde/D-PBS 
solution was prepared by dissolving paraformaldehyde (3.2 g, Sigma) in D-PBS (40 
mL, Sigma) at 60 °C for 15 min at a concentration of 8% w/v. Sodium hydroxide (0.1 
M) was added drop-wise (10–15 drops). The solution was stirred at 60 °C until it 
became clear and was then removed from heat. D-PBS (40 mL) was added to adjust 
the concentration to 4% paraformaldehyde/D-PBS. The fibroblast-encapsulated 
alginate fibres were subsequently stained with DAPI and rhodamine-phalloidin 
(Section 4.3.7) to label cell nuclei and actin filaments, respectively, after the cells 
were permeabilized with Triton. The samples were examined perpendicular to the 
long axis, and images were captured every 3 µm (10× magnification) using CLSM. 
 
4.3.5 Encapsulation of human adult dermal fibroblasts (HDFa) in macroporous 
alginate fibres 
Preparation of the gelatin powders and the required antiseptic procedures were carried 
out as described in section 4.3.3. Suspensions were produced with gelatin:alginate 
w/w ratios of 4:3, corresponding to 57% gelatin loading as a fraction of the total 
polymer content. HDFa cells (1.3 × 10
6
 cells/mL, 3 mL) were dispersed in the 
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prepared gelatin/alginate suspension (10 mL) to achieve a final cell concentration of 3 
× 10
5
 cells/mL in an equivalent 1.5% w/v alginate solution. Cell–alginate solution (0.5 
mL) was wet-spun into 0.5 M filtered CaCl2 solution (50 mL) through a syringe 
needle (0.6 × 32 mm). A syringe pump was used to feed the cell–alginate solution to 
the needle tip at a rate of 2 mL/min. Alginate fibres were collected from the spinning 
bath, rinsed in distilled water and triplicate samples were cultured in complete culture 
medium (3 mL) for 12 days.  
 
4.3.6 Viability assay of HDFa cells encapsulated in macroporous alginate fibres 
using Calcein-AM staining 
Calcein-AM is a cell-permeant dye that can be used to determine cell viability in most 
eukaryotic cells. In live cells the nonfluorescent Calcein-AM is converted to a 
green-fluorescent Calcein after acetoxymethyl ester hydrolysis by intracellular 
esterases (Figure 4.4). Calcein-AM stock solution in anhydrous DMSO (1 mg/mL, 1 
µM) was prepared by adding 50 µL of anhydrous DMSO (≥99.9%, Sigma-Aldrich) to 
50 µg of Calcein-AM. The prepared stock solution was stored at −20 °C in the dark. A 
working solution was prepared by pipetting 10 µL of the stock solution into 9 ml of 
culture medium to achieve a concentration of 10 nM. Next, 1 mL of the 10 nM 
working solution was added to the HDFa-encapsulated alginate fibres (approximately 
1-cm section), and the samples were incubated at 37 °C under a 5% CO2 atmosphere 
for 45 min.  
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Figure 4.4 Calcein-acetoxymethyl ester (Calcein-AM) [240].  
 
4.3.7 Cell Staining 
The Swiss 3T3 fibroblast-encapsulated alginate fibres were stained with 
rhodamine-phalloidin and DAPI to label the actin filament and cell nuclei respectively. 
HDFa-encapsulated alginate fibres were stained with wheat germ agglutinin (WGA) 
and DAPI to label the plasma membrane and cell nuclei respectively.  
 
Rhodamine-phalloidin staining  
Phalloidin is a seven amino acid peptide toxin from the mushroom  Amanita 
phalloides, which binds specifically and with high affinity (Kd 20 nM) to the 
polymerized form of actin (F-actin). Phalloidin lowers the critical concentration of 
actin polymerization to less than 1 µg/mL, thereby acting as a polymerization 
enhancer. Phalloidin labelled with tetramethylrhodamine B isothiocyanate [241] is 
widely used as an alternative to actin antibodies for specifically labelling actin 
filaments in tissue cultured cells and tissue sections [242] and cell-free preparations. 
Rhodamine phalloidin-labelled actin filaments retain many functional characteristics 
of unlabelled actin including their ability to interact with myosin.  
A stock solution of rhodamine phalloidin was prepared by addition of 1.5 mL of 
methanol to Phalloidin - FluoProbes®  415 '300U' vials to yield a final concentration 
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of 200 units/mL (equivalent to 6.6 nmol/mL). The staining solution was prepared by 
addition of 100 µL of stock solution in 25 mL PBS with 1 % BSA (250 mg BSA in 25 
mL D-PBS). Staining solution (700 µL) was added to each well of 24 well plates 
containing Swiss 3T3 fibroblast-encapsulated alginate fibres (approximately 1-cm), 
and incubated for 1 h at room temperature in the dark. Following incubation, fibres 
were washed twice (800 μL/well) with D-PBS (at room temperature) for 5 min each 
(on a shaker) in the dark. 
 
Wheat germ agglutinin (WGA) staining  
Wheat germ agglutinin (WGA) is a carbohydrate-binding protein of approximately 36 
kDa that selectively recognizes sialic acid and N-acetylglucosaminyl sugar residues 
which are predominantly found on the plasma membrane. Molecular probe produces 
WGA conjugated to fluorophores, including the Alexa Fluor fluorophores, that have 
excellent photostability and illumination, are pH insensitive and may be used with a 
wide spectrum of emission wavelengths [243].  
A working solution of WGA in PBS (5 µg/mL) was prepared by adding a WGA stock 
solution (5 µL, 1 mg/mL) to PBS (1 mL). Next, 1 mL of the working solution was 
added to the fixed HDFa-encapsulated–alginate fibres (approximately 1-cm section) 
and incubated at room temperature for 30 min in the dark. Following incubation, the 
samples were washed twice for 5 min each with copious D-PBS.  
 
DAPI (4',6-diamidino-2-phenylindole) staining 
DAPI is a blue fluorescent nucleic acid stain that preferentially stains double-stranded 
DNA (dsDNA). It attaches to AT clusters in the DNA minor groove having one 
molecule of dye for each 3 base-pairs [244]. Binding of DAPI to dsDNA produces an 
approximate 20-fold fluorescence enhancement. The fluorescence is directly 
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proportional to the amount of DNA present, with emission maximum at 
approximately 460nm. A working solution of DAPI in distilled water (2.5 µg/mL) was 
prepared by adding a DAPI stock solution (5 µL, 5 mg/mL) to distilled water (10 mL). 
Then, 1 mL of the working solution was added to the fixed HDFa-encapsulated 
alginate fibres (approximately 1-cm sections), and incubated at room temperature for 
50 min in the dark. Following incubation, the samples were washed twice for 5 min 
each with copious amount of D-PBS.  
 
4.3.8 Imaging of encapsulated HDFa in alginate fibres using CLSM  
Alginate fibres containing human adult dermal fibroblasts which had been maintained 
in cell culture for 12 days were cut into approximately 5-mm segments and rinsed 
with D-PBS for 20 min. Samples were routinely examined under a FluoView FV1000 
confocal microscope (Olympus Corporation, Japan) in a 2-well Permanox plastic 
chamber slide system (Fisher Scientific) mounted in distilled water (1 mL). The 
samples were subsequently fixed and stored in 4% paraformaldehyde/D-PBS solution 
(1 mL) before staining. The paraformaldehyde/D-PBS solution was prepared as 
described in Section 4.3.4.  
To acquire stacks of 2-dimensional parallel images, laser excitation was performed at 
488 nm and 405 nm for WGA and DAPI with maximum emission detection at 535 nm 
and 461 nm, respectively. The image size was 640 × 640 pixels, with each pixel 
corresponding to 1.9884 µm in the X and Y directions. Images were acquired using a 
Z-axis spacing of 4 µm.  
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4.3.9 Image compilation and data analysis following Calcein-AM staining of 
HDFa 
Calcein-AM stained fibres were imaged using a FluoView FV1000 confocal 
microscope (Olympus Corporation, Japan). Samples (1-cm) were cut from the middle 
section of the spun fibre and placed in 2-well Lab-Tek chamber slides, Permanox®  in 
contact with distilled water. To acquire stacks of 2-dimensional parallel images, laser 
excitation was performed at 488 nm with maximum emission detection at 498–598 
nm. The image size was 640 × 640 pixels, with each pixel corresponding to 1.9884 
µm in the X and Y directions. Images were acquired using a Z-axis spacing of 4 µm. 
The cell distribution was analysed in 2D planes on the XY-axis and vertically through 
the fibre scaffold along the Z-axis. The 2D cross-sections of the fibre were used to 
generate 3D images using the following protocol. To visualize cell distribution in the 
fibre section, the low-surface-area cross sections at the top and base of the fibre were 
discarded and a stack of approximately 200 images was acquired. Further selection of 
every fifth image of the 200 images was carried out to provide an analysis depth of 
800 µm. The selected fibre sections were compiled using Adobe Illustrator CS4 
(Figure 4.5). Cell numbers were physically counted using only those cells that were in 
focus on each plane (Figure 4.5A) and were subsequently compiled into 3D images 
via 3D-rotate (Figure 4.5C). Under “Effect > 3D > Rotation”, values were set at 
horizontal (x) axis  -38
o
, vertical (y) axis  46
o
, and depth (z) axis  -32
o
. Cells 
marked in green represent Calcein-AM positive (live) cells on each 2D plane Counted 
cells were labelled in red to avoid double counting (Figure 4.5B). Data for total cell 
number/mm
3
 were acquired from the middle section of quintuplicate individual fibres 
for HDFa-encapsulated macroporous fibres and non-macroporous fibres (control) 
respectively. (Assuming a uniform distribution of cells across the fibre) A flowchart 
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depicting image compilation and data analysis is shown in Figure 4.5. 
Figure 4.5 Analysis of HDFa cell distribution and density in macroporous alginate 
fibre after 12 days of cell culture. Cells were stained using Calcein-AM prior to 
analysis (viable cells emit strong green fluorescence). (A) Live cells that are in focus 
on each 2D plane were counted within a 1 mm
2
 area in each image section and were 
marked in green. (B) Counted cells from each slide were labelled in different colour 
(red) to avoid double counting. (C) The sum of green-labelled cells in all image 
sections was used to determine the overall cell density.   
 
The number of live cells (shown in green) was also counted in a 3D reconstruction of 
the HDFa-loaded alginate fibre (1 mm
3
) and the inter-cell spacing of HDFa cells in 
both non-macroporous and macroporous fibres were measured directly from the  
reconstructed images (Figure 4.6).  
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Figure 4.6 Internal cell to cell distance measured for HDFa-loaded alginate fibres (1 
mm
3
). (A) non-macroporous alginate fibre, (B) macroporous alginate fibre.  
 
4.4 RESULTS AND DISCUSSION 
4.4.1 Encapsulation of Swiss 3T3 fibroblasts in alginate fibres.  
Experiments were conducted to establish the fibre spinning conditions required for 
successful encapsulation of fibroblasts in alginate fibres and the viability of 
encapsulated cells in the hydrogel environment. The optical micrograph of control 
alginate fibres (no encapsulated cells) in Figure 4.7A shows the typical translucent 
and longitudinal rippled texture of cell-free fibres. Optical micrographs of fibres spun 
using fibroblasts suspended in alginate solution at a cell density of 1.4 × 10
4
 cells/mL, 
showed that the cells (arrowed) were successfully encapsulated and evenly though 
widely distributed in the fibres (Figure 4.7B). Encapsulation of cells was clearly 
demonstrated by CLSM following staining of the cells with DAPI to label the cell 
nucleus blue and rhodamine to label the actin filaments pink (Figure 4.8A).  
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Figure 4.7 Optical micrograph of (A) control cell-free alginate fibres and (B) Swiss 
3T3 fibroblasts encapsulated in alginate fibres at day 10 in culture. Fibres produced 
by spinning cell-alginate solution (cell density of 1.4 × 10
4
 cells/mL in 1.5% w/v 
alginate solution) into 0.5 M filtered CaCl2 solution. 
 
Figure 4.8 CLSM images of (A) Swiss 3T3 fibroblasts encapsulated in alginate fibres 
after 8 weeks in cell culture. (B) Magnified view of elongated fibroblasts in selected 
field of view. Fibre produced by spinning cell-alginate solution (cell density of 1.4 × 
10
4
 cells/mL in 1.5% w/v alginate solution) into 0.5 M filtered CaCl2 solution. Cells 
stained with DAPI to label the cell nucleus (blue) and rhodamine to label the actin 
filaments (pink). 
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Swiss 3T3 fibroblast-encapsulated alginate fibres were incubated in complete culture 
medium for 8 weeks. On day 10, some fibroblasts were observed to have elongated 
within the fibres (Figure 4.8B), but the majority maintained a spherical morphology. It 
is evident that the cells are efficiently encapsulated within the alginate matrix and are 
sustained by efficient nutrient inflow and waste product outflow through the porous 
alginate microstructure. Some cells were observed at the base of the well at day 50, 
which been released from fibres that had partly broken down during cell culture. The 
cells displayed a distinct spindle-shaped morphology characteristic of fibroblasts, 
providing evidence that encapsulated fibroblasts remained viable within the alginate 
fibres for an extended time period of 8 weeks and were capable of resuming growth 
outside the fibres. Thus, controlled degradation of the alginate fibre may be 
considered in future work to permit cell growth. Several studies have reported similar 
findings when seeding Schwann cells [245], chondrocytes [246], hepatocytes [247] or 
encapsulating perichondrium cells [248], ovine intervertebral disc nucleus pulposus 
(NP) cells [249] using unmodified alginate. When cultured in or on unmodified 
alginate, cells tend to retain their spherical morphology and show little proliferation 
but remain viable. Retention of the rounded form results from the absence of cell 
binding moieties along the polysaccharide chain which are necessary to establish 
cell-substrate adhesion (Chapter 1, Section 1.1.10). The inability of 
anchorage-dependent cells to adhere to alginate has consequences for cell growth, 
differentiation and gene expression.  
It should be noted that the starting fibroblast concentration in the alginate solution 
used for fibre spinning was relatively low (1.4 × 10
4
 cells/mL) and therefore, the cell 
distribution in the resultant fibres may not have been sufficient to establish cell-cell 
interactions. Interestingly, while the effect of scaffold material properties (e.g. 
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strength, adhesion, porosity) in 3D cell culture has been widely investigated [154, 235, 
202], the effect of cell density, which directly influences cell–cell signalling has often 
been overlooked. Interactions between cells are important for cellular activities, such 
as cell differentiation during embryogenesis and cell survival. Moreover, cell to cell 
communication through paracrine signalling could also elicit changes in cell 
behaviour or function to other cells alongside [250, 251]. Puliafito et al. [252] and 
Heckman [253] reported that high cell seeding density in 2D cultures facilitated 
cell-cell contact and stimulated cell cycle arrest leading to „contact inhibition‟. On the 
other hand, cell-cell contact has been shown to stimulate choriocarcinoma cell 
differentiation [254] suggesting cell-to-cell communication is ancillary to 
cyto-differentiation in cell aggregates on matrix gels.  
Relatively few studies have examined the effect of initial cell seeding density in 3D 
systems, where cells are embedded within a hydrogel-like matrix. Under such 
conditions, cell–cell interactions may be easily hindered if cells are entrapped at too 
low a density [255]. The „„optimal‟‟ cell seeding density for 3D culture is dependent 
on the type of cells and matrix. For example, Lin and Anseth [256] reported a 
minimum loading density of 10
7
 cells/mL was necessary to maintain the survival of 
encapsulated pancreatic β-cells in poly(ethylene glycol) (PEG) hydrogels in the 
absence of material functionalities (e.g. cell adhesion ligands). Maia et al. [257] 
showed that a high density of human mesenchymal stem cells (hMSCs) (1.5 × 10
7 
cells/mL) entrapped within RGD-alginate hydrogels resulted in improved cell 
viability and cell–cell signalling. Maguire et al. [258] described the aggregation of 
hepatocytes within alginate beads, a process that played a central role in controlling 
cell differentiation. Aggregation was dependent on the initial cell seeding density, 
with larger aggregates being obtained at the highest density tested (5 × 10
6
 cells/mL). 
Cao et al. [259] demonstrated that viability and proliferation of pancreatic β-cells in 
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alginate hydrogels could depend on the concentration of the polymer and the 
crosslinking solution in addition to the cell density. 
Swiss 3T3 fibroblasts were successfully encapsulated in alginate fibres using a cell 
density 1.4 × 10
4
 cells/mL in the spinning solution and could survive for up to 50 days 
in cell culture. However, the encapsulated cells were essentially trapped within the 
alginate hydrogel and had limited space for cell elongation and proliferation. The cell 
density in the spinning solution was subsequently increased by approximately 100 
times (1.5 × 10
6
 cells/mL) to increase the cell density in the spun fibre and to 
determine its effect on cell growth. Optical micrographs obtained from 
fibroblast-loaded alginate fibres at day 17 and day 23 of cell culture revealed that the 
cells were successfully encapsulated and evenly distributed in the fibres (Figure 4.9B 
and 4.9C). At day 17, the first evidence of fibroblast elongation was found (arrowed 
in Figure 4.9B), but the majority maintained a spherical morphology as in the 
previous study using a lower cell density in the spinning solution (1.4 × 10
4
 cells/mL). 
At day 23, some of the fibroblasts displayed the characteristic spindle-shaped 
structure (Figure 4.9D) which may be explained by local fracture of the hydrogel 
(Figure 4.9E), providing space for cell extension. Alginate is known to degrade over 
time by Ca
2+
 ion exchange [63] with monovalent cations such as sodium and 
potassium as well as phosphate ions which are present in cell culture media and the in 
vivo environment [260-262]. Swiss 3T3 fibroblasts encapsulated in 3D gelatin 
methacrylate (GelMA) hydrogel by Grimme & Cropek [263] also adopted elongated 
spindle morphology, but at earlier culture time points of 1, 3 and 5 days (Figure 4.10). 
Early biodegradation and dissolution of the gelatin matrix is suggested in this case, 
which permits cell extension. 
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Figure 4.9 Optical micrographs of (A) hydrated cell-free alginate fibres, (B) Swiss 
3T3 fibroblasts encapsulated in alginate fibres at day 17 of cell culture (C) day 23 of 
cell culture (D) magnified view of elongated fibroblasts (arrowed) in selected field of 
view. (E and F) fractured fibre at day 17 of cell culture. Alginate fibre produced by 
spinning suspension of fibroblasts in alginate solution (cell density 1.5 × 10
6
 cells/mL 
in 1.5% w/v alginate solution) into 0.5 M CaCl2 solution. 
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Figure 4.10 Cell morphology and organization of 3T3 Fibroblasts encapsulated in 
GelMA hydrogel. (A) Rhodamine B stained GelMA hydrogel construct shows 
patterned and unpatterned regions. (B) Representative phase contrast images of 
3T3-fibroblasts (10 × 10
6
 cells/mL) encapsulated in patterned (top row) and 
unpatterned regions (bottom row) of the hydrogel on days 1, 3 and 5 of culture. Cell 
elongation increases over time for all hydrogels, while alignment is only induced in 
patterned constructs [263]. 
 
4.4.2 Incorporation of Swiss 3T3 fibroblasts in macroporous alginate fibres 
Swiss 3T3 fibroblasts were incorporated in macroporous alginate fibres by wet 
spinning alginate solutions containing both gelatin particles and suspended cells (cell 
concentration 1.5 × 10
6
 cells/mL). Fibroblast elongation was observed at day 7 in cell 
culture (Figure 4.11C and 4.11D), approximately 10 days earlier than was observed in 
fibres spun from suspensions containing Swiss 3T3 fibroblasts (cell concentration 1.5 
× 10
6
 cells/mL) without gelatin particles (Figure 4.10B). Contact between fibroblasts 
was observed in the fibres at day 13 in cell culture (Figure 4.11E and 4.11F). Thus, 
the incorporation of gelatin particles in alginate fibres as a porogen appears to 
facilitate fibroblast elongation and cell-cell contact. This behaviour is expected to 
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result from two factors. Solubilisation and extraction of gelatin from the fibres over 
time in the culture medium provides macropores and consequently space for cell 
elongation. In addition, gelatin modification of the macropore surface (Chapter 3, 
Section 3.3.1) is expected to provide a cell adhesive surface for the fibroblasts, which 
enables the formation of focal contacts and cell elongation to the spindle form.  
 
 
Figure 4.11 Optical micrographs of (A) cell-free gelatin particle-loaded alginate fibre 
before particle extraction (B) cell-free gelatin particle-loaded alginate fibres following 
particle extraction (C) macroporous alginate fibres incorporating Swiss 3T3 
fibroblasts at day 7 of cell culture (D) magnified view of elongated fibroblasts 
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(arrowed) in selected field of view, (E) macroporous alginate fibres incorporating 
Swiss 3T3 fibroblasts at day 13 of cell culture, (F) magnified view of contacting 
fibroblasts (arrowed) in selected field of view. Macroporous alginate fibres produced 
by wet spinning suspension of Swiss 3T3 fibroblasts and gelatin particles in alginate 
solution into 0.5 M CaCl2 (cell density 1.5 × 10
6
 cells/mL, gelatin particle 57% w/w, 
1.5% w/v alginate solution).  
 
Based on observation, alginate fibres containing 3T3 mouse fibroblasts at high density 
weakened in cell culture at a faster rate (day 17, Figure 4.10E and F) relative to those 
containing cells at low density (day 40). This behaviour could be attributed to the 
uptake of calcium ions in alginate hydrogel by the encapsulated cells [264] and thus 
not being available for cross-linking of the alginate. Calcium is utilised by cells in cell 
signalling [265], cell proliferation and adhesion to culture substrates [266]. Work 
carried out by Hunt et al. [267] correlated calcium release from alginate hydrogels in 
culture medium with NIH 3T3 cell loading density and hydrogel degradation. Their 
results showed that high amounts of calcium were released from alginate hydrogels 
exposed to cell culture media within the first 6 days of culture resulting in weakening 
of the cell-scaffold construct.  
 
4.4.3 Incorporation of HDFa in macroporous alginate fibres 
Non-macroporous and macroporous alginate fibres were spun from an intermediate 
HDFa cell suspension concentration of 3 × 10
5
 cells/mL in an attempt to maintain the 
integrity of the supporting scaffold. Assay of cell viability using Calcein-AM revealed 
that more than 90% of the cells encapsulated in both non-macroporous and 
macroporous fibres were viable after 12 days of cell culture. Calcein-AM staining 
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also enabled estimates to be made for cell density and inter-cell spacing in the fibres 
as described in Section 4.3.7.4 On day 12, the cell density in HDFa-containing 
macroporous alginate fibres (3.6 × 10
2
 cells/mm
3
) was significantly higher (*P<0.05) 
than the non-macroporous control fibres (1.4 × 10
2
 cells/mm
3
) (Figure 4.12) 
demonstrating that creation of macropores in the alginate fibres by gelatin extraction 
enhances cell proliferation. 
 
Figure 4.12 Human adult dermal fibroblast cell (HDFa) density in non-macroporous 
and macroporous alginate fibres. HDFa were suspended in alginate solution with or 
without gelatin particles at 3 × 10
5
 cells/mL. Wet spun fibre samples subjected to 
Calcein-AM staining and cell density determined using CLSM. (One way ANOVA 
*P<0.05, n = 5). 
 
The HFDa cell density in the fibres was estimated by two methods. In the first 
approach the number of live cells (show in green) was counted in a 3D reconstruction 
of the fibre (1 mm
3
). The mean cell spacing was obtained by measuring the distance 
between neighbouring cells (Figure 4.6, Table 4.2). A more precise counting method 
was based on the model of Thevenot et al. [268] who quantified the 3D cell 
distribution and infiltration of 3T3-Swiss albino mouse fibroblasts in 
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poly(lactide-co-glycolide) (PLGA) scaffolds as illustrated in the flow chart in Figure 
4.14. Images of stained cells in the scaffold (approximately 100 sections at 20 µm 
separation) were obtained by fluorescence microscopy then stacked and recompiled, 
prior to cell counting using the Volume Builder plug-in of Imaged (Figure 4.14). In 
the present study, HDFa cells encapsulated in macroporous fibres were imaged using 
CLSM to acquire stacks of 2D images at a Z-axis spacing of 4 µm (Section 4.3.9). 
The cell distribution was analysed in 2D planes on the XY-axis and vertically through 
the fibre scaffold along the Z-axis (Figure 4.5). By this means, 3.6 × 10
2
 cells/mm
3
 
were counted in HDFa -loaded macroporous alginate fibre compared with 2.0 × 10
2
 
cells/mm
3
 when counting cells directly from the 3D reconstructed image (Figure 
4.13F).    
 
Table 4.2 Cell density and inter-cell spacing of HDFa cells encapsulated in alginate 
fibre. 
 
 
 
Initial cell loading density in
fibre /mL
Cell count /mm
3
Inter-cell spacing range
(Mean distance ± SEM)
(μm)
Non-macroporous 3 × 10
5
/mL 1.4 × 10
2 
cells/mm
3 31-284 (111 ± 13)
Macroporous 3 × 10
5
/mL 3.6 × 10
2
 cells/mm
3 19-144 (57 ± 6)
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Figure 4.13 CLSM image at day 12 in cell culture of HDFa cells loaded in 
macroporous alginate fibres. WGA- and DAPI-labelled HDFa cells in (A) 
non-macroporous alginate fibre, (B) macroporous alginate fibre. Live/dead staining 
with Calcein-AM of HDFa cells in (C) non-macroporous alginate fibre, (D) 
macroporous alginate fibre. 3D visualisation of DAPI- and WGA-labelled HDFa cells 
in (E) non-macroporous alginate fibre, (F) macroporous alginate fibre. 
Non-macroporous HDFa-containing alginate fibre produced by spinning cell 
suspension in alginate solution (cell density of 1.3 × 10
6
 cells/mL in 1.5% w/v 
alginate solution) into CaCl2 solution. Macroporous HDFa-containing fibre produced 
by spinning suspension of HDFa fibroblasts and gelatin particles in alginate solution 
into CaCl2 solution (cell density 1.3 × 10
6
 cells/mL, gelatin particle 57% w/w, 1.5% 
w/v alginate solution).  
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Figure 4.14. Flowchart illustrating the method of Thevenot et al. to quantify 3D cell 
distribution and infiltration [268].  
 
4.5 CONCLUSION 
Cell-containing alginate fibres were produced by wet spinning cell suspensions in 
alginate solution into CaCl2 crosslinking solution. Swiss 3T3 mouse fibroblasts 
remained viable over 8 weeks in cell culture but cell elongation and cell-cell contact 
was hindered. The incorporation of gelatin particles in alginate fibres as a porogen 
facilitated Swiss 3T3 fibroblast elongation and cell-cell contact by providing 
macropores following gelatin extraction. Modification of the pore surface by gelatin is 
anticipated to produce fibroblast adhesion and permit subsequent elongation to the 
spindle form.  On day 12 in cell culture, the cell density in HDFa-containing 
macroporous alginate fibres (3.6 × 10
2
 cells/mm
3
) was significantly higher than  
non-macroporous fibres (1.4 × 10
2
 cells/mm
3
) suggesting that the creation of 
macropores in the alginate fibres by gelatin extraction enhances cell proliferation. 
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CHAPTER 5 
Encapsulation of Primary Rat Dorsal Root Ganglia in Macroporous 
Alginate Fibres for Nerve Regeneration 
 
ABSTRACT 
Macroporous alginate fibres were produced by wet spinning alginate solution 
containing dispersed gelatin particles and nerve cells (primary rat dorsal root ganglia 
(DRGs)) to investigate their potential as tissue engineering scaffolds for nerve repair. 
The gelatin particles were employed as porogens and simultaneously to provide cell 
adhesion molecules (CAM) for modification of macropore surfaces to promote nerve 
cell attachment and proliferation within the polysaccharide fibre structure. Marked 
outgrowth of DRGs was evident within the fibre at day 11 in cell culture, indicating 
that macropores and channels created within the alginate hydrogel by gelatin 
extraction were providing a favourable environment for nerve cell development. 
Evidence of neurite contact was obtained at day 9. These findings indicate that 
macroporous alginate fibres encapsulating nerve cells may provide a useful strategy 
for nerve repair.  
 
5.1 INTRODUCTION 
Nerve repair using tissue engineering principles seeks to regenerate the nerve fibre 
(Chapter 1, Figure 1.4) which is made up of neurons that transmit nerve impulses 
from the brain, supported and protected by glial cells (Schwann cells (SCs)) in the 
peripheral nervous system (PNS), astrocytes and oligodendrocytes in the central 
nervous system (CNS). Glial cells increase the speed of signal transmission and 
produce neurotrophic factors to modulate neuron growth. Nerve fibres are bundled 
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together to form a fascicular structure which is ensheathed by the epineurium 
(outermost surface layer) of the nerve. The process of natural peripheral nerve repair 
involves the formation of longitudinal arrangements of proliferating SCs (Büngner 
bands) that guide axonal growth from the damaged distal nerve segment [269] 
coupled with the sprouting of new axons from myelinated and non-myelinated nerve 
fibres in the proximal segment [270]. Nerve repair strategies in tissue engineering are 
generally based on a 3D scaffold or „biological template‟ or artificial extracellular 
matrix (ECM) which is designed to support cells and guide tissue development. 
Refinements of this basic approach involve the incorporation of growth factors, stem 
cells and transfected cells, which express axon growth-promoting molecules [270, 
271]  
Both synthetic and natural polymer scaffolds (summarised in Table 5.1) have been 
utilised as guides for directing growth of nerve cells along the scaffold surface or 
within the scaffold [271, 272]. Poly-ε-caprolactone (PCL) [273], poly(L-lactic acid) 
(PLLA) [3, 274] and polyglycolic acid (PLGA) [28, 73] are the most commonly used 
synthetic polymers for nerve repair. Electrospun aligned fibres of 
poly(ε-caprolactone), for example, have been shown to produce longer oriented 
neurite outgrowth of PC12 cells compared with random fibres [273]. Natural 
polymers including ECM components (e.g. laminin, collagen and fibronectin) as well 
as polysaccharide materials (e.g. agarose, alginate and chitosan) have been shown to 
be highly effective in promoting axonal development and repair processes.  
Alginate, a polysaccharide derived from brown seaweed, has been widely investigated 
for drug delivery and scaffold production in tissue engineering because of its good 
biocompatibility and low toxicity. Importantly, the material is converted to a hydrogel 
by exposure to divalent cations such as Ca
2+
 under mild aqueous conditions. As a 
result the polymer has been studied extensively for encapsulation of cells (e.g. 
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pancreatic islets, recombinant cells) and is also a material of interest in regeneration 
of neural tissue. Alginate has been fabricated in various forms including 
heterogeneous conduits [275], freeze-dried sponges [144, 276] and hydrogels [153, 
235]. Pfister et al. [275] successfully prepared an alginate/chitosan conduit by 
dissolving alginate and chitosan (3:2 w/w mixture) in water and 1% acetic acid 
respectively, followed by addition of ethanol (44% with respect to the total amount of 
liquid) to both solutions. After homogenisation the dispersed alginate/chitosan 
complex was transferred via a syringe onto a spinning steel mandrel and solvent was 
allowed to evaporate under a stream of air to form a hydrogel tube. Freeze-dried 
alginate sponge covalently crosslinked using carbodiimide [144] was used to assess 
the degree of nerve regeneration from 2 weeks to 21 months in the rat sciatic nerve 
(10 mm defect) [276]. Early sprouting axons (100 μm) extended into the partially 
degraded alginate gel 4 days post implantation. Numerous Schwann cells migrated 
into the alginate gel at the distal lesion site over 8–14 days. The diameter of 
regenerated myelinated axons increased from 0 – 2 to 12 – 14 μm at 2 and 21 months 
post-implantation. It was also observed that regenerated axons extended though the 
partially degraded gel rather than through the pore structure as was anticipated, 
suggesting the significance of controlling the scaffold biodegradability over pore size 
for nerve regeneration [276]. Prang et al. [153] demonstrated axon regrowth following 
spinal cord injury in young rats using alginate-based, highly anisotropic capillary 
hydrogels (ACH). The scaffolds were produced by impinging cupper nitrate solution 
onto the surface of alginate solution using pump spray bottles to create hexagonally 
structured anisotropic capillary gels. The ACH scaffolds were shown to promote 
oriented axon regeneration in vivo; across the complete length of the capillaries (500 
μm) in the injured mammalian CNS and the survival of adult neural progenitor cells. 
Matyash et al. [235] showed that non-functionalised alginate hydrogels formed by 
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crosslinking with Ca
2+
, Ba
2+
, or Sr
2+
 support neural adhesion, and rapid and abundant 
neurite outgrowth on the surface and within the hydrogel in vitro. Furthermore, 
alginate hydrogel was found to exhibit neuroprotective properties against oxidative 
stress induced by hydrogen peroxide (H2O2).  
The previous chapter described investigations of the ability of macroporous alginate 
fibres to maintain the viability of encapsulated cells and to promote cell growth. 
Human adult dermal fibroblasts (HDFa) were incorporated in macroporous alginate 
fibres by wet spinning alginate solutions containing both gelatin microparticles and 
suspended cells. Cell viability was maintained for time periods of at least 12 days. 
Incorporation of gelatin particles in the alginate fibres served as a porogen to facilitate 
fibroblast elongation and cell-cell contact by providing macropores, surface modified 
by gelatin for fibroblast adhesion and subsequent elongation to the spindle form.  
In this chapter, rat dorsal root ganglion (DRG) cells were encapsulated in 
macroporous alginate fibres, using the method developed for HDFa, with the aim of 
facilitating neurite outgrowth and the formation of neuronal contacts throughout the 
scaffold. Growth of encapsulated DRG cells was monitored over 15 days in cell 
culture using optical microscopy. The neuron-specific marker TU-20 was employed to 
confirm neurite outgrowth from encapsulated neurons using CLSM and cell viability 
was assayed by Calcein-AM staining.  
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Table 5.1 A Summary of different approaches for nerve regeneration in vitro. 
Materials Fabrication methods Cell types Key findings Ref.
Synthetic Polymers
PCL
Polycaprolactone (PCL) aligned
/random fiber meshes,
electrospining
Rat pheochromocytoma 12
(PC12) cells
PC12 neurite extentsion on aligned PCL
fibers with diameters of 3.7 ± 0.5 μm and 5
± 0.9 μm were significantly longer than on
randomly-orientated fibers with a diameter
of 4.4 ± 0.5 μm and neurites extended
parallel to the aligned fibers for all fiber
diameters studied.
[273]
PPy-PLGA
Polypyrrole-coated poly(lactic-
co-glycolic acid) nanofibers
(PPy–PLGA), electrospining
followed by coating with PPy
through in-situ polymerization
to creat PPy shells.
Rat pheochromocytoma 12
(PC12) cells and
hippocampal neurons
Both electrospun aligned and random PPy-
PLGA meshes were shown to provide
electric stimulation to promote and guide
neurite extension. Electrically stimulated
PC12 cells had significantly longer
neurites than cells on un-stimulated
scaffolds .
[274]
PLLA
Poly-L-lactic acid (PLLA)
scaffolds, electrospining
Neonatal mouse cerebellum
C17.2 stem cells (NSCs)
Electrospun nano-sized fibers (300 nm) of
PLLA enhanced neural differentiation of
NSCs as compared to micron-sized (1.25 μ
m) fibers
[73]
Natural Polymers
Alginate
Soft alginate hydrogel, produced
by cross-linking low viscosity
manuronic/ guluronic acid rich
alginates with cations (Ca
2+
,
Ba
2+
, and Sr
2+
) with no >10% of
gelation sites of alginate
Neuronal stem cell cultures
prepared from E20 Wistar
rat fetuses
Supported neural adhesion, penetration and
facilitated rapid and abundant neurite
outgrowth on surface as well as within the
hydrogel. Alginates conferred protection to
neurons against oxidative stress induced by
H2O2, hence prolonged cell survival up to 4
months.
[235]
Collagen
Collagen scaffolds,
unidirectional freezing process
followed by freeze-drying.
DRG explants from the
spinal column of Lewis rats
Penetration of the axonal growth in the
collagen gel (756 ± 318 µm) was
approximately 3 folds more than that in the
commercially available fibrin gel (253 ±
131 µm) over period of 21 days.
[277]
Gelatin/ alginate
Gelatin containing alginate
capillary hydrogels (ACHs),
ACHs with different capillary
diameters and biochemically
modified by introducing gelatin
into the self-assembly process
DRGs from postnatal day 2–
6 Wistar rats
Gelatin-containing ACHs promoted more
axon elongation in comparison with ACHs
without gelatin over 7 days. However, no
significant difference in axon and Schwann
cell density was observed. Findings suggest
that gelatin provides better adhesion for
DRG axons growing into the hydrogel.
[278]
Chitosan
Chitosan membrane,
decetaylation of chitin followed
by gelation and neutralisation
with 1% NaOH for 24h. The
chitosan fibers, 15 µm in
diameter, were purchased from
Shanghai Gao Chun biomaterial
Company (Shanghai, China).
Schwann cells (SCs) from
Six neonatal Sprague–
Dawley rats sciatic nerve
fragments
Majorities of SCs migrated on to both
chitosan materials after 7 days. In
Comparison, SCs migrated faster onto the
stereoframe of chitosan fibers than the
membrane. The study showed good
biological compatibility and adherence
between chitosan and SCs, however, cells
on the membrane retained better viability
after 3-14 days than that of the
corresponding groups.
[279]
Fibrin
Fibrin matrix, enzymatically-
induced polymerization of
fibrinogen.
DRGs from chick embryos
The rate of neurite invasion into the matrix
was effected primarily by fibrin density
(neurite in-growth decreased by increasing
fribrin density) and not by the diameter or
numbers of fibrin bundles.
[280]
Laminin
Laminin-containing cryogel
scaffolds, cryogelation of
dextran and gelatin linked to
laminin.
Cord blood-derived stem
cells (CBSCs)
laminin-rich scaffolds attracted infiltration
of rats' neuroblasts (NF200+, Nestin+)
indicating high neuroregeneration
properties both in vitro  and in vivo
models.
[281]
Silk Silk Fibers, electrospining
Rat retinal ganglion cells
(RGCs)
RGCs exhibited longer axonal growth when
in contact with the biofunctionalized fibers.
Compared with unfunctionalized fibers
(46.9 ± 2.4 μm). The growth of neurites
increases 2-fold (82.3 ± 2.8 µm) on fibers
containing BDNF, 2.5-fold (105.2 ± 1.3 µ
m) on fibers containing CNTF and almost
3-fold (117.7 ± 2.9 µm) on fibers
containing both factors
[282]
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5.2 MATERIALS 
Sodium alginate (Protanal RF 6650, G:M 2:1) was obtained from IMCD Australia 
Limited. Calcium chloride (dehydrate) was purchased from UniLab. Gelatin from 
porcine skin (Type A, Bloom 300, average molecular mass 50-100 kDa), Dulbecco‟s 
phosphate-buffered saline (with MgCl2 and CaCl2, liquid, sterile filtered, suitable for 
cell culture, D8662) were purchased from Sigma. Cryopreserved rat DRG neurons 
(0.25 mL cell suspension, R-DRG-505) and primary neuron growth medium 
(PNGM
TM
) BulletKit
®
 (CC-4461) containing primary neuron basal medium (PNBM) 
and the primary neuron growth SingleQuots™ Kit. The PNGM™ SingleQuots™ Kit 
contains the necessary volumes of L-glutamine (GA-1000), and neural survival 
factor-1 (NSF-1), a supplement supporting neuronal growth and survival, to 
complement the basal medium volume provided; were purchased from Lonza. The 
mouse monoclonal anti- –tubulin-III, (clone TU-20, MAB1637) was obtained from 
Chemicon and Cy3-conjugated AffiniPure Goat Anti-Mouse IgG (H+L) and 
Calcein-AM (C3100-MP) were purchased from Invitrogen. Anti-fade Vectashield 
mounting medium containig DAPI (1.5 µg/mL) (H-1200, Vector) was purchased from 
Vector Laboratories Ltd. Dimethyl sulphoxide (anhydrous, ≥99.9%) was purchased 
from Sigma-Aldrich. Mouse retinal tissue (species:7.211) was contributed by Dr Sally 
Firth from School of Pharmacy, University of Queensland, Australia. 
 
5.3 METHODS 
5.3.1 Preparation of cryo-sectioned mouse retinal tissue 
Mouse retinal tissue (species:7.211) was fixed with 4% paraformaldehyde in 0.1 M 
sodium phosphate buffer (pH 7.4) for 2 h and rinsed in 0.01 M phosphate-buffered 
saline (PBS; pH 7.4). Prior to sectioning, the retinal tissues were cryoprotected with 
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30% sucrose in PBS overnight and freeze-mounted in Tissue-Tek®  optimum cutting 
temperature (OCT) medium at −20 °C. Vertical sections with a thickness of 
approximately 20 µm were cut using a cryostat (Leica CM 1850) and the sections (in 
duplicate) were thaw-mounted onto electrostatic glass slides and allowed to dry at 
room temperature for 1–2 h.  
 
5.3.2 Immunolabelling of retinal tissue  
Investigations of immunolabelling of cryosectioned mouse retinal tissue were 
performed using anti-Tubulin, beta III isoform, C-terminus, clone TU-20 (Similar to 
TUJ1) to determine the suitable dilutions and sample staining protocols for DRG 
cell-containing alginate fibres. Class III β-tubulin is a microtubule element expressed 
predominantly in neurons of the central and peripheral nervous system [283], and is a 
popular selective marker for neurons in nervous tissue. Microtubules are one 
component of the cytoskeleton in neurites that serve as a scaffold for organelle 
transport and structural components of the neurite in neurite elongation (Figure 5.1). 
 
Figure 5.1 Schematic representation of a neuron and detailed view of the growth cone 
with its main cytoskeletal components (actin filaments and microtubules) [284].  
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Preparation of serial dilutions of the primary antibody (TU-20) in blocking solution 
Serial dilutions of the primary antibody (clone TU-20, MAB1637; 1:100, 1:250, 1:500 
and 1:1000) (Figure 5.2) were prepared in 2mL blocking solution as illustrated in 
Figure 1 and maintained at 2 – 4 °C. The blocking solution was prepared by adding 
10% Triton-X (6 µL, 0.3% v/v, Sigma) to normal donkey serum (20 µL, 1% v/v, 
Jackson Immuno Research) and making up to a volume of 2 mL by adding PBS.  
 
 
Figure 5.2 Serial dilutions of the primary antibody (TU-20) in blocking solution. 
 
Immunolabelling with the primary antibody (TU-20) 
Sections were incubated in dilutions of the primary antibody (TU-20) (1:100, 1:250, 
1:500 and 1:1000) at 4 °C in a humid atmosphere for 24 h. The container was capped 
and carefully transferred to a 4 °C incubator. After incubation, the slides were rinsed 5 
times for 10 min each in PBS at 4 °C. Next, the slides were incubated with 
Cy3-conjugated Affinipure Donkey Anti-Mouse IgG (dilution 1:200) for 1 h at room 
temperature followed by 4–5 rinses of 10 min each with copious PBS protected from 
light at 4 °C. Prepared sections were mounted with one drop anti-fade Vectashield 
mounting medium containing DAPI (1.5 µg/mL) (to label the nuclei) and kept in PBS 
in the dark at all times.  
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5.3.3 Imaging of immunolabelled mouse retinal tissue 
Images of the mounted sections were acquired using a fluorescence microscope 
(Nikon Eclipse Ti) with an oil immersion lens (Plan Fluar 40×/1.30 Oil) and images 
were acquired with a digital camera (CoolSNAP HQ
2
). A standard 
rhodamine/Cy3/TRITC filter (Cy3 HYQ filter, Nikon) was used for double labelling 
with Alexa Fluor 488–FITC conjugated antibodies. Excitation was at 568 nm for Cy-3 
with emission filters of 530–560 nm. The brightness and contrast of the images of all 
retina sections labelled with primary antibody dilutions (1:100, 1:250, 1:500 and 
1:1000) were adjusted with Adobe Photoshop CS4 (Adobe).   
 
5.3.4 Encapsulation of primary rat DRG cells in non-macroporous and 
macroporous alginate fibres  
The primary DRG cell culture or explants derived from embryonic [285], post-natal 
[286] and adult animals [287] from the peripheral nervous system have been 
commonly utilised as a neuronal model to study neuron function, disease-related 
axonal degeneration and repair. Unlike peripheral motor neurons (Chapter 1, Figure 
1.2), dorsal root ganglion, also called spinal ganglion, is the ganglion of the posterior 
root of each spinal segmental nerve, containing the cell bodies of the unipolar primary 
sensory neurons (Figure 5.3). It composes the cell body sites above the neuronal 
process, which extends in both directions. One axon extends centrally toward the 
spinal cord; the other axon extends toward the skin or muscle. It is difficult to 
distinguish which projections is axon or dendrite as the cell is not arranged as a 
typical neuron (Chapter 1, Figure 1.2).  
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Figure 5.3 Sensory peripheral neurons are called pseudounipolor neurons [288].  
 
Preparation of DRG cell suspensions 
A vial of suspended rat DRG cells (2 × 10
5
 cells/ 0.25 mL) was removed from liquid 
nitrogen and placed in a water bath preheated to 37 °C. The vial was removed after 
1.5 min and immediately placed into a laminar flow hood following disinfection of 
the vial surface with 70% ethanol. The thawed cell suspension was gently transferred 
into a 15 mL centrifuge tube followed by dropwise addition of 7.75 mL of preheated 
(37 
o
C) primary neuron growth medium (PNGM
TM
) (contains 2mM L-glutamine, 50 
μg/mL gentamicin/37ng/mL, amphotericin, and 2% NSF-1) onto the cells while 
rotating the tube by hand. The cells were suspended by pipetting up and down slowly 
with a 2 mL plastic disposable serological pipette and by carefully inverting the tube 
twice. One millilitre of the cell suspension (2.5 × 10
4
 cells) was transferred to another 
10 mL centrifuge tube and diluted again with preheated (37 °C) PNGM
TM
 culture 
medium (3 mL) to achieve a cell concentration of 6.25 × 10
3
 cells/mL. The diluted 
cell suspension (0.5 mL) was pipetted into a 6-well plate (3.13 × 10
3
 cells/well) and 
cultured for 4 h at 37 °C under a 5% CO2 atmosphere. The medium was replaced with 
fresh medium after 4 h [289] (Note. small volume of old medium was left in the plate 
when replacing with fresh, pre-warmed medium to ensure the cells do not dry out) 
and then again at 2 days. Media were changed every 2 days thereafter up to 15 days. 
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Assay of cell viability was carried out using Live/Dead Calcein-AM staining as 
described in Section 5.3.6. Cell morphology was observed using an inverted optical 
microscope (CKX 41; Olympus) equipped with a digital camera (DP21; Olympus) 
and DP Controller software (Olympus).  
 
DRG cell encapsulation in non-macroporous alginate fibres  
The prepared DRG cell suspension (1 mL, cell density 2.5 × 10
4
 cells/mL) derived 
from the above method was added to 3 mL of filtered (syringe filter (0.2 µm 33 mm) 
Millex Filter Units, Millipore), alginate solution (2% w/v) to achieve a final cell 
concentration of 6.25 × 10
3
 cells/mL in a 1.5% w/v alginate solution. The cells were 
mixed with the alginate solution by pipetting slowly up and down with a 3 mL 
disposable plastic syringe. The cell suspension in alginate solution (0.5 mL) was wet 
spun into 50 mL of 0.5 M CaCl2 solution. The resulting fibre was rinsed with distilled 
water and cut into 3 sections (approximately 5-cm each) that were each placed into 
individual wells of a 6-well plate. The cell-containing fibre samples were then 
cultured in 5 mL of PNGM
TM
 culture medium for 4 h at 37 °C under a 5% CO2 
atmosphere. The medium was replaced with fresh medium after 4 h and then every 
day up to 15 days (Figure 5.4 – blue arrowed).  
 
DRG cell encapsulation in macroporous alginate fibres  
Gelatin powder was sieved through a 90 µm mesh sieve. The collected powder was 
sterilized under UV irradiation in a cell culture hood for 20 min. The container was 
agitated during sterilization to ensure that all particles were exposed to UV. A 2% w/v 
alginate solution (10 mL) was sterilized by filtration using a syringe filter (0.2 × 33 
mm Millex filter units, Millipore). All equipment (homogeniser, syringe pump) was 
sterilized by wiping the surfaces with 70% ethanol. Glassware and tools were 
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autoclaved. Antiseptic techniques were strictly followed to prevent contamination. 
Sterilized gelatin particles (<90 µm, 200 mg) were added to cold filtered 2% w/v 
alginate solution (10 mL) and homogenised using a IKA Ultra-Turrax®  T25 Basic 
homogeniser in the cell culture hood. A gelatin:alginate w/w ratios of 4:3 was 
employed, corresponding to 57% w/w gelatin particle loading as a fraction of the total 
polymer content. DRG cell suspension (1 mL, cell density 2.5 × 10
4
 cells/mL) was 
added to the gelatin particle/alginate solution (3 mL) to achieve a final cell 
concentration of 6.25 × 10
3
 cells/mL in a 1.5% w/v alginate solution. Cells were 
mixed in the gelatin/alginate solution by pipetting slowly up and down with a 3-mL 
disposable plastic syringe. The suspension of cells and gelatin particles in /alginate 
solution (0.5 mL) was wet spun into 50 mL of 0.5 M CaCl2 solution. The resulting 
fibre was rinsed with distilled water and cut into 3 equivalent sections (approximately 
5-cm each) prior to incubation in primary neuron basal medium (5 mL) for 4 h at 37 
°C under a 5% CO2 atmosphere. The medium was replaced by fresh medium after 4 h 
and then every day up to 15 days (Figure 5.4 – black arrowed).  
Figure 5.4 Preparation of non-macroprous (blue arrowed) and macroporous (black 
arrowed) alginate fibres encapsulating primary rat DRG cells.  
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5.3.5 Immunolabelling of DRG cells encapsulated in alginate fibres  
Hydrated alginate fibres encapsulating DRG cells which had been retained in culture 
medium for 15 days were fixed in 1 mL of 4% paraformaldehyde/D-PBS solution 
(prepared as described in Chapter 4, Section 4.3.4) for 15 min.  
Immunolabelling of DRGs encapsulated in the alginate fibres was carried out with the 
primary antibody (neuron-specific mouse monoclonal anti-tubulin-III (clone TU-20, 
MAB1637; 1:250)). Fixed fibre samples (approximately 0.5-cm in length) were rinsed 
with copious D-PBS and then transferred into 1-mL Eppendorf tubes. The fibre 
samples were incubated with 200 µL of the primary antibody solution for 48 h at 4 °C 
in a humid atmosphere. The primary antibody solution was prepared in blocking 
solution as described in Section 5.3.2. After incubation, the fibre samples were rinsed 
5 times for 10 min each with copious cold D-PBS at 4 °C. 
Immunolabelling of encapsulated DRGs with the secondary antibody 
(Cy3-conjugated Affinipure Donkey Anti-Mouse IgG (H+L)) was performed by 
adding 7.5 µL of the antibody solution to D-PBS (1.5 mL) to achieve a dilution of 
1:200. Fibre samples were incubated with the prepared solution at room temperature 
for 50 min in the dark. Following incubation, fibre samples were rinsed 5 times for 10 
min each with copious D-PBS. Washing was performed in the dark to prevent the 
fluorescence from fading. Fibre samples were then washed with copious cold D-PBS 
and preserved in one drop anti-fade Vectashield mounting medium with DAPI (1.5 
µg/mL). Prior to imaging, the samples were stored at 4 °C in the dark.  
 
5.3.6 Assay of viability of primary rat DRG cells encapsulated in alginate fibres 
using Calcein-AM staining 
The viability of DRGs encapsulated in both non-macroporous and macroporous 
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alginate fibres by wet spinning were evaluated using Calcein-AM staining. 
Calcein-AM stock solution in anhydrous DMSO (1 mg/mL, 1 µM) was prepared by 
adding 50 µL of anhydrous DMSO (≥99.9%, Sigma-Aldrich) to 50 µg of Calcein-AM. 
The prepared stock solution was stored at −20 °C in the dark. A working solution was 
prepared by pipetting 10 µL of the stock solution into 9 mL of PNGM
TM 
culture 
medium to achieve a concentration of 10 nM. Then, 1 mL of working solution was 
added to DRG-containing –alginate fibre samples (approximately 1-cm long sections) 
and incubated at 37 °C under a 5% CO2 atmosphere for 45 min.  
Following Calcein-AM staining, a FluoView FV1000 confocal microscope (Olympus 
Corporation, Japan) was used to image DRG containing alginate fibre sections placed 
in a 2-well Permanox Plastic Chamber Slide System (Fisher Scientific) and mounted 
in anti-fade mounting medium containing n-propyl gallate. The anti-fade medium was 
prepared from a stock solution of 20% w/v n-propyl gallate (Sigma P3130) in DMSO 
by first thoroughly mixing 1 part of D-PBS with 9 parts of glycerol (ACS grade, 
99%–100% purity), after which 0.1 part of the n-propyl gallate solution was slowly 
added (drop-wise) with rapid stirring. Stacks of 2-dimensional parallel longitudinal 
images of the fibres (i.e. parallel to the fibre axis), were acquired using laser 
excitation at 405 nm and emission detection at 461 nm in conjunction with a 10× 
objective lens with numerical aperture of 0.4.  
Imaging of immunolabelled of DRG-loaded alginate fibres was performed using laser 
excitation at 559 nm for Cy-3 with emission detection at 564–664 nm. The image 
size was 640 × 640 pixels, with each pixel corresponding to 1.9884 µm in the X and Y 
directions. Images were acquired using a Z-axis spacing of 8 µm.  
 
5.4 RESULTS AND DISCUSSION 
Primary rat DRG cells were successfully encapsulated in alginate fibres using wet 
136 
 
spinning wherein a suspension of cells (6.25 × 10
3
 cells/mL) and gelatin particles 
(<90 µm, 57% w/w) in alginate solution (1.5% w/w), was extruded through a syringe 
needle into 0.5 M CaCl2 solution used as a crosslinking/gel forming agent for the 
alginate phase. The gelatin particles were employed as porogens to provide a 
macroporous fibre structure and simultaneously to provide cell adhesion molecules 
(CAM) for modification of macropore surfaces. The aim was to provide space and a 
favourable adhesive pore surface to promote nerve cell attachment and growth within 
the polysaccharide fibre structure. DRG-containing non-macroporous alginate fibres 
were produced by spinning DRG suspensions in alginate solution without gelatin 
particles and showed no significant cell growth up to day 15 (Figure 5.5). Magnified 
images of the fibre showed the translucent appearance of the alginate fibre with 
characteristic „chevron-like‟ flow markings (Figure 5.5A) and the presence of rounded, 
highly separated cells. An isolated example of neurite extension and network 
formation (arrowed) by DRG cells was observed at day 5 (Figure 5.5B and 5.5C). 
During “neuritogenesis” (formation of neurites), spherical neurons differentiate and 
form membrane projections or dynamic extensions (outgrowths) called neurites that 
could later become dendrites or axons. Neuronal axons elongate from the growth cone 
at the axon tip and subsequently form synaptic contacts with other neurons. Matyash 
et al. showed that non-functionalised alginate hydrogel supports neural adhesion, and 
abundant neurite outgrowth (on the surface) and penetration into the hydrogel (up to 
1000 μm), creating a three-dimensional network by day 10 in vitro [235]. 
Krantis et al. [290] reported extensive neurite outgrowth from cryopreserved DRG 
neurons on day 2–3 culture on micro-ruled Cellattice™ coverslips in 96-well plate. 
Likewise, adult mouse DRG neurons (cell size up to 50 μm) were also shown to 
generate long myelinated axons (100–200 μm) at day 3 in cell culture [287]. The 
virtual absence of neurite outgrowth in the present study indicates that nerve cells are 
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efficiently encapsulated within the alginate hydrogel matrix and there is no pore and 
channel structure of dimensions sufficient to accommodate neurite growth. In addition, 
biodegradation of the matrix is not adequately advanced at day 15 to allow neurite 
growth through a weakened hydrogel structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Bright field microscopy images of DRGs encapsulated in a 
non-macroporous alginate fibre at Day 1 (A), Day 5 (B), Day 11 (C) and Day 15 (D) 
in cell culture.  
 
In contrast, DRG cells encapsulated in alginate fibres that developed macroporosity 
on extraction of incorporated gelatin particles developed a branched neurite structure, 
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and cell–cell contact was observed at day 9 (Figure 5.6). On day 1, undissolved 
gelatin particles, approximately 50–200 µm in size are evident in the fibres (Figure 
5.6A). By day 2 (Figure 5.6B), the majority of the gelatin particles had been extracted, 
which would have served to increase the internal macroporosity. Rapid gelatin release 
from alginate fibres was discussed in Chapter 2. On day 5 (Figure 5.6C) and similar to 
non-macroporous fibres, the first evidence of neurite outgrowth and branching was 
observed over a distance of around 40 µm (arrowed). By day 9 (Figure 5.6D), cell–
cell contact was evident, and at day 11 (Figure 5.6E), extensive neurite outgrowth and 
spreading within the alginate fibre was confirmed. This behaviour indicates formation 
of a channel structure within the alginate hydrogel which supports neurite extension.   
Alginate hydrogels are known to be non-adhesive for cultured cells in general and 
have thus been functionalised with molecules, such as fibronectin [291] or peptides 
(i.e. Tyr-Ile-Gly-Ser-Arg (YIGSR) [109] to enhance neuron growth. In the present 
study, extensive neurite outgrowth was observed in macroporous alginate fibres 
produced by wet spinning alginate solution containing DRGs and gelatin particles. 
The gelatin particles were employed as porogens to provide a macroporous fibre 
structure and simultaneously to provide cell adhesion molecules (CAM) for 
modification of macropore surfaces to promote nerve cell attachment and growth. The 
investigations described in Chapter 3 revealed protein residues lining the macropore 
cavities formed by gelatin extraction (Chapter 3, Figure 3.12B). However the 
extensive dendrite outgrowth observed at day 11 (Figure 5.6E), suggests that the pores 
and channels in the alginate hydrogel phase, external to the macropores have also 
been modified by cell adhesion molecules. This condition may have been 
accomplished by adsorption of CAMs from the culture medium (e.g. fibronectin) and 
gelatin molecules during extraction of the gelatin particles. The release experiments 
reported in Chapter 2 demonstrated that 50% of the original gelatin content of the 
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fibres was retained following 2 days in release medium. 
Further observations of the morphology of DRGs encapsulated in alginate fibre are 
presented in Figure 5.7. The early stage of neurite outgrowth (day 1–5) appears to 
show a pseudounipolar-DRG-like neuron (Figure 5.7 A-C). DRGs aggregate in balls 
and extend multiple neurites becoming a densely branching network after 9 days 
(Figure 5.7 E and F). Evidence of neuronal contacts is shown in Figure 5.7G and 5.7I. 
Flavin coenzymes and reduced nicotinamide adenine dinucleotide (NADH) are the 
most commonly observed autofluorescent molecules in mammalian cells. NADH and 
flavin adenine dinucleotide (FAD) have been found to contribute in major part to rat 
DRG neuron autofluorescence excited by UV (~365 nm) and blue (~435 nm) 
excitation light respectively, through modulation of the cellular metabolism with 
cyanide (CN) and carbonyl cyanide 4-(trifluoromethoxy)phenyl-hydrazone (FCCP) 
[292]. In the present study, DRG cells encapsulated within the alginate fibre were 
autofluorescent when excited with UV at wavelength 350 nm and emission maximum 
at 460 nm, Regions of dendrite branching and extension over a distance of 
approximately 150 µm in the alginate fibre, at day 15 in cell culture, are clearly 
visible in Figure 5.8. 
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Figure 5.6 Bright field microscopy of DRGs encapsulated in a alginate fibre by wet 
spinning suspensions of cells and gelatin particles in alginate solution at Day 1 (A), 
Day 2 (B), Day 5 (C), Day 9 (D), Day 11 (E) and Day 15 (F) in cell culture.  
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Figure 5.7 Morphology of DRGs encapsulated in alginate fibre and observed using 
inverted microscopy. (A–C) Early stage of neurite outgrowth at day 1–5, (D) a 
pseudounipolar-DRG-like neuron (E–F) DRGs aggregate in balls and extend multiple 
neurites becoming a densely branching network after 9 days, (G–I) evidence of 
neuronal contacts.  
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Figure 5.8 CLSM characterisation of dendritic outgrowth from rat DRG cells 
contained in a macroporous alginate fibre at day 15 in cell culture. (A) Superimposed 
DIC/autofluorescent and (B) autofluorescent images of the neurites.  
DRG-containing fibre produced by wet spinning 1.5% w/v alginate solution 
containing DRGs (cell density 6.25 × 10
3
 cells/mL) and gelatin particles (57% w/w) 
into 0.5 M CaCl2 solution. Autofluorescence produced using UV at excitation 
wavelength 350 nm and emission maximum 460 nm. 
 
Non-fluorescent Calcein-AM is converted to green-fluorescent calcein, after 
acetoxymethyl ester hydrolysis by intracellular esterases within viable cells. At day 2, 
DRG cells displayed outgrowth and varied cell soma (cell body) size (7–20 µm) 
when cultured by conventional 2D methods on tissue culture plastic (Figure 5.9). 
Live/dead staining with Calcein-AM of DRG-containing non-macroporous and 
macroporous alginate fibres were carried out on day 2 and day 5. Aggregates of DRGs 
were occasionally visible in non-macroporous alginate fibres at day 5 and outgrowths 
were generally absent (Figure 5.9B). The low DRG cell density within the 
macroporous alginate fibres is evident from Figure 5.10C, which reveals that the cells 
are widely distributed with a spacing of around 500–1000 µm. Calcein AM staining 
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revealed outgrowths or extensions from DRGs in macroporous alginate fibres at day 5 
in culture (Figure 5.10D). However further studies described in Chapter 6, which 
included staining of cell nuclei, suggest that these outgrowths may consist of 
aggregates of DRG cells rather than neurite extension.  
 
 
Figure 5.9 Rat dorsal root ganglion cells at 5 days in cell culture, subjected to 
live/dead assay by staining with Calcein-AM. Cells were seeded on 6-well plate at 
densities of 6.25 × 10
3
 cells/mL. The DRG cells display outgrowth and varied cell 
soma size (7–20 µm).  
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Figure 5.10 Live/dead staining assay using Calcein-AM of rat DRGs encapsulated in 
non-macroporous alginate fibre at (A) day 2, (B) day 5 in culture. Rat DRGs 
encapsulated in macroporous alginate fibre at (C) day 2 and (D) day 5 in culture.  
DRG-containing macroporous alginate fibre produced by wet spinning alginate 
solution (1.5% w/v) containing DRG (cell density 6.25 × 10
3
 cells/mL) and gelatin 
particles (57% w/w) into 0.5 M CaCl2 solution. Gelatin particles omitted for 
production of DRG-containing non-macroporous fibres. 
  
Investigations of immunolabelling of cryosectioned mouse retinal tissue were 
performed to determine the suitable dilutions and sample staining protocols for DRG 
cell-containing alginate fibres. Fluorescence micrographs for each dilution (1:100, 
1:250, 1:500 and 1:1000) were acquired under the same settings and conditions for 
comparison. Mouse retina tissue presenting the ganglion cell layer was used as a 
positive control for the neuronal selective marker TU-20 antibody to ascertain the titer 
and specificity before applying to the DRG-loaded fibre sample. Immunolabelling 
using dilution of 1:1000 revealed that the concentration was too high, resulting high 
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background interference and possible non-specific binding of antibody. Dilution 1:100 
on the other hand, was insufficient to yield a satisfactory signal for detection of 
neurons, especially when considering the thickness of the DRG loaded-alginate fibre 
(~800 µm). A dilution of 1:250 was found to be optimal for labelling (Figure 5.11B); 
the image showed clearly visible labelled cells and no sign of over exposure from 
background interference. Stained mouse retinal tissue (Figure 5.12) showed the 
axonal extension (green arrowed) of a ganglion cell (yellow arrowed) present in 
ganglion cell layer (stained red) for neuronal beta III tubulin.  
Figure 5.11 Imaging of mouse retinal tissues, labelled with Vectashield Anti-fade 
containing DAPI and TU-20, using fluorescence microscopy. Crysections of mouse 
retina tissue were incubated for 24 h at 4 
o
C with anti-ß-tubulin (TU-20) at dilution (A) 
1:100, (B) 1:250, (C) 1:500 and (D) 1:1000. Cryosections were fixed in 4% 
paraformaldehyde for 15 min. and washed with copious D-PBS followed by 
incubation with primary antibodies (TU-20) for 24 h at 4 ºC and with the secondary 
antibody (Cy3-conjugated Affinipure Donkey Anti-Mouse IgG) for 1 h at room 
temperature. 
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Figure 5.12 TU-20 was used as a marker to differentiate encapsulated neurons from 
glia. (A) Hematoxylin and eosin stain of normal rat retina [293]. (B) Cryosections of 
mouse retinal tissue labelled with anti-ß-tubulin (TU-20) 1:250 dilution). 
 
Prior to immunolabelling, alginate fibre cryosections were prepared using the method 
described in Section 5.3.1. However, the fibre sections became detached from the 
slides during rinsing with PBS. Furthermore, the labelling method for alginate fibre 
samples requires that the rinsing medium contains CaCl2 (Dulbecco‟s (D) PBS was 
used) to avoid dissolution in normal PBS. Immunolabelling with TU-20 was therefore 
performed by soaking the fibre sections (approximately 0.5 cm) directly in the 
primary antibody for 48 h.  
Immunolabelling of DRG cells in a macroporous alginate fibre at day 15 of cell 
culture with the neuronal selective marker, TU-20 (mouse monoclonal anti-tubulin-III 
antibody) is shown in Figure 5.13B. Neurite outgrowth is identified from DRG cells 
forming a network that extends approximately 200 µm in the hydrogel structure 
(white arrows). The DIC and fluorescence image (Figure 5.13A) corresponds with the 
specific TU-20 labelled neurites and provides a further measure of the spacing of such 
networks of around 500 µm. These observations suggest that nerve cell density within 
the alginate fibres should be increased by a factor of at least two to increase the 
probability of neurite contact.   
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Figure 5.13 TU-20 (mouse monoclonal anti-tubulin-III antibody)-labelled DRG cells 
in a macroporous alginate fibre at day 15 of cell culture. (A) Superimposed DIC and 
fluorescence (arrowed black) and (B) TU-20 labelled images revealed neurites 
(arrowed white) encapsulated in the alginate fibre. Magnified view of highly branched 
neurite displayed in the selected field. DRG-containing alginate fibre produced by wet 
spinning 1.5% w/v alginate solution containing DRGs (cell density 6.25 × 10
3
 
cells/mL and gelatin particles 57% w/w) into 0.5 M CaCl2 solution.  
 
5.5 CONCLUSION 
Rat DRG cells were encapsulated in macroporous alginate fibres for applications in 
nerve regeneration by wet spinning alginate solution containing a suspension of 
DRGs and gelatin particles. At day 5 in cell culture neurite outgrowth and branching 
was observed over a distance of around 40 µm. By day 9 cell–cell contact was evident, 
and at day 11 extensive neurite spreading was confirmed, indicating formation of a 
connected pore and channel structure within the alginate hydrogel. These findings 
indicate that macroporous alginate fibres encapsulating nerve cells may provide a 
useful strategy for nerve repair. 
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CHAPTER 6 
Encapsulation of 661W Cone Photoreceptor Cells in Macroporous 
Alginate Fibre Scaffolds for Retinal Regeneration 
 
ABSTRACT 
Retinal degeneration including retinitis pigmentosa (RP) and age related macular 
degeneration (AMD) caused by progressive and eventual death of photoreceptor cells 
can eventually lead to blindness. Macroporous alginate fibres were produced by wet 
spinning alginate solution containing dispersed gelatin particles and cone 
photoreceptor-derived (661W) cells to investigate their potential as tissue engineering 
scaffolds for retinal repair. The gelatin particles were employed both as porogens and 
to provide cell adhesion molecules (CAM) for modification of macropore surfaces to 
promote photoreceptor cell attachment and proliferation within the poorly cell 
adhesive polysaccharide fibre structure. Significantly higher cell proliferation 
(*P<0.05) was evident within macroporous fibres at day 14 in cell culture compared 
with non-macroporous fibres. Cell flattening and elongation with formation of cell 
extensions/projections was extensive in 2D culture on tissue culture plastic (TCP)  
but was not observed in 3D culture within the fibres, indicating that a suitable 
pore/channel structure for photoreceptor cell development was not created within the 
alginate hydrogel at 14 days in cell culture. 
 
6.1 INTRODUCTION 
The photoreceptor layer located at the back of the retina adjacent to the pigmented 
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epithelium comprises rods and cones whose function is to absorb light. Visual 
information produced by changes in photoreceptor cell membrane potential is 
processed in turn by bipolar, amacrine and horizontal cells and finally ganglion retinal 
cells that connect with the optic nerve (Figure 6.1).   
 
 
Figure 6.1 Photoreceptor cells in the retina of the eye [294].  
 
Retinal degeneration including retinitis pigmentosa (RP) and age related macular 
degeneration (AMD) caused by progressive and eventual death of photoreceptor cells 
can eventually lead to blindness. Conventional treatments for AMD have focused on 
neuroprotective therapies, for example, using neurotrophic factors (e.g. brain-derived 
neurotrophic factor (BDNF)) [295], stem cells [296] or gene therapy (via subretinal 
injection) [297]. However, these approaches are confined to patients diagnosed at 
early stages of the disease with the aim of preventing further progression and 
functional deterioration. In the case of patients diagnosed at later stages of the disease, 
where loss of photoreceptor cells has occurred, cell transplantation has emerged as a 
key strategy to re-establish synapses with host retinal neurons and restore 
light-evoked electrical responses to regain retinal function [298]. However, 
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transplantation of photoreceptor precursor cells via bolus injection into the sub-retinal 
space (between the sensory retina and the retinal pigment epithelium) in animal 
models has shown lack of cell engraftment, limited cell integration and relatively low 
cell survival (less than 1% of the injected cells) [299] due to excessive shear forces 
generated during injection and movement of cells away from the injection site.  
The application of tissue engineering principles whereby photoreceptor cells are 
integrated with a support structure or scaffold and exposed to growth (or neurotrophic) 
factors provides a means of addressing the problems of photoreceptor cell injection at 
defect sites in the retina. In line with general scaffold design criteria, the ideal scaffold 
material for retinal repair must be biocompatible, biodegradable and mechanically 
stable while not inducing immunogenic responses [300]. Earlier studies [301-303] 
have recommended that the scaffold should be relatively thin, less than 150 μm 
(compare the thickness of the photoreceptor layer of 155.6 ± 12.6 μm in normal adults) 
[304] to avoid physical distortion of the overlying retina after transplantation. For 
example, Tomita et al. [301] fabricated a polymer scaffold from PLLA/PLGA (10 × 
10 mm × 150 μm) using a solid-liquid-phase separation technique to obtain a pore 
size of 35–50 μm and porosity of 95%. Prior to transplantation, retinal progenitor 
cells (RPCs) were seeded on upper and lower surfaces of the scaffold; one side was 
seeded for 3 days in culture followed by the reverse side for an additional 4 days. 
Scaffold/RPC composites were then cut into 500 × 300 μm segments and transplanted 
into the subretinal space of rhodopsin knockout mice. The results showed enhanced 
RPC survival (by 10-fold) as well as improved cell delivery (by 16-fold) compared 
with a single injection of cells. Redenti et al. [303] fabricated thin laminin-coated 
poly(ɛ-caprolactone) (PCL) films (6.00 ± 0.70 μm thick) of vertically aligned 
nanowires by casting PCL solution onto nanoporous aluminum oxide (AAO) 
membranes using a spin coater followed by incubation in mouse laminin in PBS for 
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12 h to enhance adhesion of RPCs.  The laminin coated-nanowire PCL films (1.0 × 
0.5 mm), seeded with RPCs for 7 days in cell culture were transplanted into the 
subretinal space of rhodopsin knockout mice. High numbers of RPCs were observed 
to have differentiated and migrated into the inner nuclear layer (INL) and ganglion 
cell layer (GCL) of host retinal tissue directly adjacent to the site of transplantation 
[303].  
In this chapter, mouse photoreceptor-derived (661W) cells were encapsulated in 
macroporous alginate fibres to investigate the potential for retina regeneration 
following AMD for example. 661W cells cloned from retinal tumours of a transgenic 
mouse line that expresses the simian virus (SV) 40 T antigen were shown to express 
photoreceptor-specific proteins such as cone blue opsin (SWS1), cone red or green 
opsin (L/MWS), transducin (GαT1), and cone arrestin (cArr) exhibited by cone 
photoreceptor cells [305]. Spindle-like processes displayed by 661W cells resemble 
neuronal cells. Cell viability in the fibre scaffolds was investigated by Calcein-AM 
staining and cell proliferation was monitored over 14 days in cell culture. The 
neuron-specific marker TUJ-1 was employed in combination with fluorescence 
microscopy to further identify morphological changes during cell development and 
proliferation. 
 
6.2 MATERIALS 
Sodium alginate (Protanal RF 6650, G:M 2:1) was obtained from IMCD Australia 
Limited. Calcium Chloride dihydrate (ReagentPlus®, ≥99.0%, C3881), Gelatin from 
porcine skin (Type A, Bloom 300, average molecular mass 50-100 kDa, G2500), 
Resazurin sodium salt (powder, BioReagent, suitable for cell culture, MW: 251.17, 
R7017-5G), Dimethyl sulphoxide (DMSO, anhydrous, ≥99.9%, 276855), Dulbecco‟s 
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phosphate-buffered saline (D-PBS; with MgCl2 and CaCl2, liquid, sterile filtered, 
suitable for cell culture, D8662) were purchased from Sigma-Aldrich Australia. Blue 
fluorescent Hoechst dye 33342 (cell permeable nucleic acid stain, H1399-100mg), 
Dulbecco's Modified Eagle Medium, Low Glucose (DMEM, containing 1 g/L 
D-Glucose, 11885-092), Calcein, AM (Special Packaging 20 × 50 µg, C3100MP), 
Penicillin-Streptomycin, Liquid (15140-122), Fungizone®  Antimycotic, Liquid 
(15290-018), 0.25% Trypsin (1X), phenol red (15050-065) and Hank's balanced salt 
solution (HBSS, Calcium, Magnesium, no Phenol Red, 14025-092) were purchased 
from Invitrogen Autralia. HyClone* Fetal Bovine Serum (GVD0074) was purchased 
from Thermo Scientific. Anti-β-Tubulin III (Anti-Tuj1) antibody produced in rabbit 
(T2200-200 μL), Formalin solution, neutral buffered, 10% (HT501128-4 L), Triton-X 
100 (BioXtra, T9284-100 mL) were purchased from Sigma-Aldrich Australia. Goat 
anti-rabbit IgG (H+L) Secondary Antibody, Alexa Fluor®  594 conjugate 
(A11012-500 μL), Goat Serum, New Zealand origin (16210-064-100 mL) were 
purchased from Invitrogen Australia. Photoreceptor-derived cell line (661W) was 
provided by Dr John Wood, Ophthalmic Research Laboratories, Institute of Medical 
and Veterinary Science, Adelaide, SA. 
 
6.3 METHODS 
6.3.1 661W cell growth on tissue culture plastic (TCP) 
661W cells growth medium was prepared using Dulbecco‟s modified Eagle medium 
(DMEM); containing 5mM glucose (440 mL), supplemented with 10% fetal bovine 
serum (FBS) (50 mL), 1% penicillin/ streptomycin solution (5 mL) and 1% fungizone 
(amphotericin B) (5 mL). The medium was stored at 4 
o
C until required.  
Aliquots (1 mL) of 661W cells at a seeding density 4.5 × 10
3 
cells/mL were added to 
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each well of 6-well plates. A further 1 mL of growth medium was added in each well 
and the cells were cultured for 4 h at 37 °C under a 5% CO2 atmosphere. The growth 
medium was replaced with fresh medium after 4 h and then every 3 days up to 14 
days. 
 
6.3.2 Encapsulation of 661W cells in non-macroporous alginate fibres  
Antiseptic techniques were strictly followed to prevent contamination. All instruments 
used (e.g. homogeniser, syringe pump) were sterilized by wiping the surfaces with 
70% ethanol. Glassware and tools were autoclaved. 661W cell suspension (1 × 10
5
 
cells/mL, 1 mL) was added to 3 mL of 2% w/v alginate solution to achieve a final cell 
concentration of 2.5 × 10
4
 cells/mL and alginate solution concentration of 1.5% w/v. 
Cells were mixed with the alginate solution by pipetting slowly up and down with a 
3-mL disposable plastic syringe. The suspended cell/alginate solution (0.5 ml) was 
wet spun into 50 mL of 0.5 M CaCl2 solution. The wet spun fibre was rinsed with 
D-PBS and then cut into 3 equivalent sections (5.5-cm length) that were each placed 
into a well of a 6-well plate. The cell loaded fibres were then cultured in 2 mL of 
culture medium (prepared as described in Section 6.3.1) for 4 h at 37 °C under a 5% 
CO2 atmosphere. The medium was replaced with fresh medium after 4 h and then 
every day during the first 3 days and every second day thereafter, up to 14 days. 
 
6.3.3 Encapsulation of 661W cells in macroporous alginate fibres  
Gelatin type A (Porcine, Bloom 300, Sigma) was sieved through a 90-µm mesh sieve. 
The powder was collected into a glass vial and sterilized by gamma irradiation at 1.25 
kiloGray (kGy) for 3.5 hours [306]. Sterilized gelatin particles (<90 µm, 200 mg) 
were added to cold (4 
o
C) filtered 2% w/v alginate solution (10 mL) followed by 
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homogenisation for 30 s using a homogeniser (IKA Ultra-Turrax®  T25 Basic) under 
the cell culture hood to produce suspensions with gelatin:alginate w/w ratios of 4:3 
(corresponding to 57% gelatin loading as a fraction of the total polymer content). 
661W cell suspensions (1 × 10
5
 cells/mL, 1 mL) were added to the suspension of 
gelatin particles in alginate solution (3 mL) to achieve a final cell concentration of 2.5 
× 10
4
 cells/mL and alginate solution concentration of 1.5% w/v. Cells were mixed in 
the gelatin particle/alginate solution by pipetting slowly up and down using a 3-mL 
disposable plastic syringe. The resulting suspension (0.5 mL) was wet spun into 50 
mL of 0.5 M CaCl2 solution. The wet spun fibre was rinsed with distilled water and 
cut into 3 equivalent sections (5.5-cm in length) that were each placed into separate 
wells of a 6-well plate. Cell-containing fibres were cultured in 2 mL of culture 
medium for 4 h at 37 °C under a 5% CO2 atmosphere. The medium was replaced with 
fresh medium after 4 h and then every day in the first 3 days then every second day 
thereafter, up to 14 days. 
 
6.3.4 Measurement of cell viability using the alamarBlue®  Assay  
Viable cells maintain a reducing environment within the cytoplasm. Alamar Blue 
reagent, resazurin dye (7-Hydroxy-3H-phenoxazin-3-one 10-oxide) is an oxidized 
form of redox indicator that is blue in colour and non-fluorescent. When incubated 
with viable cells, the reagent undergoes reduction of resazurin to resorufin by 
transferring electrons from NADPH+ H
+
 to resazurin. Post-reduction the blue 
resazurin colour changes into pink to highly red fluorescent resorufin which is 
consequently used as an oxidation-reduction indicator in cell viability and 
proliferation assays (Figure 6.2).  
Resazurin powder (1.76 g) was dissolved in Hank's balanced salt solution (HBSS) 
(Ca
+
/Mg
+
, 100 mL) followed by filtration using a 0.2 μm syringe filter to sterilize the 
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solution. Stock solution (70 mM) was divided into 1.5mL aliquots and stored at –20 
o
C. An aliquot of 70 mM stock resazurin was thawed and 20 μL was added to each 
well (containing samples in 2 mL culture medium) to produce a final concentration of 
700 μM. Samples were incubated with resazurin dye for 3 hrs at 37 oC in a 5% CO2 
atmosphere and analyzed using a spectrophotometer AD200C microplate reader 
(Beckman Coulter). The level of reduction was quantified by spectrophotometry as 
resazurin exhibits an absorption peak at 600 nm and resorufin at 570 nm wavelength. 
The detected absorption values of test samples at each wavelength were corrected by 
deduction of the absorption values obtained from blank culture medium. The % 
reduction of alamarBlue®  for each test sample was calculated using the following 
formula [307]. 
 
% Reduction of resazurin =  
(𝐸𝑜𝑥𝑖600 × 𝐴570) − (𝐸𝑜𝑥𝑖570 × 𝐴570)
(Ered570 × C600) − (Ered600 × C570)
  
 
 
 
Eoxi570
Eoxi600
A570
A600
Ered570
Ered600
C570
C600
: E of reduced alamarBlue at 600nm = 14652
: Absorbance of negative control well (media, alamarBlue Reagent, no cells) at 570nm
: Absorbance of negative control well (media, alamarBlue Reagent, no cells) at 600nm
: Molar extinction coefficient (E) of oxidized alamarBlue Reagent at 570nm = 80586
: E of oxidized alamarBlue Reagent at 600nm = 117216
: Absorbance of test wells at 570nm
: E of reduced alamarBlue at 570nm = 155677
: Absorbance of test wells at 600nm
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Figure 6.2 The reduction reaction of resazurin dye. 
 
6.3.5 Immunolabelling of 661W cells grown on TCP or encapsulated in alginate 
fibres using β-tubulin III antibody 
0.1% (v/v) Triton-X 100 buffer in D-PBS (DPBS-T 0.1%) was prepared by addition 
of 500 μL Triton-X 100 to D-PBS (499.5 mL). Blocking buffer, 5% Normal Goat 
Serum (NGS) in DPBS-T 0.1%, was prepared by addition of NGS (5 mL) to DPBS-T 
0.1% (95 mL). Preparation of 1% Normal Goat Serum for antibody dilution involved 
the addition of NGS (1 mL) to DPBS-T 0.1% (99 mL).  
Immunolabelling of 661W cell cultured in 2D on tissue culture plastic (TCP) and 
cultured in 3D in alginate fibres was performed using neuronal class III β-tubulin 
(TUJ-1) rabbit monoclonal antibody. Class III β-tubulin is a microtubule element 
expressed predominantly in neurons of the central and peripheral nervous system 
[307], and is a popular selective marker for neurons in nervous tissue. 
661W cells cultured on TCP and alginate fibres encapsulating 661W cells that had 
been cultured for 7 and 14 days were fixed by addition of 2 mL 10% neutral buffered 
formalin to each sample well of a 6-well plate for 20 minutes at room temperature. 
Samples were rinsed three times in D-PBS followed by addition of 0.1% Triton-X 100 
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buffer in D-PBS (2mL) to each well for 15 minutes then rinsed with D-PBS three 
times. This was followed by the addition of 2 mL 5% NGS in DPBS-T 0.1% for 15 
minutes and rinsed with D-PBS three times. Primary antibody solution (rabbit 
anti-β-tubulin III, 1.5 mL, dilution 1:200 in 1% NGS) was added to each sample and 
incubated at 4 °C overnight. The next day, the antibody solution was removed and 
samples were rinsed with blocking buffer (5% Normal Goat Serum in DPBS-T 0.1%) 
three times.  
Secondary antibody (goat anti-rabbit IgG (H+L), Alexa Fluor®  594 conjugate, 1.5 mL, 
dilution 1:500 in 1% NGS) was added to each well followed by incubation for 1 hour 
at room temperature in the dark. Post incubation, the secondary antibody solution was 
removed and samples were rinsed with D-PBS three times. D-PBS (1 mL) was added 
to each well prior to examination of samples using fluorescence microscopy (Nikon 
Eclipse TE2000-U). The instrument was equipped with CoolSNAPES camera and 
super high pressure mercury lamp (100 W). A standard filter set was utilised for 
image acquisition UV–2A (Alexa Fluor 594, Exc. 590 Emi 617). 
 
6.3.6 Fluorescent labelling of 661W cell nuclei  
Hoechst 33342 dye (2'-[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5'-bi-1H- 
benzimidazole trihydrochloride trihydrate) (Figure 6.3) is a cell-permeable DNA stain 
that is excited by ultraviolet light and emits blue fluorescence at 460-490 nm. Hoechst 
33342 dye binds preferentially to adenine-thymine (A-T) regions of DNA and exhibits 
fluorescence emission spectra that are dependent on dye:base pair ratios [308]. 
661W cells grown on TCP or encapsulated in alginate fibres were counterstained with 
Hoechst 33342 dye which was was prepared by making a dilution of 1:500 from the 
stock solution (10 μL added to 5 mL D-PBS). Samples were incubated for 15 minutes 
at room temperature in the dark following the addition of 1.5 mL dye solution to each 
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sample well. Post incubation, cells grown on TCP and cell-containing alginate fibres 
were rinsed with D-PBS 3 times prior to examination using a fluorescence microscope 
(Nikon Eclipse TE2000–U). The instrument was equipped with CoolSNAPES camera 
and super high pressure mercury lamp (100 W). A standard filter set was utilised for 
image acquisition G-2A (Hoechst 33342, Exc. 347, Emi. 483). 
 
 
Figure 6.3 Hoechst 33342 stain for nucleic acid [309].  
 
6.3.7 Assay of viability of 661W cells encapsulated in alginate fibres using 
Calcein-AM staining 
Calcein acetoxymethyl ester (Calcein-AM) is a cell-permeating dye that may be used 
to determine the viability of most eukaryotic cells. In live cells the non-fluorescent 
Calcein-AM is converted to green-fluorescent calcein after acetoxymethyl ester 
hydrolysis by intracellular esterases (Chapter 4, Figure 4.4). Calcein-AM stock 
solution in anhydrous DMSO (1 mg/mL, 1 µM) was prepared by adding 50 µL of 
anhydrous DMSO (≥99.9%) to 50 µg of Calcein-AM. The prepared stock solution 
was stored at −20 °C in the dark. A working solution was prepared by pipetting 10 µL 
of the stock solution into 9 mL of culture medium to achieve a concentration of 10 
nM and 1 mL was added to alginate fibre samples containing 661W cells 
(approximately 1-cm sections). Samples were incubated at 37 °C under a 5% CO2 
atmosphere for 45 min followed by examination using fluorescence microscopy 
(Nikon Eclipse TE2000–U). The instrument was equipped with CoolSNAPES camera 
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and super high pressure mercury lamp (100 W). A standard filter set was utilised for 
image acquisition comprising B-2A (Calcein-AM, Exc. 494, Emi. 517). 
 
6.4 RESULTS AND DISCUSSION 
The growth characteristics of mouse photoreceptor-derived cell line (661W) in 
conventional 2D culture on TCP over 6 days (initial seeding density 4.5 × 10
3 
cells/mL) are shown in Figure 6.4. 661W cells exhibited a rounded or ovular form at 
day 0 and transformed into a distinct flattened and spread morphology at day 3, 
characterised by spindle-like elongated central axes and cell contact via projected 
extensions (arrowed) [16]. Such extensions are anticipated to form connections with 
the bipolar, amacrine and horizontal cells in adjacent layers of the retina (Figure 6.1). 
The results of 661W cell immunolabelling with TUJ-1 and nuclear staining using 
Hoechst 33342 dye are shown in Figure 6.5. Positive staining with TUJ-1 provides a 
strong indication of the neuronal characteristics of the photoreceptor-derived cell line 
used in these studies and is consistent with the study reported by Wood et al. [310] 
showing 661W cells expressing the neuronal markers tau, β-III-tubulin, 
microtubule-associated protein (MAP)-1b, microtubule-associated protein 2 (MAP2), 
and PGP9.5. 
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Figure 6.4 Phase contrast microscopy images of 661W culture on TCP at Day 0 (A), 
Day 3 (B) and Day 6 (C) in cell culture. Cells were seeded on 6-well plates at a 
density of 4.5 × 10
3 
cells/mL. 
 
Figure 6.5 Fluorescence imaging of 661W cells cultured on TCP labelled with TUJ-1 
(A) Hoechst dye reveals nuclear DNA in blue (B) resulting composite image (C) at 
day 7 in culture. Cells were seeded on 6-well plates at a density of 4.5 × 10
3 
cells/mL. 
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Formalin fixed 661-W cells were permeabilized with 0.1% Triton X-100 in D-PBS for 
15 minutes at room temperature and blocked with 5% NGS + 0.1% Triton X-100 for 
15 minutes at room temperature. Cells were probed with primary antibody (TUJ-1) at 
1:200 dilution for 24 h at 4 ºC and with the secondary antibody (goat anti-rabbit IgG 
(H+L), Alexa Fluor®  594 conjugate) at 1:500 dilution for 1 h at room temperature. 
Nuclei (blue) were stained with Hoechst 33342 dye at 1:500 dilution for 15 minutes. 
 
Photoreceptor-derived cells (661W) were successfully encapsulated in macroporous 
alginate fibres by addition of cell suspension to a pre-homogenised suspension of 
gelatin particles in alginate solution, followed by wet spinning into CaCl2 solution. 
Cell encapsulated non-macroporous alginate fibres were produced by omitting the 
gelatin particles. Non-macroporous alginate fibres essentially entrapped 661W cells 
(Figure 6.6), in a hydrogel matrix and generally prevented cell growth and elongation 
to the spindle-like form, in contrast to 661W cells grown on TCP (Figures 6.4). Cells 
within the fibres retained the rounded form over 13 days in culture, similar to the 
behaviour of HDFa fibroblasts encapsulated in non-macroporous alginate fibres 
reported in Chapter 4 (Figure 4.13).  
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Figure 6.6 Differential interference contrast (DIC) images of 661W cells 
encapsulated in a non-macroporous alginate fibre at Day 0 (A), Day 6 (B), Day 10 (C) 
and Day 13 (D) in cell culture. Cell concentration of alginate spinning solution 2.5 × 
10
4
 cells/mL. 
 
661W cells encapsulated in alginate fibres that developed macroporosity on extraction 
of incorporated gelatin particles also showed restricted cell growth. Formation of 
macropores (approximately 100-250 µm) in a translucent hydrogel matrix due to 
extraction of incorporated gelatin particles is indicated by day 1. In contrast to 
non-macroporous fibres, more cell clusters were observed at day 10 in macroporous 
samples (Figure 6.7C) indicating that the macropores, surface modified by gelatin 
(discussed in Chapter 3, Section 3.4) promote cell adhesion and localised proliferation. 
Clusters of proliferating 661W cells within a macropore in a macroporous alginate 
fibre are revealed by TUJ-1 and Hoechst 33342 staining in Figure 6.8D, E and F.  
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Figure 6.7 Differential interference contrast (DIC) images of 661W cells 
encapsulated in a macroporous alginate fibre at Day 1 (A), Day 6 (B), Day 10 (C) and 
Day 13 (D) in cell culture. Cell concentration of alginate spinning solution 2.5 × 10
4
 
cells/mL. 
 
Non-macroporous and macroporous fibres both showed regions of elongated cell 
morphology at day 6 in culture (Figure 6.6B and 6.7B), which were initially thought 
to be single elongated cells similar to that observed with 3T3 fibroblasts encapsulated 
in alginate fibres (Chapter 4, Figure 4.8). However, counterstaining of cell nuclei with 
Hoechst 33342 dye revealed strings of proliferating cells within elongated pores or 
channels (Figure 6.8A, B and C).  
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Figure 6.8 Fluorescence imaging of 661W cells encapsulated in non-macroprous fibre 
labelled with TUJ-1 (A) Hoechst 33342 dye (B) superimposed image (C) and in 
macroporous fibre labelled with TUJ-1 (D) Hoechst dye (E) superimposed image (F). 
661W-containing macroporous alginate fibre produced by wet spinning 1.5% w/v 
alginate solution containing 661W cells (density 2.5 × 10
4
 cells/mL) and gelatin 
particles 57% (w/w) into 0.5 M CaCl2 solution. Non-macroporous fibres produced by 
omitting the gelatin particles. 
 
Positive staining of 661W cells with Calcein-AM in non-macroporous and 
macroporous alginate fibres (Figure 6.9) showed that cell viability was maintained for 
14 days in culture medium, highlighting the known capacity of alginate hydrogel 
matrices for permitting efficient transfer of nutrients and oxygen to encapsulated cells. 
Clustering of proliferating cells within macropores in both fibre types was observed. 
However there was no evidence of cell elongation to the spindle shape with formation 
of projections or extensions in contrast to the cells cultured on TCP (arrowed in 
Figure 6.4), indicating that a system of interconnected pores and channels suitable for 
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cell elongation had not been formed at 14 days in cell culture. Breakdown of the 
alginate hydrogel matrix would seem to be required to permit development of 
encapsulated photoreceptor cells. However it is interesting to note that extensive 
neurite outgrowth was observed for DRGs in macroporous fibres (Chapter 5, Section 
5.4, Figure 5.6), highlighting the different response of cells to scaffold structure 
depending on cell type. 
 
 
Figure 6.9 Live/dead staining assay using Calcein-AM of 661W cells encapsulated in 
non-macroporous alginate fibre (A) and macroporous alginate fibre (B) at day 14 in 
culture. 661W-containing macroporous alginate fibre produced by spinning alginate 
solution (1.5% w/v) containing 661W cells (density 2.5 × 10
4
 cells/mL) and gelatin 
particles (57% w/w) into 0.5 M CaCl2 solution. Gelatin particles omitted for 
production of 661W-containing non-macroporous fibres. 
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At day 1 in cell culture the reduction (%) of resazurin to resorufin by mitochondria 
(thus providing a measure of cell number) for (i) cells cultured on TCP (ii) cells 
encapsulated in non-macroporous fibre and (iii) cells encapsulated in macroporous 
fibre was 0.7 ± 0.3%, 1.7 ± 0.6% and 0.3 ± 0.5% respectively. The initial cell seeding 
density on TCP (1 mL per well) was 4.5 × 10
3
 cells. The cell density in the fibre 
spinning solution was 2.5 × 10
4
 cells/mL and 0.5 mL (containing 1.3 × 10
4
 cells) was 
wet spun into CaCl2 solution to produce a fibre length of approximately 16.5 cm of 
fibre. Assuming no loss of cells during fibre spinning, the estimated number of cells 
per 5.5-cm sample used for cell culture equates to 4 × 10
3
 cells. Thus the cell numbers 
cultured on TCP and encapsulated within the alginate fibre samples should be 
comparable. The differences in resazurin reduction at day 1 suggest that the cell 
numbers in the macroporous fibre are lower than in the non-macroporous fibres and 
compared with cell culture on TCP.  
The increased level of resazurin reduction measured for 661W cells on day 14 in 
macroporous alginate fibres (16.8 ± 2.9%) compared with non-macroporous (8.8 ± 
0.5%) fibre samples (Figure 6.10) indicates significantly higher cell proliferation 
(*P<0.05) in the former samples. The inclusion of gelatin particles in the fibre as 
porogens followed by rapid protein extraction during the first day of cell culture was 
designed to increase the macroporosity of the fibres and facilitate cell growth. 
However, the low particle content of the fibres resulting in large inter-particle 
separation and low macroporosity of the fibres (around 14%) precludes the formation 
of interconnections between macropores due to initial particle-particle contact. Thus 
extensive cell growth throughout the fibre would not be expected. However, 
clustering of proliferating cells within macropores was evident (Figures 6.7, 6.8, 6.9) 
and probably explains the higher cell proliferation in macroporous fibres. The protein 
residues which were observed to line the macropore surfaces or pore cavities (Chapter 
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3, Figure 3.12B) are also expected to provide a cell adhesion property and enhance the 
attachment of encapsulated 661W cells to the alginate hydrogel matrix. It should be 
noted that the cell numbers in non-macroporous and macroporous fibres may be 
different and the above explanation may be invalid. The differences in % resazurin 
reduction at day 1 indicate that the cell numbers in the macroporous fibre are lower 
than in the non-macroporous fibres, suggesting cell loss during fibre spinning. Further 
work is required, therefore, to determine 661W cell numbers within the fibres (e.g. by 
cell extraction and counting or quantification of DNA or CLSM analysis of image 
stacks (Chapter 4, Figure 4.5) in order to clarify this issue.  
 
 
 
Figure 6.10 Resazurin assay of 661W cell proliferation in culture on TCP (cells were 
seeded on 6-well plates at a density of 4.5 × 10
3 
cells/mL) (i) encapsulated in 
non-macroporous alginate fibre (ii) and encapsulated in macroporous alginate fibre 
(iii) (cell concentration of spinning solution 2.5 × 10
4
 cells/mL). (Mean ± SEM, One 
way ANOVA *P<0.05, n = 6).  
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6.5 CONCLUSIONS 
Mouse photoreceptor-derived (661W) cells were successfully encapsulated within 
macroporous alginate fibres using a technique based on wet spinning a suspension of 
cells and gelatin particle porogens in alginate solution. Cell-containing 
non-macroporous fibres were produced by wet spinning cell suspensions in alginate 
solution. Encapsulated 661W cells remained viable for 14 days in cell culture. 
Significantly higher cell proliferation was measured in macroporous fibres compared 
with non-macroporous fibres due to the formation of cell clusters within macropores, 
probably surface modified by gelatin residues. Formation of cell 
extensions/projections was extensive in 2D culture on TCP but was restricted in 3D 
culture within the fibres, indicating that a suitable pore/channel structure for 
photoreceptor cell development was not created within the alginate hydrogel at 14 
days in cell culture.    
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CHAPTER 7 
Overall Conclusions and Future Work 
The overall aim of the research presented in this thesis was to develop an advanced 
nerve substitute based on tissue engineering principles by encapsulating nerve cells in 
an alginate hydrogel fibre scaffold. The production techniques established during the 
project could be widely applied in soft tissue engineering, for example for 
encapsulating genetically modified, growth factor-secreting cells. The research is also 
expected to provide strategies for developing “model” nerves for studying the causes 
and determinants of disease progression (e.g. multiple sclerosis) and for screening 
new drugs.  
 
Alginate fibres were successfully produced by wet spinning and modified by gelatin 
by a) protein adsorption b) wet spinning into gelatin/CaCl2 solution c) wet spinning 
from a mixed alginate/gelatin solution and d) suspending gelatin particles in the 
alginate spinning solution (Chapter 2). The first three approaches were intended to 
improve nerve cell adhesion to the alginate scaffold since polysaccharides inherently 
exhibit poor cell adhesion properties. Gelatin modification of hydrated and dried 
alginate fibres by adsorption from gelatin solution resulted in retention of 50% and 
90% respectively of the protein content after incubation in distilled water at 37 
o
C for 
3–4 days, indicating the potential for provision of a cell-adhesive surface. Alginate 
fibres incorporating gelatin particles as porogens up to a loading of 24% w/w were 
successfully produced by wet spinning suspensions of gelatin particles in alginate 
solution. Around 45–60% of the gelatin content of hydrated fibres was released in 1 
h in distilled water at 37 
o
C, suggesting that a macroporous structure, potentially 
advantageous for nerve cell growth, would be rapidly established in cell culture. 
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Furthermore the residual gelatin was expected to form a favourable surface for nerve 
cell adhesion and axonal extension. 
 
Macroporous alginate fibres for application in nerve tissue engineering were produced 
by wet spinning suspensions of gelatin particles in alginate solution followed by 
extraction of gelatin (Chapter 3). CLSM image analysis exploited the 
autofluorescence properties of alginate and gelatin to provide detailed 3D 
reconstructions of the pore structure, macropore dimensions, pore size distribution, 
porosity and pore connectivity for correlation with fibre spinning conditions and 
subsequent cell ingrowth behaviour. A maximum macroporosity of 14.6% was 
obtained following particle extraction from 21% w/w gelatin-loaded alginate fibres. 
Importantly, CLSM revealed modification of the macropore surface by gelatin, which 
is expected to be advantageous for nerve cell adhesion and axonal extension.  
Further work is recommended to investigate the influence of gelatin particle size and 
concentration on fibre macroporosity with the aim of optimising the pore structure 
and connectivity for neurite outgrowth and axonal development. Further study is also 
required to correlate pore interconnectivity with fibre spinning conditions and neurite 
extension. The image analysis method described in this chapter for measuring pore 
connectivity provides a useful basis for this study. However, future work would be 
suggested to validate the developed pore analysis method with the conventional 
technique such as Brunauer–Emmett–Teller (BET) surface area analysis.  
   
Cell-containing alginate fibres were produced by wet spinning cell suspensions in 
alginate solution into CaCl2 crosslinking solution as a precursor to investigations 
using nerve cells (Chapter 4). Swiss 3T3 mouse fibroblasts remained viable within 
non-macroporous fibres over 8 weeks in cell culture but cell elongation and cell-cell 
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contact was largely prevented. These findings recommend future work on 
encapsulation of genetically engineered cells within alginate fibres to secrete growth 
factors or hormones. The creation of macropores in alginate fibres by extraction of 
gelatin particles facilitated fibroblast elongation and cell-cell contact. On day 12 in 
cell culture, the density of adult human dermal fibroblasts in macroporous alginate 
fibres (3.6 × 10
2
 cells/mm
3
) was significantly higher than non-macroporous fibres (1.4 
× 10
2
 cells/mm
3
) demonstrating that the macropores, probably surface modified by 
residual gelatin, enhance cell proliferation. 
Controlled biodegradation of the alginate fibre could be investigated in future work to 
increase cell proliferation. Cell density influences cell–cell signalling and 
subsequently cell function including for differentiation and cell survival. Hence it is 
important to determine the optimal cell seeding density in the fibre for the cell type of 
interest in future studies. Moreover, quantification of dead cells could be carried out 
by Calcein-AM staining in combination with Ethidium Homodimer-1 (ETHD-1) in 
future work to differentiate between cell proliferation and viability. 
 
Rat dorsal root ganglion (DRG) cells were encapsulated in macroporous alginate 
fibres for applications in nerve regeneration by wet spinning alginate solution 
containing a suspension of DRGs and gelatin particles (Chapter 5). At day 5 in cell 
culture neurite outgrowth and branching was observed over a distance of around 40 
µm. By day 9 cell–cell contact was evident, and at day 11 extensive neurite spreading 
was confirmed, indicating formation of a favourable connected pore and channel 
structure within the alginate hydrogel. These findings indicate that macroporous 
alginate fibres encapsulating nerve cells may provide a useful strategy for nerve repair 
but observations suggest that nerve cell density within the alginate fibres should be 
increased by a factor of at least two to increase the probability of neurite contact.  
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Photoreceptor-derived (661W) cells were successfully encapsulated within 
macroporous alginate fibres by wet spinning a suspension of cells plus gelatin particle 
porogens in alginate solution to investigate their potential as tissue engineering 
scaffolds for retinal repair (Chapter 6). Significantly higher cell proliferation was 
evident within macroporous fibres at day 14 in cell culture compared with 
non-macroporous fibres. Cell flattening and elongation with formation of cell 
extensions/projections was extensive in 2D culture on tissue culture plastic but was 
not observed in 3D culture within the fibres, indicating that a suitable pore/channel 
structure for photoreceptor cell development was not created within the alginate 
hydrogel at 14 days in cell culture. Future work is recommended to produce alginate 
fibres with a transverse pore structure and addition of neurotrophin that permits 
photoreceptor cell development and contact with adjacent bipolar, amacrine and 
horizontal neurons in the retina.  
 
Future work is recommended to develop an advanced biomimetic nerve substitute 
based on alginate hydrogel fibres.  
Incorporation of both neurons and glia in the fibres during fibre spinning is suggested 
such that they develop in close association (as in the natural axon growth 
cone/Schwann cell interaction) prior to insertion in the injury site (e.g. rat sciatic 
nerve model). A major advantage is that sustained cell viability within the fibre guide 
would avoid the need for nerve cell migration into and along the guide from damaged 
nerve ends following implantation. In the event of cell death within the nerve guide a 
repair process is expected to be triggered, similar to the response to transplanted 
autografts which lose viability. 
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Applying a layer of collagen to the outer surface of an alginate fibre nerve guide is 
suggested to model the epineurium. The epineurium (connective tissue cell layer 
comprising fibrocollagenous tissue formed from epineural cells) constitutes the 
outermost layer of peripheral nerves and provides structural support and protection to 
nerve fascicles. The applied collagen coating on the alginate fibres is designed to be 
remodelled by myofibroblast action in culture pre-implantation or in vivo and 
replaced by ECM.  
Investigation of the effect of growth factors (e.g. NGF, glial-derived neurotrophic 
factor (GDNF)) on nerve cell development within alginate fibres is recommended by 
addition of growth factor to the cell-alginate spinning solution or prior encapsulation 
within the gelatin porogens.  
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